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This chapter highlights the dynamic relationship between mammalian hosts and 
bacterial pathogens. Under mutual influence, hosts and pathogens modify their 
activities and functions during evolution. The consequence of an infection on the host 
organism relies mainly on the effectiveness of host defense systems. Successful 
pathogens have evolved a variety of unique strategies to circumvent this and 
breakdown or evade the host immunity at different stages. The virulence factors of 
pathogens are tailored to facilitate their entry, replication, and persistence by 
modulating host cellular processes. 
1.1 Host defense mechanisms  
Host defense lines against bacterial infection include natural barriers as well as 
nonspecific and specific immune responses. Natural barriers such as the skin, mucous 
membranes, and the respiratory tract develop the physical obstruction to bar the 
invading microorganisms. Once these barriers are overcome, a complex combination 
of the innate and adaptive immune systems provides a potent protection of the host 
against infectious pathogens. Generally, bacterial invasion triggers a couple of 
immune responses comprised of innate and adaptive components. When the immune 
surveillance detects foreign agents in the host, the inflammatory and phagocytic 
responses are immediately activated. Subsequently, specific immune responses are 
soon encountered responsible for elimination of pathogens and generation of host 
immunological memory.  
1.1.1 Host innate immunity 
The innate immune response constitutes the first line of defense to combat microbial 
infections or tissue damage. The innate leukocytes comprise natural killer (NK) cells, 
mast cells, eosinophils, and basophils; the phagocytic cells include macrophages, 
neutrophils, and dendritic cells (DCs). Upon pathogen invasion, the rapid 
inflammatory response can direct various immune cells to the infection sites. Guided 
by chemotaxis, phagocytes are drawn to pathogens and engulf them to limit the 
microbial spread. In phagocytes, phagocytic lysosomal contents are released to 
destroy pathogens [2]. To initiate the action of innate immunity, early recognition of 
the pathogen-associated molecular patterns (PAMPs) and damage-associated 
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molecular patterns (DAMPs) plays an essential role through a limited number of 
germline-encoded pattern recognition receptors (PRRs). PAMPs contain various 
components of bacterial cell wall (e.g., lipopolysaccharide (LPS), peptidoglycan (PG), 
and lipopeptides), flagellin, bacterial DNA and viral double-stranded RNA. DAMPs 
include intracellular proteins (e.g., heat shock proteins) and proteins derived from the 
extracellular matrix (e.g., hyaluronan fragments). Furthermore, four families of PRRs 
have been classified including transmembrane proteins, e.g., the Toll-like receptors 
(TLRs) and C-type lectin receptors (CLRs), and cytoplasmic proteins, e.g., the 
Retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) and NOD-like receptors 
(NLRs) [1]. PRR-induced signal transduction pathways result in synthesis of various 
molecules including cytokines, chemokines, cell adhesion molecules, and 
immunoreceptors. These PRRs are not only present on DCs and macrophages, but 
also on several non-immune cell types (e.g., epithelial cells, endothelial cells, and 
fibroblasts), which regulate receptor-mediated inflammation [2].  
Among PRRs, the family of TLRs is the most extensively studied. Based on 
homology to the Drosophila Toll protein, TLRs are evolutionarily conserved with an 
extracellular domain containing leucine-rich-repeat (LRR) motifs and a cytoplasmic 
domain homologous to the interleukin (IL)-1 receptor, termed the Toll/IL-1R 
homology (TIR) domain [3, 4]. TLRs play a pivotal role in cell activation in response 
to PAMPs. Based on related PAMPs, TLRs can be further divided into several 
subfamilies: the subfamilies of TLR1, TLR2, and TLR6 on the cell surface recognize 
lipopeptides, whereas TLR3, TLR7, TLR8, and TLR9, which are found exclusively in 
intracellular compartments, recognize nucleic acids. Furthermore, TLR4 and TLR5 
recognize bacterial LPS and flagellin from flagellated bacteria, respectively. Upon 
engagement with ligands, TLRs first recruit the adaptor proteins via the cytoplasmic 
TIR domain. They bind myeloid differentiation primary-response protein 88 (MyD88), 
MYD88-adaptor-like protein (Mal; also known as TIRAP), TIR domain-containing 
adaptor inducing IFN-β (TRIF; also known as TICAM-1), and TRIF-related adaptor 
molecule (TRAM) [5]. Based on the usage of the different adaptor proteins, each TLR 
induces unique signaling cascades. A detailed overview of TLR signal transduction is 
shown in Figure 1 [6].  
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The MyD88-dependent pathway is commonly shared by all TLR signaling pathways, 
with the exception of TLR3-mediated responses. For instance, TLR2 and TLR4 
signaling require the adaptor Mal as the bridge linking to MyD88. Subsequently, 
MyD88 interacts with IL-1R-associated kinase (IRAK)-4 to activate other IRAK 
family members, IRAK-1 and IRAK-2. Upon activation, the IRAKs dissociate from 
MyD88 and interact with TNFR-associated factor 6 (TRAF6). Together with an E2 
ubiquitin-conjugating enzyme, the complex catalyzes the synthesis of a lysine 63 
(K63)-linked polyubiquitin chain on TRAF6. TRAF6-medicated K63-linked 
polyubiquitination promotes TGF-β-activated kinase 1 (TAK1) activation. In turn, 
Figure 1. Mammalian TLR signaling pathways. TLR5, TLR11, TLR4, and the heterodimers of 
TLR2-TLR1 or TLR2-TLR6 bind to their respective ligands at the cell surface, whereas TLR3, 
TLR7-TLR8, TLR9, and TLR13 localize to endosomes, where they sense microbial and 
host-derived nucleic acids. TLR4 localizes at both the plasma membrane and the endosomes. TLR 
signaling is initiated by ligand induced dimerization of receptors. Following this, the TIR domains 
of TLRs engage TIR domain-containing adaptor proteins (either MYD88 and MAL, or TRIF and 
TRAM). Engagement of the adaptors stimulates downstream signaling pathways that involve 
interactions between IRAKs and the TRAFs. Followed by the activation of MAPKs, JNK and p38, 
this leads to the activation of transcription factors, such as NF-κB, IRFs, CREB and AP1 [6]. 
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TAK1 activates in the nuclear factor κB (NF-κB) pathway the IKK complex 
composed of IKK-α, IKK-β, and NF-κB essential modulator (NEMO). Subsequently, 
the IKK complex phosphorylates the NF-κB inhibitory protein IκBα, which is then 
degraded and leads to the release of NF-κB into the nucleus. Other than for the 
activation of the NF-κB pathway, TAK1 phosphorylates MKK6 in the mitogen 
activated protein kinase (MAPK) signaling. The activation of the MAP kinase cascade 
results in the formation of the transcription factor complex AP-1. Ultimately, both 
NF-κB and AP-1 complexes transcriptionally upregulate pro-inflammatory cytokines 
such as IL-1, IL-12, and tumor necrosis factor alpha (TNF-α) [7]. In addition to 
NF-κB-regulated cytokine expression, TLR7 and TLR9 are responsible for the 
production of type I Interferons (IFNs). TLR7 and TLR9 recognize viral 
single-stranded RNA and unmethylated cytosine-phosphate-guanine (CpG)-DNA, 
respectively. In a MyD88-dependent manner, the formation of a complex with IRAKs, 
TRAF6, TRAF3, IKK-α, and interferon regulatory factor 7 (IRF-7) is triggered. In the 
following, phosphorylated IRF7 translocates to the nucleus and subsequently activates 
the expression of type I IFNs for a potent antiviral defense in DCs [8, 9]. 
While TLR4 is internalized at cytoplasmic membrane and is trafficked to endosomes, 
its downstream signaling is switched from the MyD88-dependent to the 
TRIF-dependent pathway and requires TRAM as adaptor. Similarly, TLR3 triggers 
interferon-mediated antiviral defense through the adaptor TRIF instead of MyD88. 
TRIF in turn interacts with RIP1 and RIP3 (receptor interacting protein 1 and 3) 
through its C-terminal RIP homotypic interaction motif (RHIM). The N-terminal 
TRIF contains TRAF-binding motifs, which associate with TRAF3 and TRAF6. It 
was shown that TRAF3 promotes the activation of two IKK-related kinases, 
TANK-binding kinase 1 (TBK1) and IKK-i (also known as IKK-ε). Upon activation, 
TBK1 and IKK-i phosphorylate the transcription factor IRF3, which can induce 
IFN-β expression [10]. Furthermore, the TNFR1-associated death domain protein 
(TRADD) is critical in TRIF-dependent signaling. TRADD can form a complex with 
FAS-associated death domain-containing protein (FADD) and RIP1. On one hand, 
TRADD mediates the attachment of K63-polyubiquitin chains on RIP1, which is 
sufficient to activate the NF-κB pathway directly [11]. On the other hand, 
NF-κB-dependent inflammatory responses are indirectly also triggered by the 
activation of caspase-8 and caspase-10 through FADD [12].  
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1.1.2 Host adaptive immunity 
During the presentation of bacterial antigens to the immune system, the adaptive 
immunity is developed. It is composed of antibody-mediated immunity (AMI) and 
cell-mediated immunity (CMI) which are carried out by B cells and T cells, 
respectively (Fig. 2) [13]. In AMI, activation of B cells results in expanding two types 
of daughter cells, plasma cells and memory B cells. The plasma cells produce a 
variety of specific antibodies (Abs), known as immunoglobulins (Ig), which are 
secreted to circulate in the blood stream and the lymphatic system. The classical 
functions of Abs include the neutralization of toxins and viral particles by directly 
blocking their access to host receptors. Moreover, Abs facilitate microbial clearance. 
They bind as so-called “opsonins” to foreign components and label them for clearance. 
Such antibody-ligand complexes are recognized and neutralized by immune cells, 
which bind the antibodies through the interaction with specific Fcγ receptors (FcγRs) 
and complement receptors (CRs). The most potent opsonins is IgG, which is bound to 
FcγRI (CD64) on the surface of macrophages and neutrophils, thereby promoting 
phagocytosis. The alternative complement system utilizes immune complexes formed 
by IgG or IgM with antigens to clear complement-coated pathogens via osmotic lysis 
[14]. Furthermore, antibody-dependent cellular cytotoxicity (ADCC) occurs when 
immunoglobulin G (IgG) simultaneously engages the antigens on the target cells and 
FcγRIII (CD16) on natural killer (NK) cells. During this process, activated NK cells 
synthesize cytokines such as IFN-γ and mediate the killing of target cells [15]. In 
addition, it has been shown that eosinophils also use ADCC to kill IgE-coated 
parasitic worms known as helminths [16].  
CMI is the major defensive response against intracellular bacteria. First, foreign 
antigens are detected by antigen-presenting cells (APCs), such as DCs and 
macrophages. Upon the activation of APCs, fragments of the antigen are displayed 
with the major histocompatibility complex (MHC) at the surface of APCs to initiate 
the T cell-mediated responses. Two types of T cells play pivotal roles in CMI: CD4
+
 
helper T cells (Th) and CD8
+
 cytotoxic T cells (CTL). In a classical model, the CD4
+
 
helper T cell responses are subdivided into type 1 Th (Th1) and type 2 Th (Th2) 
immunities. Generally, Th1 cells regulated by the transcription factor Tbet produce 
distinct cytokines, particularly IFN-γ. Th1-dominant responses predominantly support 
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phagocytic cells to attack the intracellular pathogens and develop the delayed-type 
hypersensitivity (DTH) skin in response to viral or bacterial antigens. By contrast, 
Th2 cells regulated by the transcription factor GATA3 are heavily reliant on IL-4 to 
trigger the humoral immunity and eosinophil activation to eliminate extracellular 
organisms. Th1 and Th2 responses are considered mutually exclusive due to specific 
cytokines secreted in the microenvironment [17]. However, both are inhibited by a 
heterogeneous family of T cells, known as adaptive T regulatory (Treg) cells. Treg 
cells are devoted to suppressing immune responses by producing anti-inflammatory 
cytokines such as transforming growth factor-β (TGF-β) and IL-10 [18, 19]. Recently, 
beyond the Th1 and Th2 cells, a distinct subset of CD4+ T cells has been discovered 
and named as Th17 cells. Initially, the function of Th17 cells appears to be the 
clearance against bacteria and fungi. Other than that, increasing evidence suggests 
that Th17 cells are potent inducers of tissue inflammation in association with 
autoimmune diseases, such as multiple sclerosis, rheumatoid arthritis, and Crohn's 
disease [20].  
 
 
Figure 2. Function of dendritic cells in the immune response. Following the uptake of foreign 
antigens, dendritic cells migrate to lymphoid tissue to prime naïve CD4
+
 T cells and CD8
+
 T cells. 
In addition, activated DCs produce a range of cytokines, such as IFNα, IL-12, and IL-15, which in 
turn activate NK cells. Depending on the cytokine signal, CD4
+
 T cells differentiate into Th1 or 
Th2 cells (dashed arrows). Th1 cell-mediated IFNγ secretion stimulates the activation of CTLs and 
the production of antibodies by B cells. Th2 cell-mediated cytokine production simulates antibody 
production by B cells but inhibits activation of Th1 cells [13]. 
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In addition to the CD4
+
 effector cell response, CD8
+
 CTLs eliminate the intracellular 
microbes by recognizing foreign peptides presented by MHC class I complex on the 
surface of infected target cells which have to be eliminated. The pro-apoptosic 
function of CTLs is based on the cytotoxic proteins: perforin and granzymes. The 
main function of perforin is to facilitate delivery of the granzymes into target cells by 
forming pores in the target cell membrane. Upon release into the cytoplasm, the 
granzymes cleave various substrates, including caspases, to initiate apoptosis. 
However, CTLs can kill target cells also in a granule-independent mechanism through 
a unique membrane receptor-ligation complex. The Fas ligand of CD8
+
 and of some 
CD4
+
 T cells is able to induce apoptosis when it binds to Fas of the target cells. 
Besides the direct cell killing, IFN-γ secreted by CTLs synergistically contributes to 
the inhibition of viral replication and activation of macrophages for host defense [21]. 
1.1.3 Dendritic cells   
The immune response to bacterial infection is based on a combination of both innate 
and adaptive immunity. As known, DCs are the most effective APCs specialized in the 
cross talk between innate and adaptive immune responses. Although DCs are a 
heterogeneous group of cells, they share several common features. All DCs originate 
from CD34 bone marrow stem cells. Through the blood stream, precursor DCs are 
strategically seeded to peripheral sites such as the lung, skin, or gut for antigen 
acquisition. Upon sensing of foreign antigens, phagocytic DCs mature and are 
transformed into efficient APCs which are able to activate T cell responses and initiate 
the adaptive immunity. Contrary to macrophages and neutrophils mediating the direct 
clearance of pathogens, the endocytic proteolysis of pathogens in DCs is aimed to 
produce antigenic peptides loaded onto MHC I and MHC II molecules and are 
presented on the DC surface to enhance the immune reaction. Moreover, DCs 
activated by pathogen encounter upregulate and display a variety of co-stimulatory 
molecules (e.g., CD40, CD80, and CD86) which bind to the complementary 
molecules on T cells (e.g., CD40L, CTLA-4, and CD28). In their maturation process, 
DCs have undergone cytoskeletal arrangements upregulate the expression of 
chemokine receptors (e.g., CCR7 and CXCR4) and adhesion molecules, which makes 
them ready for migration through the lymph to secondary lymphoid organs [22]. In 
the T cell zone of secondary lymphoid organs, antigen-presenting DCs deliver the 
  GENERAL INTRODUCTION  
- 9 - 
 
activating signals to naïve T cells through the engagement of pathogen-derived 
peptides and co-stimulatory molecules. Simultaneously, cytokines (e.g., IL-12) 
secreted by maturated DCs also condition the Th1 immunity and/or CTL development. 
All signals appear to be required for full effector T cell generation (Fig. 3) [23-25]. 
Despite the function of DCs majorly as mediator between a pathogen assault and the 
cellular immune response, DCs are more than a simple "on/off" switch of the immune 
response. The developmental stages of DCs are critical for influencing the character 
of T cell differentiation. In the steady state, the secondary lymphoid organs contain 
mainly immature DCs that maintain T cell anergy. Furthermore, Naïve T cells can also 
be driven into a regulatory cell fate characteristic for tolerance. Under this condition, 
DCs reach a stage of semi-maturation where they express high levels of MHC II and 
co-stimulatory molecules, but the pro-inflammatory cytokine production is low or 
absent [26, 27].  
 
 
1.2 Bacterial defense against host immune responses 
Central components of innate and adaptive immune responses to counter infectious 
agents are the phagocytes. Phagocytic cells are able to internalize pathogens for 
clearance and recruit additional immune cells to amplify host immune responses. 
Figure 3. Three dendritic cell-derived signals required for T cell stimulation. Signal 1 is the 
antigen-specific signal mediated through T cell receptor (TCR) triggering by MHC II-associated 
peptides. Signal 2 is the co-stimulatory signal, mainly mediated by ligation of CD28 with CD80 
and CD86. Signal 3 is the polarizing signal that is regulated by various soluble or membrane-bound 
factors, such as IL-12 and CCL2, which promote the development of Th1 or Th2 cells, respectively 
[24]. 
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However, bacteria evolve rapidly in relation to their host. Consequently, pathogenic 
bacteria have developed a range of strategies to overcome host immunological 
defenses, which contribute to the virulence of the microbe and the pathology of the 
disease. In the following paragraphs, various molecular mechanisms used by bacteria 
to subvert the functions of phagocytes in order to hide from the host immune system 
will be discussed. 
1.2.1 Avoidance of phagocytosis 
Phagocytosis constituting the first line of host defense provides an efficient way for 
the removal and destruction of microbial pathogens. Unlike intracellular bacteria that 
develop sophisticated strategies to survive within phagocytic cells, other bacteria have 
evolved mechanisms to prevent phagocytosis, thereby impairing the development of 
cellular immunity and enhancing the extracellular survival. The first step of 
phagocytosis is the receptor-mediated recognition, classified into opsonin-dependent 
(e.g., FcγRs and CRs) or opsonin-independent (e.g., mannose receptors, type A 
scavenger receptors, and integrins) mechanisms [28]. To counter their recognition, 
surface antigenic variation is one of the most common strategies of bacteria. For 
example, Neisseria spp. alters the antigenicity of several surface molecules, including 
pilus components, to avoid FcγR-mediated phagocytosis. Other bacteria (e.g., 
Streptococcus pneumoniae, Escherichia coli (E. coli) K1, Klebsiella pneumoniae, 
Neisseria meningitidis and Staphylococcus aureus) create capsules of surface 
polysaccharides to physically prevent the complement deposition in the opsonization 
process [29-33]. In the case of Streptococcus pyogenes, its M proteins are not only 
major virulence and antigenic determinants, but play themselves a major and so far 
controversial role in resistance to phagocytosis [34]. Similarly, YadA adhesin of 
Yersinia enterocolitica binds plasma proteins (e.g., factor H) to interfere with 
complement-mediated opsonization [35].  
Other than surface molecule variation, pathogenic bacteria harbor antiphagocytic 
properties in their effector proteins that they deliver through secretion systems at the 
site of bacterial direct contact. The protein tyrosine phosphatase (PTP) YopH of Y. 
enterocolitica was first effector described with an antiphagocytic function. It 
dephosphorylates host signaling proteins which are activated by the engagement of 
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surficial receptors [36]. Another Yersinia effector YopE mimicking a eukaryotic 
GTPase activating protein prevents actin polymerization and phagocytosis by 
inactivating small GTPases [37]. Similarly as YopE, two toxins of Pseudomonas 
aeruginosa, ExoS and ExoT, disrupt the internalization by targeting the GTPase 
family [39, 40]. YopT, a cysteine protease, exerts an influence on actin filaments, 
which results in excessive depolymerization and suggests for YopT a role in 
antiphagocytosis [38]. A mechanism neither targeting small GTPases nor actin directly, 
is used by the extracellular pathogen enteropathogenic E. coli (EPEC), which shows 
neutralization of phagocytic activity via inhibition of the PI3K-dependent phagocytic 
signals through its T3SS-dependent effectors [41]. 
1.2.2 Prevention of intracellular pathogen degradation 
Various bacteria reside in an assortment of organelles: early endosomes 
(Mycobacterium tuberculosis), late endosomes (Salmonella typhimurium), lysosomes 
(Coxiella burnetii), and rough endoplasmic reticulum (Legionella pneumophila) [42, 
43]. For intracellular bacteria to survive within phagocytes, they have to divert 
themselves from fatal delivery to the lysosome. To escape from the phagosome, 
Shigella is released into the cytosol via Ipa-mediated lysis of the endocytic structure 
surrounding it. Listeria monocytogenes and some Rickettsia species secrete lysins to 
effectively perforate the vacuolar membrane. The common strategy of intracellular 
bacteria to escape their degradation in a lysosomal compartment is the blockage of 
phagosome-lysosome fusion, although it is not well understand how these pathogens 
alter the involved vesicle transport to their benefit. M. tuberculosis persists in 
macrophages and arrests the phagosomal maturation. To achieve this, a 
bacteria-containing phagosome recruits early phagosomal proteins such as coronin-1 
but excludes the vesicular proton ATPase from the phagosomal membrane, which 
results in a failure of organelle acidification and helps maintain an intraphagosomal 
environment permissive for pathogen survival [44, 45]. Similarly, VacA of 
Helicobacter pylori disrupts the process of phagosome maturation by the recruitment 
and retention of coronin-1. Besides that, VacA supports the formation of large 
vesicular compartments called megasomes for H. pylori persistence in macrophages 
[46]. Likewise, many other bacterial factors are described to support the exploitation 
and modification of endocytic compartments to the benefit of the pathogen. For 
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example, the RalF protein of L. pneumophila is delivered through the Dot/ICM type 
IV secretion system to the host cytoplasm where it functions as a GTPase exchange 
factor to recruit ARF1 to bacteria-containing phagosomes for creation of a replicative 
organelle [47]. Whereas in L. pneumophila the T4SS plays a central role, it is the 
T3SS in S. typhimurium. The Salmonella pathogenicity island 2 (SPI-2) T3SS is used 
to secrete two effector proteins SseJ and SifA, which were identified to be responsible 
for the vacuolar membrane stability, which is crucial for bacterial replication within 
the host cell [48].  
Another antimicrobial mechanism of phagocytic cells to keep intracellular pathogens 
in check is through reactive nitrogen intermediates (RNIs). To protect themselves 
from such toxic intermediates, S. typhimurium interferes with the recruitment of nitric 
oxide synthase (iNOS) to the Salmonella-containing phagosome by the action of SPI2 
[49]. Similarly, Salmonella SPI2 is also required to prevent phagocyte NADPH 
oxidase-mediated killing [50]. Bacterial pathogens have also evolved ways to detoxify 
iNOS and thereby avoid killing. H. pylori produces arginase to degrade the iNOS 
substrate L-arginine, thereby avoiding NO-dependent killing [51]. For Citrobacter 
rodentium, an infection causes a remarkable iNOS activity but the iNOS level 
surrounding the bacteria is very low, suggesting that bacteria locally limit their 
exposure to host-derived NO [52]. 
1.2.3 Attenuation of pro-inflammatory responses 
Interference with intracellular signal transduction cascades 
Upon antigen recognition, a diverse set of cellular PRRs triggers intracellular signal 
transduction cascades for the secretion of immunomodulatory chemokines and 
cytokines as antimicrobial defense mechanisms. An increasing number of examples 
shows that bacterial pathogens utilize their secreted proteins to dampen host innate 
immune responses by interfering with two main inflammatory pathways: the MAPK 
signaling and the NF-κB pathway (Fig. 4) [53]. One of the earliest studies discovered 
anthrax lethal toxin (LF) of Bacillus anthracis as a metalloproteinase, which cleaves 
the amino terminus of MAPKK1 and MAPKK2 for the direct inhibition of MAPKs 
[54]. In addition, the acetyltransferase YopJ of Y. pestis targets multiple members of 
the MAPK kinase superfamily (e.g., all mitogen-activated protein kinase kinases 
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(MKKs) and IKKβ, excluding IKKα) to prevent them from target phosphorylation. 
The functional consequence of YopJ is the suppression not only of MAPK, but also of 
NF-κB pathways, which results in downregulation of various cytokines, chemokines, 
and adhesion molecules (e.g., TNF-α, IL-8, and intercellular adhesion molecule-1 
(ICAM-1)) [55]. Both AvrA of Salmonella and VopA/P of Vibrio parahaemolyticus 
which are homologous to YopJ show similar acetyltransferase activity. AvrA 
specifically targets MAPK4 and MAPK7 of the c-Jun NH2-terminal kinase (JNK) 
signaling pathway [56]. VopA/P inhibits the MAPK signaling pathways by acetylating 
MKKs [57, 58]. A different strategy to interfere with MAPK signaling is followed by 
Shigella flexneri. Its type III effector protein OspF (a homolog to the Salmonella 
SpvC and Pseudomonas syringae HopAI1) was discovered as a phosphothreonine 
lyase to catalyze a β-elimination reaction of phosphothreonine to a 
β-methyldehydroalanine, thus permanently dephosphorylating host MAPK enzymes. 
The OspF family takes advantage of a conserved MAPK docking motif (D motif) in 
mammals to specifically target the host substrates and inhibit the inflammatory 
activation [59].  
Beside the MAPK kinase signaling, the NF-κB pathway is another essential route 
involving TLR recognition. In the classical NF-κB pathway, NF-κB/p65 proteins are 
bound and inhibited by IκB proteins. Upon stimulation, kinase activity of the 
NEMO/IKKα/IKKβ complex is activated to free NF-κB/p65 complexes, which 
translocate to the nucleus and induce target gene expression. Several bacterial 
pathogens take advantage of the inhibition of NF-κB signaling pathways, thus greatly 
suppressing the induction of inflammation. Shigella, for instance, has evolved several 
unique mechanisms to interfere with NF-κB signaling transduction. OspI of S. flexneri 
deamidates the E2 ubiquitin ligase UBC13, thus prohibiting TRAF6 
autopolyubiquitination [60]. Shigella IpaH9.8, an E3 ubiquitin ligase, targets the 
NEMO complex for proteasomal degradation [61]. Besides, Shigella OspG is 
designed to inhibit the NF-κB-mediated inflammation by reducing E3-mediated 
ubiquitination of IκB and thereby preventing the dissociation of IκB/NF-κB/p65 
complexes [62]. The modulation of NF-κB-dependent responses is also critical to the 
success of attaching/effacing (A/E) human pathogenic E. coli (EPEC and EHEC). 
One of the type III effector proteins discovered in A/E pathogens is the translocated 
intimin receptor (Tir), which contributes dual functions to bacterial pathogenicity, 
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including the strong bacterial attachment to host cells and the suppression of host 
innate immune responses. To down-regulate the inflammatory cytokines, the 
tyrosine-based inhibitory motif (ITIM)-like motifs of the Tir effector promote 
recruitment of SHP-1 and SHP-2 to subsequently inhibit the ubiquitination of TRAF6, 
thereby dampening both MAPK and NF-κB pathways as introduction in chapter 1.1.1 
[63, 64]. Beyond Tir, some Nle proteins of A/E pathogens are identified to specifically 
inhibit NF-κB activation. In response to TNF-α stimulation, NleB targets 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an interaction partner to 
suppress TNF-α-dependent TRAF2-mediated polyubiquitination [65]. Furthermore, 
NleC and NleD catalyze the cleavage of p65 and thereby block NF-κB and AP-1 
activation [66]. NleE, a homolog of Shigella OspZ, possesses 
S-adenosyl-L-methionine-dependent methyltransferase activity to disrupt the binding 
of TAB2 and TAB3 to ubiquitin chains, which disables the activation of TAK1 and 
IKKs. Ultimately, NleE prevents thus the NF-kB components from being released for 
translocation to the nucleus [67]. 
 
 
Figure 4. Bacterial effectors that manipulate inflammatory pathways. In a MyD88-dependent 
manner, TLRs trigger intracellular signal transduction cascades (MAPK and NF-κB) for the 
secretion of immunomodulatory cytokines. Bacterial effector proteins inhibit this process in many 
different ways [52]. 
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Some cases of bacterial infections show a dampening effect on the host inflammatory 
cytokines, but the molecular mechanisms behind such phenotypes are not well 
elucidated. With unknown targets, Yersinia YopH contributes to the downregulation of 
TNF-α, IL1β, and the monocyte chemoattractant protein-1 (MCP-1) by suppressing 
the PI3K/Akt pathway. Furthermore, YopM possibly interferes with the expression of 
IL-15 receptor α (IL-15Rα) and IL-15, thereby resulting in global depletion of NK 
cells in hosts [68]. A recent study reveals that YopM directly binds caspase-1 and 
blocks formation of the mature inflammasome to prevent cell death and inflammation 
[69]. Unlike Yersinia which establishes acute infection, M. tuberculosis promotes 
long-term persistence. In the latent phase of infection, M. tuberculosis suppresses 
IL-12 expression. Furthermore, M. tuberculosis and LPS of H. pylori bind to the 
C-type lectin DC-SIGN, which blocks Th1 development and blocks DC maturation. 
[70, 71]. Additionally contributing to the inability of bacterial eradication during M. 
tuberculosis infection is the inhibition of macrophage responses to IFN-γ without 
inhibiting the production of NO [72]. In another bacterial pathogen, Brucella abortus, 
the TIR-contaning protein Btp1 (a homolog of Salmonella TlpA) inhibits the process 
of DC maturation including the repression of cytokines and the limitation of antigen 
presentation [73]. Although Francisella tularensis induces the phenotypic maturation 
of infected DCs, it represses the secretion of pro-inflammatory cytokines (e.g., TNF-α) 
and replicates efficiently within DCs [74]. 
Suppression of innate immune secretory mechanisms 
Bacterial pathogens harbor a variety of elegant strategies to dampen the host 
inflammatory response by interfering with cellular signal pathways. Recent evidence 
reveals that bacteria have evolved alternative mechanisms to inhibit innate immunity 
by blocking protein trafficking. The host general secretory pathway (GSP) delivers 
molecular cargo (e.g., cell-surface receptors and cytokines) from the endoplasmic 
reticulum (ER) to the Golgi apparatus and eventually releases proteins from the cell 
by vesicular fusion of the cytokine- and receptor-containing carriers with the plasma 
membrane. In general, secretory proteins cotranslationally enter the ER and are 
subsequently transported through different membrane bound compartments by means 
of vesicular transport. The latter requires coat proteins, which help collect cargo and 
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support vesicle formation. Key small GTPases in this process are ARF1 and SAR1, 
which regulate coat protein complexes I and II (COPI and COPII), which have their 
function in the vesicular anterograde and retrograde ER-Golgi and intra-Golgi 
transport. The type III effector proteins NleA (EspI), NleF, and EspG of A/E 
pathogens function as GSP inhibitors by targeting the early steps of GSP. Although 
the mechanism is not fully understood, it is clear that NleA directly interacts with the 
Sec24 subunit of COPII to inhibit the production of cargo-containing COPII vesicles 
at the ER-membrane destined for anterograde transport [75]. In contrast, NleF binds 
to the transmembrane protein Tmp21 to block COPI-type vesicles in the retrograde 
transport [76]. Furthermore, EspG servers as a bacterial catalytic scaffold and induces 
bi-directional traffic arrest by preventing the cycling of ARF1-GTP and by 
simultaneously inactivating Rab1 signaling [77]. S. flexneri, which is not an A/E 
pathogen, shows a similar strategy for GSP inhibition. Its VirA protein, a homolog of 
EspG, mediates the suppression of Rab1-mediated ER-to-Golgi trafficking [78]. 
Another Shigella effector IpaJ specifically cleaves the myristoylated glycine of ARF1 
and numerous lipid-modified substrates, thereby resulting in profound Golgi 
fragmentation [79]. The rapid turnover of GTPase signaling networks is essential for 
surficial receptor localization and cytokine secretion. Thus targeting the host GTPases 
and their downstream pathways by bacterial effectors constitutes a powerful 
mechanism for host immune evasion. 
1.2.4 Exploitation of anti-inflammatory cytokines 
Inflammation is a sophisticated and protective response to infection by the host 
immune system. Secreted cytokines provide signals for the communication between 
various immune cells to coordinate their actions. Although the acute inflammatory 
response provides a beneficial front-line defense against the bacterial infection, a 
dysregulation of inflammatory processes may lead to a harmful and chronic state, 
which can lead to destruction of tissues and result in autoimmune disorders. To 
balance host inflammatory responses, immunosuppressive cytokines (e.g., IL-10) 
function as negative feedback mechanisms to deactivate macrophages and abate the 
development of Th1 immunity. IL-10 is produced by macrophages, DCs, B cells, and 
various subsets of CD4
+
 and CD8
+
 T cells. Effects of IL-10 on monocytes and 
macrophages include the inhibition of MHC class II and co-stimulatory molecule 
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expression as well as the downregulation of pro-inflammatory cytokine and 
chemokine secretion. Besides, IL-10 can act directly on CD4
+
 T cells to inhibit cell 
proliferation and production of IL-2, IFN-γ, IL-4, IL-5, and TNF-α [80].  
Many bacterial pathogens with a stealth strategy (e.g., Bordetella bronchiseptica, M. 
tuberculosis, H. pylori, and L. monocytogenes) markedly exploit these 
immunosuppressive properties of IL-10 to shut off the host inflammatory responses 
[81]. This can be exemplified by the type III effector BopN of B. bronchiseptica. 
BopN, involved in the downregulation of MAP kinases, is translocated into the 
nucleus and enhances the nuclear translocation of NF-κB associated with increased 
IL-10 production [82]. Upon M. tuberculosis infection, macrophages and monocytes 
secrete not only pro-inflammatory, but also anti-inflammatory, cytokines, notably 
IL-10. A recent publication reveals that TLR3 is important for the sensing of 
mycobacterial RNA to induce IL-10 production through PI3K/AKT signaling [83]. H. 
pylori infection causes the formation of tolerogenic DCs, which secrete IL-18 and 
efficiently induce Foxp3
+ 
regulatory Treg cells. This promotes host immune tolerance 
and consequently enhances bacterial persistence [84]. Besides Treg cells, IL-10 
producing B cells are expanded at a relative early stage of H. pylori infection [85]. 
Similarly, B cells in the splenic marginal zone are dominant IL-10 producing cells in 
response to L. monocytogenes infection [86]. Interestingly, the impact of IL-10 is 
clearly determined by the timing and the site of its production where elevated IL-10 
correlates with poor pathogen control by the host. Thus, IL-10 represents a regulatory 
cytokine which is exploited by the bacterial pathogens to establish a state of chronic 
infection. 
1.2.5 Suppression of antigen presentation 
As described in the above paragraphs, inhibition of phagocyte activation by bacterial 
effectors always results in the downregulation of secreted cytokines and along with it 
in the inability of antigen-presentation. Evidence exists bacteria also developed 
unique strategies to specifically disrupt the antigen-presenting complex. For example, 
one function of the 19 kDa lipoprotein of M. tuberculosis is to inhibit MHC class II 
processing and presentation. This inhibition is attributed to intracellular sequestration 
of MHC II molecules and to decreased expression of the class II transactivator (CIITA) 
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[87, 88]. Besides the MHC class II complex, CD1 expression on DCs, which is 
responsible for presenting lipid antigens to T cell recognition, is also interfered with 
by Mycobacteria infection. Via CR-3-mediated phagocytosis, Mycobacteria infection 
activates ATF-2, which binds to the CD1A promoter and thereby inhibits CD1 
transcription [89]. Another example taken from Salmonella infection is the 
SPI2-T3SS-dependent suppression of intracellular loading of peptides on the MHC 
class II complex in DCs. The type III effectors (PipB2, SifA, SlrP, SopD2, and SspH2) 
of Salmonella are equally important for the interference with antigen presentation [90]. 
Furthermore, Salmonella infection induces T3SS-dependent polyubiquitination of 
HLA-DR which leads to removal of mature, peptide loaded MHC class II complexes 
from the cell surface [91]. This precise targeting of MHC class II molecules to reduce 
the presentation of antigens to T cells is crucial for bacterial evasion from the host 
adaptive immune response. 
1.2.6 Blockage of acquired immunity  
Most bacterial pathogens evade from the adaptive immune response by avoiding its 
activation as described above. However, few examples have shown that bacteria can 
directly counteract host acquired immunity. Yersinia YopH is responsible for 
inhibiting both T cell specific cytokine production and expression of the 
co-stimulatory receptor CD86 on B cells based on its phosphatase activity [92]. Also 
two cytotoxins of H. pylori, CagA through the type IV secretion system and VacA via 
a type V auto-transport secretion system, display immunomodulatory properties. It 
was shown that ectopical expression of CagA inhibits B cell proliferation by 
suppressing JAK/STAT signaling [93]. VacA in turn inhibits the stimulation-induced 
proliferation of CD4
+
 T cells, CD8
+
 T cells, and B cells [94]. In CD8
+
 T cells but not 
in CD4
+ 
T cells, the cytoplasmic presence of VacA inhibits NFAT nuclear 
translocation and subsequently downregulates IL-2 secretion by blocking the calcium 
influx [95]. VacA also causes an aberrant Rac activation what results in actin 
polymerization disorders and ultimately in defects in T cell activation [96]. Also 
Neisseria gonorrhoeae infection arrests the activation and proliferation of CD4
+ 
T 
cells. The Neisseria Opa proteins bind to CEACAM1 containing an ITIM motif (cf. 
chapter 1.2.3), thereby suppressing T cell responses [97]. Another strategy developed 
by several mucosal pathogens (e.g., Neisseria spp. and various Streptococci) is to 
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secrete bacterial IgA proteases by an auto-transporter mechanism. The IgA proteases 
specifically cleave the secretory antibody IgA1 in the hinge region, thereby 
annihilating IgA1-mediated agglutination and bacterial elimination [98]. 
1.3 Bartonella species 
The genus Bartonella constitutes a group of facultative intracellular pathogens with 
24 different species evolutionarily subdivided into four lineages (Fig. 5) [99, 100]. 
Bartonella species (spp.) are highly adapted to mammalian reservoir hosts, and an 
infection thus results in a long-lasting intraerythrocytic bacteremia through distinct 
stealth-attack strategies [101, 102]. Depending on the level of adaptation to the host, 
the disease develops a broad spectrum of symptoms from subclinical to clinical 
manifestations with limited morbidity to even fatal disease. Although Bartonella 
infections are ubiquitous among mammals as principal reservoir hosts, the majority of 
human diseases are caused by three species: the human-specific species B. 
bacilliformis and B. quintana, and the zoonotic feline-specific species B. henselae 
[103]. B. bacilliformis elicits life-threatening Carrión’s disease with two clinical 
phases: a primary acute stage of hemolytic anemia called “Oroya fever”, and a 
secondary chronic stage “verruga peruana” characterized by skin nodules and mulaire 
lesions (erythematous round lesions) along with bleeding, which lead to fibrosis [104, 
105]. Trench fever caused by B. quintana is usually mild and rarely fatal with 
characteristic five-day cycle of relapsing fever [106]. People are usually infected with 
B. henselae through cat scratches or cat fleas and immunocompetent patients typically 
suffer from cat scratch disease (CSD), characterized by local lymph node swelling and 
fever [107]. In contrast, immunocompromised patients (e.g., acquired immune 
deficiency syndrome (AIDS) patients) with B. henselae or B. quintana infections can 
develop vasoproliferative lesions (bacillary angiomatosis). Bacillary angiomatosis is 
often associated with peliosis hepatis, which is characterised by multiple blood-filled 
cavities throughout the liver. [108]. These tumor-like lesions arise from bacterial 
infection of vascular endothelial cells leading to their enhanced migration and 
proliferation [109]. 
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1.3.1 Cycle of Bartonella infection  
The infection cycle of Bartonella is initiated with the inoculation of a mammalian 
reservoir host, following transmission via bloodsucking arthropods (Fig. 6) [110, 111]. 
Sand fly (Lutzomyia verrucarum) is the most important vector for B. bacilliformis as 
the agent of human bartonellosis [112]. Moreover, previous studies have shown that B. 
quintana, B. henselae, and B. schoenbuchensis can infect and replicate in the digestive 
systems of their vectors: human body lice (Pediculus humanus corporis), cat fleas 
(Ctenocephalides felis), and deer ked (Lipoptena cervi), respectively [113-115]. 
Generally, other hematophagous arthropods are also to be considered as transmission 
vectors in which Bartonella can survive and gain access to new hosts. For example, 
ticks and biting flies are potential vectors of Bartonella spp. in nature.    
Little evidence is available to understand precisely Bartonella infection stages 
between the inoculation into the skin (e.g., from the feces of arthropod vectors) and 
the bacteremic stage. As exemplified by B. tribocorum infection in the rat model, a 
preceding period of residence in a primary niche is essential before intravenous 
Figure 5. Phylogeny tree of Bartonella spp. The phylogenetic analysis is based on 478 core 
genome genes of ten sequenced Bartonella spp. (indicated by bold and color font) and Brucella 
abortus. Bartonellae are subdivided into the ancestral Lineage 1 and the modern Lineages 2-4. 
Lineages harboring the VirB T4SS are shaded in gray. The primary mammalian hosts are indicated 
for each species [100].  
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inoculation. B. tribocorum seems unable to directly enter erythrocytes and thus 
rapidly clear out from circulating blood. During the primary phase of residence in a 
niche, bacteria remain below detectable levels for about four days and subsequently 
re-appear in the bloodstream, implying that Bartonella persists and becomes 
competent for erythrocyte interaction during colonization of the primary niche prior to 
blood-stage infection [116]. The synchronous release of bacteria into the bloodstream 
may recur at intervals of approximately five days and sustain the bacteremia for about 
ten weeks. Upon invasion of erythrocytes, bacterial replication and intraerythrocytic 
persistence enable continuous vector transmission [117].  
 
 
In vitro data show the marked affinity of Bartonella for endothelial cells. Their 
proximity to the bloodstream leads to the suggestion that endothelial cells may be one 
of the constituents of the primary niche. [118]. However, it remains elusive how it 
reaches its primary niche in the host. Although it is not yet supported by experimental 
data, it is tempting to speculate that Bartonella initially enters migratory cells, such as 
DCs, which assist the passage of bacteria from the typical intradermal inoculation 
environment to the primary site of infection. Moreover, the lymph node swelling 
caused by Bartonella infections may indicate that Bartonella is transported via the 
Figure 6. Bartonella infection strategy Following transmission by an arthropod vector (1), 
bartonellae colonize the dermis (2) and enter into migratory cells, likely DCs (3). DCs may 
disseminate bartonellae towards the primary niche (4). The vascular endothelium is considered as 
the primary niche and is referred to as the blood seeding niche (5). Bacteria are released into the 
bloodstream (6), where they invade erythrocytes and likely reinfect the primary niche. After limited 
replication (7), bacteria persist intraerythrocytically (8) competent for transmission by a 
bloodsucking arthropod (9) [111]. 
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lymphatic system. Consistently, a murine model of B. henselae infection showed that 
bacteria DNA are detectable in liver and lymph nodes already within six hours post 
intraperitoneal injection, proposing that lymphocytes or mononuclear phagocytes 
could be the vehicles of Bartonella transport [119]. Further, the most recent 
publication has revealed that Bartonella is capable of translocating bacterial effectors 
into DCs, thereby affecting cell migration [120]. Overall, current evidences strongly 
suggest that DCs may contribute the dissemination of Bartonella from the dermis to 
the lymphatic system eventually culminating in their release to the bloodstream. 
Further studies supporting this hypothesis including how Bartonella interacts with 
DCs by in vitro and in vivo models will be addressed in the next chapters. 
1.3.2 Bartonella virulence factors   
Bartonella adhesin A 
The trimeric autotransporter adhesins (TAAs) are important virulence factors in 
numerous gram-negative bacteria, e.g., Y. enterocolitica, N. meningitides, 
Haemophilus inﬂuenzae, and Moraxella catarrhalis. TAAs are modularly constructed 
consisting of typical head, stalk and anchor domains and they perform type Vc 
secretion [121]. Most research on the TAAs of Bartonella has been performed on 
Bartonella adhesin A (BadA) which is the largest identiﬁed TAA with the size of 328 
kDa per monomer and a length of about 240 nm [122]. The key functions of BadA in 
the molecular pathogenesis of B. henselae have been thoroughly studied with the 
Marseille strain (i.e., in the absence of a functional VirB/D4 T4SS: see chapter 1.3.3. 
for VirB/D4 T4SS). BadA contributes to the adhesion of B. henselae to extracellular 
matrix proteins (e.g., ﬁbronectin (Fn), laminin, and collagens) and possesses 
antiphagocytic properties [123]. Furthermore, BadA plays an important role in the 
induction of host cell proangiogenic responses. In a VirB/Bep-independent manner, 
BadA promotes the activation of hypoxia-inducible factor 1 (HIF-1), a key 
transcription factor of angiogenesis [124], and the subsequent secretion of 
vasoproliferative cytokines, such as vascular endothelial growth factor (VEGF) [125]. 
With the exception of Fn binding, these functional properties are mediated by both the 
head and stalk domain of BadA whereas the stalk domain is exclusively responsible 
for Fn binding [126, 127]. 
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VirB/D4 type IV secretion system 
Type IV secretion systems (T4SSs) are ancestrally related to bacterial conjugation 
systems. A variety of bacteria intimately interacting with eukaryotic hosts utilize 
T4SSs to translocate bacterial effectors into recipient cells [128]. For the adaption to a 
wide range of mammalian hosts, Bartonella evolved two T4SSs, VirB/D4 and Trw. 
According to the prototype of Agrobacterium tumefaciens, the VirB/D4 T4SS consists 
of ten essential components, VirB2-11, and the coupling protein VirD4 serving as a 
substrate recognition module. Two signature-tagged mutagenesis (STM) screens in B. 
birtlesii and B. tribocorum showed that VirB/D4 T4SS is indispensible for the 
development of a successful bacteremia [129, 130]. Besides, the B. tribocorum 
infection model in rats strongly indicates that the VirB/D4 system is required at an 
early stage of infection before the onset of intraerythrocytic bacteremia [131]. To date, 
the VirB/D4 T4SS of B. henselae and its translocated effector proteins (Beps) are well 
studied in the Houston-1 strain (i.e., in the absence of a functional BadA). Although 
both VirB/D4 T4SS and BadA play crucial roles in B. henselae pathogenicity, most 
research studying B. henselae infections of human cells has been performed using B. 
henselae strains that either express a VirB/D4 T4SS but lack a full-length BadA or 
vice versa. The direct investigation of the potential functional interaction between 
BadA and the VirB/D4 T4SS is addressed in the Research article I (chapter 3.1). We 
show that VirB/D4-dependent effector secretion is negatively affected by BadA, but 
the functions of BadA itself remain intact when both factors are coexpressed in B. 
henselae [132]. However, in an earlier publication of our lab, a certain regulatory 
antagonism between VirB/D4 and BadA was found. Transcriptional analysis revealed 
that the expression of the VirB/D4 T4SS is upregulated whereas the one of BadA is 
downregulated under certain conditions in the in vitro model [133]. Therefore, 
VirB/D4 and BadA might not only have a functional interaction, but also their 
expression may be linked to balance the incorporation of both pathogenicity factors. 
Further experiments elucidating the regulatory patterns of these two systems are 
needed to understand the underlying mechanisms of gene regulation. 
Seven distinct Beps (BepA-G) of B. henselae have been identiﬁed as conjugative 
substrates delivered through the VirB/D4 T4SS (Fig. 7) [109]. The Beps display a 
highly modular architecture by sharing at least one copy of the Bep-intracellular 
delivery (BID) domain and positively charged residues at the C terminus together 
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acting as secretion signal for their transport through the VriB/D4 T4SS. In a subset of 
the Beps (BepE-G), additional BID domains are present and likely developed 
functions adapted to interfere with the host cell. BepG is exclusively composed of 
four BID domains. Moreover, BepA-C are homologs carrying a N-terminal 
filamentation induced by cAMP (FIC) domain. FIC domains of B. schoenbuchensis 
VbhT and B. rochalimae Bep2 were shown to mediate AMPylation, i.e., the covalent 
transfer of an AMP moiety onto hydroxyl side chains of target proteins, thereby 
contributing to the posttranslational regulation of protein function [134-136]. This 
peculiar enzymatic activity is also detected for BepA of B. henselae [137]. The 
N-terminal regions of BepD-F contain tandem-repeated tyrosine-containing sequences 
as EPLYA (Glu-Pro-Ile-Tyr-Ala)-related motifs [138]. Upon translocation into 
endothelial cells, tyrosine residues of BepD and BepE undergo phosphorylation [139]. 
Further validation revealed that BepE binds Csk and SHP-2 in a 
phosphorylation-dependent manner [140]. However, none of the FIC domains or 
EPIYA-related motifs of B. henselae effectors has been demonstrated to contribute to 
Bartonella virulence. In the Research article II (chapter 3.2), we demonstrate for the 
first time that the subversion of cellular functions relates to the EPIYA-related motifs 
of BepD by using in vitro and in vivo models.  
 
 
So far, several T4SS-dependent cellular phenotypes caused by B. henselae infection 
are described in association with a single effector or a subset of Beps. One example is 
the entry of B. henselae into host cells via invasomes. In a sequential process, B. 
Figure 7. Bartonella VirB/VirD4 and Beps (a) The genetic structure of the virB/virD4/bep 
pathogenicity island, which encodes 18 type IV secretion-related proteins. (b) The domain structure 
of BepA-G. BID, Bep intracellular delivery; Fic, filamentation induced by cAMP; Y, tyrosine 
residue within a putative phosphorylation motif [109]. 
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henselae is first taken up by the host cell in Bartonella-containing vacuoles (BCVs) 
within few hours after pathogen exposure [142]. A combination of BepC and BepF or 
BepG alone subsequently stall BCV-formation and lead to bacterial uptake in huge 
clusters, so called invasomes [143, 144]. This process goes along with massive 
rearrangements of the actin cytoskeleton and takes 16 to 24 hours [141, 142]. 
Invasome formation is elicited due to the inhibition of endocytosis-like uptake of 
individual bacteria in BCVs [143, 144]. It has been shown that the assembly of the 
F-actin invasome structure by B. henselae infection results from β1-integrin outside-in 
signaling mediated by FAK, Src kinase, paxillin, and vinculin in combination with 
talin1-mediated inside-out signaling [145]. A further example for the impact of Beps 
on host cell behavior relates to angiogenic properties of B. henselae. An in vitro 
three-dimensional spheroid sprouting assay disclosed that BepA profoundly induces 
capillary-like sprouting while the same process is inhibited by BepG; thus, both 
proteins seem to play a opposing role in controlling the angiogenic response triggered 
by B. henselae infection [143]. While promoting sprout formation, the VirB/Bep 
system antagonizes exogenous angiogenic stimulation of VEGFR2 signaling by 
VEGF, which is Bartonella induced [146]. These two independent lines of evidences 
suggest that the VirB/Bep system as an important factor balances the angiogenic 
potential of B. henselae with both pro- and anti-angiogenic characteristics. 
Furthermore, BepA efficiently prevents infected endothelial cells from apoptosis via 
elevating the cytosolic concentration of the second messenger cAMP [147, 148]. This 
BepA-mediated elevation of cAMP level depends on the stimulus of Gαs released 
from a G protein-coupled receptor [149]. Both in vitro phenotypes of BepA are 
closely related to its BID domain, likely through the same molecular activity. 
Additionally to the above, a recent publication of our lab shows that a deleterious cell 
fragmentation phenotype caused by BepC is restored by BID domains of BepE via the 
RhoA signaling pathway. Moreover, BepE is required for systemic dissemination 
from the dermal inoculation site to the bloodstream in the in vivo infection model 
[120].  
Trw type IV secretion system 
Unlike VirB/D4, the Trw T4SS apparently neither harbors a coupling protein nor does 
it translocates any known effectors. It carries multiple tandem gene duplications of 
trwL and trwJIH forming a multiprotein complex that spans the inner and outer 
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bacterial membranes and possesses a hypothetical pilus structure [150]. Moreover, 
only TrwJ1 and TrwJ2 are localized at the cell surface and bind to the band3 protein, 
one of the major outer-membrane glycoproteins of erythrocytes, thereby promoting 
the recognition of erythrocytes [151]. Strikingly, host specificity is defined by the 
capacity of Bartonella species to adhere exclusively to erythrocytes of their reservoir 
host in a Trw T4SS-dependent manner [129, 130].  
1.3.3 Immune evasion and immunomodulation  
Some bacterial pathogens cause an acute infection characteristically inducing disease 
symptoms that overwhelm the host innate defenses. In contrast, Bartonella using 
stealth-attack strategies characteristically avoid elicitation of a host immune response 
via both passive immune evasion and active immunomodulation. At a late stage of 
Bartonella infection, the colonization of the intraerythrocytic niche protects 
bartonellae from both innate and adaptive immunity [152]. As described above (see 
chapter 1.1.1), the LPS of gram-negative bacteria are endotoxins recognized by TLR4 
and trigger a strong inflammatory response, which prohibits bacterial persistence. 
Critically, LPS of Bartonella shows unusual structural features connected to a 
significantly lower endotoxic activity [153]. The immunomodulatory property of 
Bartonella LPS is extensively studied in B. quintana. Interestingly, B. quintana LPS 
acts as a TLR4 antagonist leading to transcriptional downregulation of the 
pro-inflammatory cytokines (e.g., TNF-α, IL-1β, and IL-6) whose production is 
triggered by E. coli LPS. However, a LPS-associated component of B. quintana 
selectively stimulates the secretion of IL-8 likely via TLR2 and induces leukocytosis 
[154-156]. Furthermore, many studies have reported that Bartonella infection (e.g., B. 
bacilliformis, B. quintana, and B. henselae) elevates IL-10 levels in human patients 
and various experimental models [157-160]. IL-10, as a multifunctional 
immunoregulatory molecule, is critically involved in persistence of bacteria by 
disarming innate and adaptive responses. [161]. Strikingly, B. birtlesii loses the ability 
to establish bacteremia in the IL-10 deficient mice, implicating that IL-10 plays a 
pivotal role for Bartonella pathogenicity [162].  
From the severity point of view of the disease symptoms, B. birtlesii infection 
establishes longer and higher bacteremia in CD4 deficient mice (i.e., lacking T helper 
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cells) compared to wild-type mice. In contrast, the bacteremia development is 
indistinguishable between CD8 deficient and wild-type mice [162]. In accordance 
with the central role of phagocytic cells and humoral immunity in Bartonella 
clearance, the course of B. grahamii bacteremia is transient in immunocompetent 
mice. However, bacteremia persists in Igh
−/−
 mice (i.e., lacking Ig-producing B cells) 
and Rag
−/−
 mice (i.e., devoid of both an intact B and T cell compartment). To further 
demonstrate that antibodies are necessary to abrogate B. grahamii infection, adoptive 
transferring of immune serum against B. grahamii into infected immunocompromised 
recipients results in a transient bacteremia congruent with the situation in an 
immunocompetent host [163]. In the case of feral cats with a natural infection of the 
feline-specific B. henselae, Th2 responses are induced culminating in the secretion of 
specific antibodies. Although the production of specific antibodies plays an important 
role in removing Bartonella from the bloodstream, it cannot eliminate relapses of 
bacteremia [164, 165]. Consistently, another report showed that passive antibodies to 
B. henselae protect cats from clinical disease symptoms but fail to prevent the 
establishment of bacteremia [166]. The induction of Th2, which is known to suppress 
Th1 immune responses, may contribute to the establishment of B. henselae 
persistence in naturally infected cats [167]. In accordance with this, experimental 
infection with B. henselae in cats revealed that rapid bacteremia clearance is 
associated with Th1 immune responses including IFN-γ and TNF-α production [156]. 
Consistently, various studies of the heterologous murine model have reported that B. 
henselae infection elicits Th1 responses and fails to cause bacteremia [119, 158, 168]. 
In addition, although B. henselae is able to enter and survive within the mouse 
macrophags cell line J774, IFN-γ mediated activation of macrophages significantly 
decreases the number of recoverable bacteria [169]. These results strongly suggest 
that the Th1 responses associated with IFN-γ secretion play a crucial role in recruiting 
phagocytes and activating T helper-mediated immunity for the elimination of 
bartonellae. Even so, it remains unclear how natural infection of Bartonella in the 
reservoir host leads to Th2-dominated responses instead of the Th1 immunity which is 
triggered in the experimental setup. In light of the complex interplay between 
pathogen and immune system, it has to be emphasized that the inflammatory profile 
observed after Bartonella infection in different hosts is inconsistent. This may 
partially explain the distinct outcome of Bartonella infection in reservoir and 
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incidental hosts. 
Among CSD patients, the characteristic lymphadenopathy originates from the 
formation of B cell rich granulomas with continuous recruitment of infected 
macrophages. These macrophages undergo apoptosis and likely lead to self-limitation 
of CSD [170]. In vitro analysis revealed that B. henselae-driven DC activation goes 
along with classical phenotypic changes as the increase of surface expression of 
co-stimulatory molecules and MHC class II complex as well as the release of 
cytokines (e.g., TNFα, IL-6, IL-10, CXCL8, and CXCL13). These cytokines are 
known to activate and recruit B cells. Remarkably, CXCL13-producing DCs are 
observed in CSD granulomas and likely contribute to the B cell and neutrophil 
recruitment [160]. To investigate the mechanisms causing lymphadenopathy in vivo, a 
comparative analysis of B. henselae (feline-specific species) and B. grahamii 
(rodent-specific species) was performed by subcutaneous infection in mice. 
Interestingly, only B. henselae infection causes a massive and long-lasting regional 
lymph node (LN) swelling in wild-type mice as incidental hosts. In vitro analysis 
showed that the production of IFN-α/β by bone marrow-derived dendritic cells 
(BMDCs) is significantly lower in response to B. henselae compared to B. grahamii. 
As opposed to that, both B. henselae and B. grahamii are able to induce 
lymphadenopathy in IFN-α/β receptor-deficient (IFNARI−/−) mice. Taken together, 
these findings indicate that homologous infection with Bartonella may induce the 
IFN-α/β secretion, which in turn exerts an inhibitory effect on the development of 
lymphadenopathy in its reservoir hosts [171]. In summary, both cellular and humoral 
immunity are essential for complete eradication of bartonellae from the hosts. 
Apparently, Bartonella actively counteracts the establishment of host immune 
responses to create a moderated inflammatory profile which is beneficial for bacterial 
persistence. However, Bartonella immunosuppression is restricted by host specificity. 
A mild Bartonella infection course is mostly observed in reservoir hosts, while the 
morbid course of infection in incidental hosts results from the failure in 
immunomodulation. Despite the phenotypic description of immunological attenuation 
during Bartonella infection, it is still elusive how Bartonella obstructs functions of 
the host immune system and which Bartonella virulence factors may contribute to it. 
These aspects will be addressed in the next chapters of the thesis.  
  GENERAL INTRODUCTION  
- 29 - 
 
1.4 References 
1. Tang, D., et al., PAMPs and DAMPs: signal 0s that spur autophagy and immunity. 
Immunol Rev, 2012. 249(1): p. 158-75. 
2. Medzhitov, R. and C. Janeway, Jr., Innate immunity. N Engl J Med, 2000. 343(5): 
p. 338-44. 
3. Medzhitov, R., P. Preston-Hurlburt, and C.A. Janeway, Jr., A human homologue 
of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 
1997. 388(6640): p. 394-7. 
4. Bowie, A. and L.A. O'Neill, The interleukin-1 receptor/Toll-like receptor 
superfamily: signal generators for pro-inflammatory interleukins and microbial 
products. J Leukoc Biol, 2000. 67(4): p. 508-14. 
5. Akira, S., S. Uematsu, and O. Takeuchi, Pathogen recognition and innate 
immunity. Cell, 2006. 124(4): p. 783-801. 
6. O'Neill, L.A., D. Golenbock, and A.G. Bowie, The history of Toll-like receptors - 
redefining innate immunity. Nat Rev Immunol, 2013. 13(6): p. 453-60. 
7. Takeda, K. and S. Akira, TLR signaling pathways. Semin Immunol, 2004. 16(1): 
p. 3-9. 
8. Negishi, H., et al., Evidence for licensing of IFN-gamma-induced IFN regulatory 
factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene 
induction program. Proc Natl Acad Sci U S A, 2006. 103(41): p. 15136-41. 
9. Schmitz, F., et al., Interferon-regulatory-factor 1 controls Toll-like receptor 
9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol, 2007. 
37(2): p. 315-27. 
10. Tenoever, B.R., et al., Multiple functions of the IKK-related kinase IKKepsilon 
in interferon-mediated antiviral immunity. Science, 2007. 315(5816): p. 1274-8. 
11. Ermolaeva, M.A., et al., Function of TRADD in tumor necrosis factor receptor 1 
signaling and in TRIF-dependent inflammatory responses. Nat Immunol, 2008. 
9(9): p. 1037-46. 
12. Takahashi, K., et al., Roles of caspase-8 and caspase-10 in innate immune 
responses to double-stranded RNA. J Immunol, 2006. 176(8): p. 4520-4. 
13. Lambotin, M., et al., A look behind closed doors: interaction of persistent viruses 
with dendritic cells. Nat Rev Microbiol, 2010. 8(5): p. 350-60. 
14. Quie, P.G., Humoral factors in host defense against microbial invaders. Scand J 
Infect Dis Suppl, 1982. 31: p. 34-40. 
15. Wang, S.Y., et al., NK-cell activation and antibody-dependent cellular 
cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b 
component of complement. Blood, 2008. 111(3): p. 1456-63. 
  GENERAL INTRODUCTION  
- 30 - 
 
16. Giembycz, M.A. and M.A. Lindsay, Pharmacology of the eosinophil. Pharmacol 
Rev, 1999. 51(2): p. 213-340. 
17. Mosmann, T.R., et al., Two types of murine helper T cell clone. I. Definition 
according to profiles of lymphokine activities and secreted proteins. J Immunol, 
1986. 136(7): p. 2348-57. 
18. Kidd, P., Th1/Th2 balance: the hypothesis, its limitations, and implications for 
health and disease. Altern Med Rev, 2003. 8(3): p. 223-46. 
19. Romagnani, S., Regulation of the T cell response. Clin Exp Allergy, 2006. 36(11): 
p. 1357-66. 
20. Bedoya, S.K., et al., Th17 cells in immunity and autoimmunity. Clin Dev 
Immunol, 2013. 2013: p. 986789. 
21. Janeway CA Jr, T.P., Walport M, et al. , Immunobiology: The Immune System in 
Health and Disease., 2001. 
22. MartIn-Fontecha, A., et al., Regulation of dendritic cell migration to the draining 
lymph node: impact on T lymphocyte traffic and priming. J Exp Med, 2003. 
198(4): p. 615-21. 
23. Guermonprez, P., et al., Antigen presentation and T cell stimulation by dendritic 
cells. Annu Rev Immunol, 2002. 20: p. 621-67. 
24. Kapsenberg, M.L., Dendritic-cell control of pathogen-driven T-cell polarization. 
Nat Rev Immunol, 2003. 3(12): p. 984-93. 
25. Reis e Sousa, C., Dendritic cells in a mature age. Nat Rev Immunol, 2006. 6(6): 
p. 476-83. 
26. Mahnke, K., et al., Tolerogenic dendritic cells and regulatory T cells: a two-way 
relationship. J Dermatol Sci, 2007. 46(3): p. 159-67. 
27. Lutz, M.B. and G. Schuler, Immature, semi-mature and fully mature dendritic 
cells: which signals induce tolerance or immunity? Trends Immunol, 2002. 23(9): 
p. 445-9. 
28. Celli, J. and B.B. Finlay, Bacterial avoidance of phagocytosis. Trends Microbiol, 
2002. 10(5): p. 232-7. 
29. Claverys, J.P., et al., Adaptation to the environment: Streptococcus pneumoniae, 
a paradigm for recombination-mediated genetic plasticity? Mol Microbiol, 2000. 
35(2): p. 251-9. 
30. Silver, R.P., W. Aaronson, and W.F. Vann, The K1 capsular polysaccharide of 
Escherichia coli. Rev Infect Dis, 1988. 10 Suppl 2: p. S282-6. 
31. Alvarez, D., et al., Capsular polysaccharide is a major complement resistance 
factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae 
clinical isolates. Infect Immun, 2000. 68(2): p. 953-5. 
32. Vogel, U., et al., Complement factor C3 deposition and serum resistance in 
  GENERAL INTRODUCTION  
- 31 - 
 
isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B 
Neisseria meningitidis. Infect Immun, 1997. 65(10): p. 4022-9. 
33. Thakker, M., et al., Staphylococcus aureus serotype 5 capsular polysaccharide is 
antiphagocytic and enhances bacterial virulence in a murine bacteremia model. 
Infect Immun, 1998. 66(11): p. 5183-9. 
34. Fischetti, V.A., Streptococcal M protein: molecular design and biological 
behavior. Clin Microbiol Rev, 1989. 2(3): p. 285-314. 
35. China, B., et al., Role of the YadA protein in prevention of opsonization of 
Yersinia enterocolitica by C3b molecules. Infect Immun, 1993. 61(8): p. 
3129-36. 
36. Rosqvist, R., I. Bolin, and H. Wolf-Watz, Inhibition of phagocytosis in Yersinia 
pseudotuberculosis: a virulence plasmid-encoded ability involving the Yop2b 
protein. Infect Immun, 1988. 56(8): p. 2139-43. 
37. Rosqvist, R., A. Forsberg, and H. Wolf-Watz, Intracellular targeting of the 
Yersinia YopE cytotoxin in mammalian cells induces actin microfilament 
disruption. Infect Immun, 1991. 59(12): p. 4562-9. 
38. Zumbihl, R., et al., The cytotoxin YopT of Yersinia enterocolitica induces 
modification and cellular redistribution of the small GTP-binding protein RhoA. 
J Biol Chem, 1999. 274(41): p. 29289-93. 
39. Garrity-Ryan, L., et al., The arginine finger domain of ExoT contributes to actin 
cytoskeleton disruption and inhibition of internalization of Pseudomonas 
aeruginosa by epithelial cells and macrophages. Infect Immun, 2000. 68(12): p. 
7100-13. 
40. Goehring, U.M., et al., The N-terminal domain of Pseudomonas aeruginosa 
exoenzyme S is a GTPase-activating protein for Rho GTPases. J Biol Chem, 
1999. 274(51): p. 36369-72. 
41. Celli, J., M. Olivier, and B.B. Finlay, Enteropathogenic Escherichia coli mediates 
antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. 
EMBO J, 2001. 20(6): p. 1245-58. 
42. Swanson, M.S. and E. Fernandez-Moreira, A microbial strategy to multiply in 
macrophages: the pregnant pause. Traffic, 2002. 3(3): p. 170-7. 
43. Rosenberger, C.M. and B.B. Finlay, Phagocyte sabotage: disruption of 
macrophage signalling by bacterial pathogens. Nat Rev Mol Cell Biol, 2003. 4(5): 
p. 385-96. 
44. Sturgill-Koszycki, S., et al., Lack of acidification in Mycobacterium phagosomes 
produced by exclusion of the vesicular proton-ATPase. Science, 1994. 263(5147): 
p. 678-81. 
45. Ferrari, G., et al., A coat protein on phagosomes involved in the intracellular 
  GENERAL INTRODUCTION  
- 32 - 
 
survival of mycobacteria. Cell, 1999. 97(4): p. 435-47. 
46. Zheng, P.Y. and N.L. Jones, Helicobacter pylori strains expressing the 
vacuolating cytotoxin interrupt phagosome maturation in macrophages by 
recruiting and retaining TACO (coronin 1) protein. Cell Microbiol, 2003. 5(1): p. 
25-40. 
47. Nagai, H., et al., A bacterial guanine nucleotide exchange factor activates ARF 
on Legionella phagosomes. Science, 2002. 295(5555): p. 679-82. 
48. Ruiz-Albert, J., et al., Complementary activities of SseJ and SifA regulate 
dynamics of the Salmonella typhimurium vacuolar membrane. Mol Microbiol, 
2002. 44(3): p. 645-61. 
49. Chakravortty, D., I. Hansen-Wester, and M. Hensel, Salmonella pathogenicity 
island 2 mediates protection of intracellular Salmonella from reactive nitrogen 
intermediates. J Exp Med, 2002. 195(9): p. 1155-66. 
50. Vazquez-Torres, A., et al., Salmonella pathogenicity island 2-dependent evasion 
of the phagocyte NADPH oxidase. Science, 2000. 287(5458): p. 1655-8. 
51. Gobert, A.P., et al., Helicobacter pylori arginase inhibits nitric oxide production 
by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A, 
2001. 98(24): p. 13844-9. 
52. Vallance, B.A., et al., Modulation of inducible nitric oxide synthase expression 
by the attaching and effacing bacterial pathogen citrobacter rodentium in infected 
mice. Infect Immun, 2002. 70(11): p. 6424-35. 
53. Reddick, L.E. and N.M. Alto, Bacteria fighting back: how pathogens target and 
subvert the host innate immune system. Molecular cell, 2014. 54(2): p. 321-8. 
54. Duesbery, N.S., et al., Proteolytic inactivation of MAP-kinase-kinase by anthrax 
lethal factor. Science, 1998. 280(5364): p. 734-7. 
55. Mukherjee, S., et al., Yersinia YopJ acetylates and inhibits kinase activation by 
blocking phosphorylation. Science, 2006. 312(5777): p. 1211-4. 
56. Wu, H., R.M. Jones, and A.S. Neish, The Salmonella effector AvrA mediates 
bacterial intracellular survival during infection in vivo. Cell Microbiol, 2012. 
14(1): p. 28-39. 
57. Trosky, J.E., et al., Inhibition of MAPK signaling pathways by VopA from Vibrio 
parahaemolyticus. J Biol Chem, 2004. 279(50): p. 51953-7. 
58. Trosky, J.E., et al., VopA inhibits ATP binding by acetylating the catalytic loop of 
MAPK kinases. J Biol Chem, 2007. 282(47): p. 34299-305. 
59. Wei, P., et al., Bacterial virulence proteins as tools to rewire kinase pathways in 
yeast and immune cells. Nature, 2012. 488(7411): p. 384-8. 
60. Sanada, T., et al., The Shigella flexneri effector OspI deamidates UBC13 to 
dampen the inflammatory response. Nature, 2012. 483(7391): p. 623-6. 
  GENERAL INTRODUCTION  
- 33 - 
 
61. Ashida, H., et al., A bacterial E3 ubiquitin ligase IpaH9.8 targets 
NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory 
response. Nat Cell Biol, 2010. 12(1): p. 66-73; sup pp 1-9. 
62. Zhou, Y., et al., The Shigella type three secretion system effector OspG directly 
and specifically binds to host ubiquitin for activation. PLoS One, 2013. 8(2): p. 
e57558. 
63. Yan, D., et al., Inhibition of TLR signaling by a bacterial protein containing 
immunoreceptor tyrosine-based inhibitory motifs. Nat Immunol, 2012. 13(11): p. 
1063-1071. 
64. Yan, D., et al., Enteropathogenic Escherichia coli Tir recruits cellular SHP-2 
through ITIM motifs to suppress host immune response. Cell Signal, 2013. 25(9): 
p. 1887-94. 
65. Gao, X., et al., NleB, a bacterial effector with glycosyltransferase activity, targets 
GAPDH function to inhibit NF-kappaB activation. Cell Host Microbe, 2013. 
13(1): p. 87-99. 
66. Yen, H., et al., NleC, a type III secretion protease, compromises NF-kappaB 
activation by targeting p65/RelA. PLoS Pathog, 2010. 6(12): p. e1001231. 
67. Zhang, L., et al., Cysteine methylation disrupts ubiquitin-chain sensing in 
NF-kappaB activation. Nature, 2012. 481(7380): p. 204-8. 
68. Navarro, L., N.M. Alto, and J.E. Dixon, Functions of the Yersinia effector 
proteins in inhibiting host immune responses. Curr Opin Microbiol, 2005. 8(1): p. 
21-7. 
69. LaRock, C.N. and B.T. Cookson, The Yersinia virulence effector YopM binds 
caspase-1 to arrest inflammasome assembly and processing. Cell Host Microbe, 
2012. 12(6): p. 799-805. 
70. Geijtenbeek, T.B., et al., Mycobacteria target DC-SIGN to suppress dendritic cell 
function. J Exp Med, 2003. 197(1): p. 7-17. 
71. Bergman, M.P., et al., Helicobacter pylori modulates the T helper cell 1/T helper 
cell 2 balance through phase-variable interaction between lipopolysaccharide and 
DC-SIGN. J Exp Med, 2004. 200(8): p. 979-90. 
72. Fortune, S.M., et al., Mycobacterium tuberculosis inhibits macrophage responses 
to IFN-gamma through myeloid differentiation factor 88-dependent and 
-independent mechanisms. J Immunol, 2004. 172(10): p. 6272-80. 
73. Salcedo, S.P., et al., Brucella control of dendritic cell maturation is dependent on 
the TIR-containing protein Btp1. PLoS Pathog, 2008. 4(2): p. e21. 
74. Bosio, C.M. and S.W. Dow, Francisella tularensis induces aberrant activation of 
pulmonary dendritic cells. J Immunol, 2005. 175(10): p. 6792-801. 
75. Thanabalasuriar, A., et al., Sec24 interaction is essential for localization and 
  GENERAL INTRODUCTION  
- 34 - 
 
virulence-associated function of the bacterial effector protein NleA. Cell 
Microbiol, 2012. 14(8): p. 1206-18. 
76. Olsen, R.L., et al., The enterohemorrhagic Escherichia coli effector protein NleF 
binds mammalian Tmp21. Vet Microbiol, 2013. 164(1-2): p. 164-70. 
77. Selyunin, A.S., et al., Selective protection of an ARF1-GTP signaling axis by a 
bacterial scaffold induces bidirectional trafficking arrest. Cell Rep, 2014. 6(5): p. 
878-91. 
78. Dong, N., et al., Structurally distinct bacterial TBC-like GAPs link Arf GTPase 
to Rab1 inactivation to counteract host defenses. Cell, 2012. 150(5): p. 1029-41. 
79. Burnaevskiy, N., et al., Proteolytic elimination of N-myristoyl modifications by 
the Shigella virulence factor IpaJ. Nature, 2013. 496(7443): p. 106-9. 
80. Moore, K.W., et al., Interleukin-10 and the interleukin-10 receptor. Annu Rev 
Immunol, 2001. 19: p. 683-765. 
81. Couper, K.N., D.G. Blount, and E.M. Riley, IL-10: the master regulator of 
immunity to infection. J Immunol, 2008. 180(9): p. 5771-7. 
82. David, R., Immune evasion: Bordetella escapes by inducing IL-10. Nat Rev 
Immunol, 2010. 10(2): p. 84-85. 
83. Bai, W., et al., TLR3 regulates mycobacterial RNA-induced IL-10 production 
through the PI3K/AKT signaling pathway. Cell Signal, 2014. 26(5): p. 942-50. 
84. Oertli, M. and A. Muller, Helicobacter pylori targets dendritic cells to induce 
immune tolerance, promote persistence and confer protection against allergic 
asthma. Gut Microbes, 2012. 3(6): p. 566-71. 
85. Wei, L., J. Wang, and Y. Liu, Prior to Foxp3 regulatory T-cell induction, 
interleukin-10-producing B cells expand after Helicobacter pylori infection. 
Pathog Dis, 2014. 
86. Lee, C.C. and J.T. Kung, Marginal zone B cell is a major source of Il-10 in 
Listeria monocytogenes susceptibility. J Immunol, 2012. 189(7): p. 3319-27. 
87. Wojciechowski, W., et al., Attenuation of MHC class II expression in 
macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin 
involves class II transactivator and depends on the Nramp1 gene. J Immunol, 
1999. 163(5): p. 2688-96. 
88. Noss, E.H., et al., Toll-like receptor 2-dependent inhibition of macrophage class 
II MHC expression and antigen processing by 19-kDa lipoprotein of 
Mycobacterium tuberculosis. J Immunol, 2001. 167(2): p. 910-8. 
89. Gagliardi, M.C., et al., Mycobacteria exploit p38 signaling to affect CD1 
expression and lipid antigen presentation by human dendritic cells. Infect Immun, 
2009. 77(11): p. 4947-52. 
90. Halici, S., et al., Functional analysis of the Salmonella pathogenicity island 
  GENERAL INTRODUCTION  
- 35 - 
 
2-mediated inhibition of antigen presentation in dendritic cells. Infect Immun, 
2008. 76(11): p. 4924-33. 
91. Lapaque, N., et al., Salmonella regulates polyubiquitination and surface 
expression of MHC class II antigens. Proc Natl Acad Sci U S A, 2009. 106(33): p. 
14052-7. 
92. Yao, T., et al., Suppression of T and B lymphocyte activation by a Yersinia 
pseudotuberculosis virulence factor, yopH. J Exp Med, 1999. 190(9): p. 1343-50. 
93. Umehara, S., et al., Effects of Helicobacter pylori CagA protein on the growth 
and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene, 2003. 
22(51): p. 8337-42. 
94. Torres, V.J., et al., Helicobacter pylori vacuolating cytotoxin inhibits 
activation-induced proliferation of human T and B lymphocyte subsets. J 
Immunol, 2007. 179(8): p. 5433-40. 
95. Gebert, B., et al., Helicobacter pylori vacuolating cytotoxin inhibits T 
lymphocyte activation. Science, 2003. 301(5636): p. 1099-102. 
96. Boncristiano, M., et al., The Helicobacter pylori vacuolating toxin inhibits T cell 
activation by two independent mechanisms. J Exp Med, 2003. 198(12): p. 
1887-97. 
97. Boulton, I.C. and S.D. Gray-Owen, Neisserial binding to CEACAM1 arrests the 
activation and proliferation of CD4+ T lymphocytes. Nat Immunol, 2002. 3(3): p. 
229-36. 
98. Kilian, M., et al., Biological significance of IgA1 proteases in bacterial 
colonization and pathogenesis: critical evaluation of experimental evidence. 
APMIS, 1996. 104(5): p. 321-38. 
99. Breitschwerdt, E.B., et al., Bartonellosis: an emerging infectious disease of 
zoonotic importance to animals and human beings. J Vet Emerg Crit Care (San 
Antonio), 2010. 20(1): p. 8-30. 
100. Engel, P., et al., Parallel evolution of a type IV secretion system in radiating 
lineages of the host-restricted bacterial pathogen Bartonella. PLoS Genet, 2011. 
7(2): p. e1001296. 
101. Chomel, B.B., et al., Ecological fitness and strategies of adaptation of Bartonella 
species to their hosts and vectors. Vet Res, 2009. 40(2): p. 29. 
102. Chomel, B.B., et al., Bartonella spp. in pets and effect on human health. Emerg 
Infect Dis, 2006. 12(3): p. 389-94. 
103. Maguina, C. and E. Gotuzzo, Bartonellosis. New and old. Infect Dis Clin North 
Am, 2000. 14(1): p. 1-22, vii. 
104. Ihler, G.M., Bartonella bacilliformis: dangerous pathogen slowly emerging from 
deep background. FEMS Microbiol Lett, 1996. 144(1): p. 1-11. 
  GENERAL INTRODUCTION  
- 36 - 
 
105. Maguina, C., et al., Bartonellosis (Carrion's disease) in the modern era. Clin 
Infect Dis, 2001. 33(6): p. 772-9. 
106. Bass, J.W., J.M. Vincent, and D.A. Person, The expanding spectrum of 
Bartonella infections: I. Bartonellosis and trench fever. Pediatr Infect Dis J, 1997. 
16(1): p. 2-10. 
107. Florin, T.A., T.E. Zaoutis, and L.B. Zaoutis, Beyond cat scratch disease: 
widening spectrum of Bartonella henselae infection. Pediatrics, 2008. 121(5): p. 
e1413-25. 
108. Koehler, J.E., et al., Molecular epidemiology of bartonella infections in patients 
with bacillary angiomatosis-peliosis. N Engl J Med, 1997. 337(26): p. 1876-83. 
109. Dehio, C., Bartonella-host-cell interactions and vascular tumour formation. Nat 
Rev Microbiol, 2005. 3(8): p. 621-31. 
110. Harms, A. and C. Dehio, Intruders below the radar: molecular pathogenesis of 
Bartonella spp. Clin Microbiol Rev, 2012. 25(1): p. 42-78. 
111. Siamer, S. and C. Dehio, New insights into the role of Bartonella effector 
proteins in pathogenesis. Curr Opin Microbiol, 2014. 23C: p. 80-85. 
112. Caceres, A.G., et al., Possible role of Lutzomyia maranonensis and Lutzomyia 
robusta (Diptera: Psychodidae) as vectors of human bartonellosis in three 
provinces of region nor Oriental del Maranon, Peru. Rev Inst Med Trop Sao 
Paulo, 1997. 39(1): p. 51-2. 
113. Fournier, P.E., et al., Experimental model of human body louse infection using 
green fluorescent protein-expressing Bartonella quintana. Infect Immun, 2001. 
69(3): p. 1876-9. 
114. Higgins, J.A., et al., Acquisition of the cat scratch disease agent Bartonella 
henselae by cat fleas (Siphonaptera:Pulicidae). J Med Entomol, 1996. 33(3): p. 
490-5. 
115. Dehio, C., U. Sauder, and R. Hiestand, Isolation of Bartonella schoenbuchensis 
from Lipoptena cervi, a blood-sucking arthropod causing deer ked dermatitis. J 
Clin Microbiol, 2004. 42(11): p. 5320-3. 
116. Schulein, R., et al., Invasion and persistent intracellular colonization of 
erythrocytes. A unique parasitic strategy of the emerging pathogen Bartonella. J 
Exp Med, 2001. 193(9): p. 1077-86. 
117. Seubert, A., R. Schulein, and C. Dehio, Bacterial persistence within erythrocytes: 
a unique pathogenic strategy of Bartonella spp. Int J Med Microbiol, 2002. 
291(6-7): p. 555-60. 
118. Dehio, C., Bartonella interactions with endothelial cells and erythrocytes. Trends 
Microbiol, 2001. 9(6): p. 279-85. 
119. Karem, K.L., et al., Characterization of Bartonella henselae-specific immunity in 
  GENERAL INTRODUCTION  
- 37 - 
 
BALB/c mice. Immunology, 1999. 97(2): p. 352-8. 
120. Okujava, R., et al., A translocated effector required for bartonella dissemination 
from derma to blood safeguards migratory host cells from damage by 
co-translocated effectors. PLoS Pathog, 2014. 10(6): p. e1004187. 
121. Linke, D., et al., Trimeric autotransporter adhesins: variable structure, common 
function. Trends Microbiol, 2006. 14(6): p. 264-70. 
122.Riess, T., et al., Bartonella adhesin a mediates a proangiogenic host cell response. 
J Exp Med, 2004. 200(10): p. 1267-78. 
123.O'Rourke, F., et al., Adhesins of Bartonella spp. Adv Exp Med Biol, 2011. 715: p. 
51-70. 
124. Kempf, V.A., et al., Activation of hypoxia-inducible factor-1 in bacillary 
angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial 
infections. Circulation, 2005. 111(8): p. 1054-62. 
125. Kempf, V.A., et al., Evidence of a leading role for VEGF in Bartonella 
henselae-induced endothelial cell proliferations. Cell Microbiol, 2001. 3(9): p. 
623-32. 
126. Kaiser, P.O., et al., The head of Bartonella adhesin A is crucial for host cell 
interaction of Bartonella henselae. Cell Microbiol, 2008. 10(11): p. 2223-34. 
127. Kaiser, P.O., et al., Analysis of the BadA stalk from Bartonella henselae reveals 
domain-specific and domain-overlapping functions in the host cell infection 
process. Cell Microbiol, 2012. 14(2): p. 198-209. 
128. Christie, P.J., et al., Biogenesis, architecture, and function of bacterial type IV 
secretion systems. Annu Rev Microbiol, 2005. 59: p. 451-85. 
129. Saenz, H.L., et al., Genomic analysis of Bartonella identifies type IV secretion 
systems as host adaptability factors. Nat Genet, 2007. 39(12): p. 1469-76. 
130. Vayssier-Taussat, M., et al., The Trw type IV secretion system of Bartonella 
mediates host-specific adhesion to erythrocytes. PLoS Pathog, 2010. 6(6): p. 
e1000946. 
131. Schulein, R. and C. Dehio, The VirB/VirD4 type IV secretion system of 
Bartonella is essential for establishing intraerythrocytic infection. Mol Microbiol, 
2002. 46(4): p. 1053-67. 
132. Lu, Y.Y., et al., Bartonella henselae trimeric autotransporter adhesin BadA 
expression interferes with effector translocation by the VirB/D4 type IV secretion 
system. Cell Microbiol, 2013. 15(5): p. 759-78. 
133. Quebatte, M., et al., The BatR/BatS two-component regulatory system controls 
the adaptive response of Bartonella henselae during human endothelial cell 
infection. J Bacteriol, 2010. 192(13): p. 3352-67. 
134. Engel, P., et al., Adenylylation control by intra- or intermolecular active-site 
  GENERAL INTRODUCTION  
- 38 - 
 
obstruction in Fic proteins. Nature, 2012. 482(7383): p. 107-10. 
135. Roy, C.R. and S. Mukherjee, Bacterial FIC Proteins AMP Up Infection. Sci 
Signal, 2009. 2(62): p. pe14. 
136. Pieles, K., et al., An experimental strategy for the identification of AMPylation 
targets from complex protein samples. Proteomics, 2014. 14(9): p. 1048-52. 
137. Palanivelu, D.V., et al., Fic domain-catalyzed adenylylation: insight provided by 
the structural analysis of the type IV secretion system effector BepA. Protein Sci, 
2011. 20(3): p. 492-9. 
138. Hayashi, T., H. Morohashi, and M. Hatakeyama, Bacterial EPIYA 
effectors--where do they come from? What are they? Where are they going? Cell 
Microbiol, 2013. 15(3): p. 377-85. 
139. Schulein, R., et al., A bipartite signal mediates the transfer of type IV secretion 
substrates of Bartonella henselae into human cells. Proc Natl Acad Sci U S A, 
2005. 102(3): p. 856-61. 
140. Selbach, M., et al., Host cell interactome of tyrosine-phosphorylated bacterial 
proteins. Cell Host Microbe, 2009. 5(4): p. 397-403. 
141. Dehio, C., et al., Interaction of Bartonella henselae with endothelial cells results 
in bacterial aggregation on the cell surface and the subsequent engulfment and 
internalisation of the bacterial aggregate by a unique structure, the invasome. J 
Cell Sci, 1997. 110 ( Pt 18): p. 2141-54. 
142. Kyme, P.A., et al., Unusual trafficking pattern of Bartonella henselae -containing 
vacuoles in macrophages and endothelial cells. Cell Microbiol, 2005. 7(7): p. 
1019-34. 
143. Scheidegger, F., et al., Distinct activities of Bartonella henselae type IV secretion 
effector proteins modulate capillary-like sprout formation. Cell Microbiol, 2009. 
11(7): p. 1088-101. 
144. Truttmann, M.C., T.A. Rhomberg, and C. Dehio, Combined action of the type IV 
secretion effector proteins BepC and BepF promotes invasome formation of 
Bartonella henselae on endothelial and epithelial cells. Cell Microbiol, 2011. 
13(2): p. 284-99. 
145. Truttmann, M.C., et al., Bartonella henselae engages inside-out and outside-in 
signaling by integrin beta1 and talin1 during invasome-mediated bacterial uptake. 
J Cell Sci, 2011. 124(Pt 21): p. 3591-602. 
146. Scheidegger, F., et al., The Bartonella henselae VirB/Bep system interferes with 
vascular endothelial growth factor (VEGF) signalling in human vascular 
endothelial cells. Cell Microbiol, 2011. 13(3): p. 419-31. 
147. Schmid, M.C., et al., A translocated bacterial protein protects vascular 
endothelial cells from apoptosis. PLoS Pathog, 2006. 2(11): p. e115. 
  GENERAL INTRODUCTION  
- 39 - 
 
148. Schmid, M.C., et al., The VirB type IV secretion system of Bartonella henselae 
mediates invasion, proinflammatory activation and antiapoptotic protection of 
endothelial cells. Mol Microbiol, 2004. 52(1): p. 81-92. 
149. Pulliainen, A.T., et al., Bacterial effector binds host cell adenylyl cyclase to 
potentiate Galphas-dependent cAMP production. Proc Natl Acad Sci U S A, 
2012. 109(24): p. 9581-6. 
150. Seubert, A., et al., A bacterial conjugation machinery recruited for pathogenesis. 
Mol Microbiol, 2003. 49(5): p. 1253-66. 
151. Deng, H.K., et al., Identification of Bartonella Trw host-specific receptor on 
erythrocytes. PLoS One, 2012. 7(7): p. e41447. 
152. Merrell, D.S. and S. Falkow, Frontal and stealth attack strategies in microbial 
pathogenesis. Nature, 2004. 430(6996): p. 250-6. 
153. Zahringer, U., et al., Structure and biological activity of the short-chain 
lipopolysaccharide from Bartonella henselae ATCC 49882T. J Biol Chem, 2004. 
279(20): p. 21046-54. 
154. Popa, C., et al., Bartonella quintana lipopolysaccharide is a natural antagonist of 
Toll-like receptor 4. Infect Immun, 2007. 75(10): p. 4831-7. 
155. Matera, G., et al., The Janus face of Bartonella quintana recognition by Toll-like 
receptors (TLRs): a review. Eur Cytokine Netw, 2008. 19(3): p. 113-8. 
156. Kabeya, H., et al., Experimental infection of cats with Bartonella henselae 
resulted in rapid clearance associated with T helper 1 immune responses. 
Microbes Infect, 2009. 11(6-7): p. 716-20. 
157. Capo, C., et al., Bartonella quintana bacteremia and overproduction of 
interleukin-10: model of bacterial persistence in homeless people. J Infect Dis, 
2003. 187(5): p. 837-44. 
158. Kabeya, H., et al., Characterization of Th1 activation by Bartonella henselae 
stimulation in BALB/c mice: Inhibitory activities of interleukin-10 for the 
production of interferon-gamma in spleen cells. Vet Microbiol, 2007. 119(2-4): p. 
290-6. 
159. Papadopoulos, N.G., et al., Circulating cytokines in patients with cat scratch 
disease. Clin Infect Dis, 2001. 33(6): p. e54-6. 
160. Vermi, W., et al., Role of dendritic cell-derived CXCL13 in the pathogenesis of 
Bartonella henselae B-rich granuloma. Blood, 2006. 107(2): p. 454-62. 
161. Mege, J.L., et al., The two faces of interleukin 10 in human infectious diseases. 
Lancet Infect Dis, 2006. 6(9): p. 557-69. 
162.Marignac, G., et al., Murine model for Bartonella birtlesii infection: New aspects. 
Comp Immunol Microbiol Infect Dis, 2010. 33(2): p. 95-107. 
163. Koesling, J., et al., Cutting edge: antibody-mediated cessation of hemotropic 
  GENERAL INTRODUCTION  
- 40 - 
 
infection by the intraerythrocytic mouse pathogen Bartonella grahamii. J 
Immunol, 2001. 167(1): p. 11-4. 
164. Kordick, D.L. and E.B. Breitschwerdt, Relapsing bacteremia after blood 
transmission of Bartonella henselae to cats. Am J Vet Res, 1997. 58(5): p. 492-7. 
165. Kabeya, H., et al., Predominant T helper 2 immune responses against Bartonella 
henselae in naturally infected cats. Microbiol Immunol, 2006. 50(3): p. 171-8. 
166. O'Reilly, K.L., et al., Passive antibody to Bartonella henselae protects against 
clinical disease following homologous challenge but does not prevent bacteremia 
in cats. Infect Immun, 2001. 69(3): p. 1880-2. 
167. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann, Two types of mouse T helper 
cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 
clones. J Exp Med, 1989. 170(6): p. 2081-95. 
168. Arvand, M., et al., Bartonella henselae-specific cell-mediated immune responses 
display a predominantly Th1 phenotype in experimentally infected C57BL/6 
mice. Infect Immun, 2001. 69(10): p. 6427-33. 
169. Musso, T., et al., Interaction of Bartonella henselae with the murine macrophage 
cell line J774: infection and proinflammatory response. Infect Immun, 2001. 
69(10): p. 5974-80. 
170. Schweyer, S. and A. Fayyazi, Activation and apoptosis of macrophages in cat 
scratch disease. J Pathol, 2002. 198(4): p. 534-40. 
171. Kunz, S., et al., Lymphadenopathy in a novel mouse model of 
Bartonella-induced cat scratch disease results from lymphocyte immigration and 
proliferation and is regulated by interferon-alpha/beta. Am J Pathol, 2008. 172(4): 
p. 1005-18. 
  
  
- 41 - 
 
 
 
 
 
 
 
 
 
2. AIM OF THE THESIS 
 
 
  
  AIM OF THE THESIS  
- 42 - 
 
Started in May 2011, my first project was collaborated with the group of Prof. Kempf 
in the Institute of Medical Microbiology and Infection Control at the University 
Hospital of the Johann Wolfgang Goethe-University in Frankfurt. Two pathogenicity 
factors of Bartonella henselae have been greater characterized in individual activities: 
the trimeric autotransporter Bartonella adhesin A (BadA) and the type IV secretion 
system VirB/D4 (VirB/D4 T4SS). In this study, we deeply investigated how these 
major virulence factors affect each other in their specific activities. 
In the second project, I focused on the natural host interface with Bartonella, 
particularly on the bacterial defense mechanisms against host immunity. To achieve 
this, my work was divided into two directions. One was to identify which Bartonella 
effector proteins as immunomodulatory molecules involved in intracellular 
communications to subvert the immunological signaling cascade. The other was to 
find the primary niche of Bartonella entry and replication in the natural reservoir host. 
By understanding the Bartonella infection cycle, I aimed to explore how Bartonella 
manipulate host immunity towards its pathogenicity in vivo. Taken in vitro and in vivo 
results together, I sought to complete this project with a comprehensive insight into 
which Bep displays immunosuppressive properties, how it works and what are the 
consequences of its function on host immunity. 
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3.1 Research article I 
Bartonella henselae trimeric autotransporter adhesin BadA 
expression interferes with effector translocation by the VirB/D4 type 
IV secretion system. 
Yun-Yueh Lu
#
, Bettina Franz
#
, Matthias C. Truttmann
#
, Tanja Riess, Marco 
Faustmann, Volkhard A.J. Kempf
*
 and Christoph Dehio
*
 
#
 These authors contributed equally 
*
 Corresponding authors 
Cellular Microbiology, May 2013, Volume 15, Issue 5, pages 759–778  
Statement of my contribution 
The project is collaborated with the group of Prof. V. Kempf in the Institute of 
Medical Microbiology and Infection Control at the University Hospital of the Johann 
Wolfgang Goethe-University in Frankfurt. In this study, the interaction of BadA and 
the VirB/D4 T4SS in B. henselae was analyzed. Our group focused on the functional 
analysis of the VirB/D4 T4SS and the BadA specific phenotypes were studied by the 
group of Prof. Kempf. My contributions include the characterization of clinical 
Bartonella henselae (Bhe) isolates and constructed Bhe mutants by analyzing BadA 
and VirB coexpression through the western blot and immunofluorescent labeling (Fig. 
1, 4A, and S2A). The phenotypic T4SS-dependent effects were studied in a variety of 
clinical Bhe isolates and constructed Bhe mutants by invasome formation and CRAfT 
assay (Fig. 3, 5, and 7). Moreover, to visualize the BadA structures and to further 
investigate the negative effect of BadA on the function of the VirB/D4 T4SS, Bhe 
infected cell samples were prepared for transmission electron microscopy (Fig. 6). 
The stability of the Cre-BID fusion constructs was showed by the western blot and 
CRAfT assay (Fig. S1A and S2B). Besides the protein level, gene regulation of bepD, 
virB4 and virB7 of Bhe mutants was analyzed by quantitative PCR (Fig. S2C). Finally, 
the manuscript was written by me, Dr. B. Franz, Dr. M. Truttmann, Prof. V. Kempf, 
and Prof. C. Dehio.  
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3.1.1 Summary   
The trimeric autotransporter Bartonella adhesin A (BadA) and the type IV secretion 
system VirB/D4 (VirB/D4 T4SS) of Bartonella spp. represent two of the most 
important pathogenicity factors of this genus - each displaying multiple functions in 
host cell interaction. The key functions of BadA in the molecular pathogenesis of B. 
henselae have been thoroughly studied with the Marseille strain (i.e., in the absence of 
a functional VirB/D4 T4SS). BadA mediates the binding to fibronectin (Fn), 
adherence to endothelial cells (ECs) and secretion of vascular endothelial growth 
factor (VEGF). The VirB/D4 T4SS of B. henselae are well studied in Houston-1 strain 
(i.e., in the absence of a functional BadA). It translocates several Bartonella effector 
proteins (Beps) into the cytoplasm of infected ECs, resulting in uptake of bacterial 
aggregates via the invasome structure, inhibition of apoptosis and activation of a 
proangiogenic phenotype. Despite this knowledge of the individual activities of BadA 
or VirB/D4, it is unknown whether these major virulence factors affect each other in 
their specific activities. In this study, expression and function of BadA and VirB/D4 
were analyzed in a variety of clinical B. henselae isolates. Data revealed that most 
isolates have lost expression of either BadA or VirB/D4 during in vitro passages. 
However, the phenotypic effects of coexpression of both virulence factors were 
studied in one clinical isolate stably coexpressing BadA and VirB/D4, as well as by 
ectopic expression of BadA in a strain only expressing VirB/D4. Our results showed 
that BadA forming a dense layer on the bacterial surface negatively affected 
VirB/D4-dependent Bep translocation and invasome formation by likely preventing 
close contact between the bacterial cell envelope and the host cell membrane. In 
contrast, BadA-dependent phenotypes, e.g., Fn binding, adhesion to ECs, and VEGF 
secretion, were not affected by a functional VirB/D4 T4SS. However, a certain 
regulatory antagonism is shown from previous transcriptional data that expression of 
the VirB/D4 T4SS was upregulated and that of BadA downregulated under certain 
conditions in the in vitro model, implying these essential virulence factors BadA and 
VirB/D4 are likely differentially expressed during different stages of the infection 
cycle of Bartonella. Further experiments elucidating the regulatory patterns of these 
two systems are needed to understand the underlying mechanisms of gene regulation 
in detail.  
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3.1.2 Manuscript  
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3.2 Research article II  
Bartonella translocated effectors, BepA and BepD, interfere with the 
maturation of dendritic cells 
Yun-Yueh Lu, Christoph Schmutz, Rusudan Okujava, Claudia Mistl, Timo Glatter, 
Antonius G. Rolink and Christoph Dehio* 
* Corresponding author 
Manuscript in preparation  
Statement of my contribution  
My contributions in this study include the establishment of BMDCs as an ex vivo 
model system (Fig. S1), characterization of phenotypic changes of infected BMDCs 
by Bartonella strains and E. coli LPS treatment (Fig. 1-2) as well as various 
comparative analyses of impaired DC maturation patterns by a vast number of Bhe 
mutants (Fig. 3-8 and Fig. 10-13). I constructed the listed of plasmids and Bhe 
mutants which were first described in this study, including strains overexpressing 
BepABhe homologs, BepDBhe homologs, all of the tyrosine substitution mutants of 
BepD-BXBIDBhe, and lenti-constructs of BepD (table S1 and Fig. S2). Furthermore, I 
established an in vitro model of JAWSII cell line (Fig. S7 and 14) and an inducible 
lentiviral system to ectopically express interest proteins (Fig. S8). This model was 
further used for identifying the interaction partners of BepD by Dr. C. Schmutz. In the 
following, I analyzed the STAT3 activation of infected BMDCs using immunoblotting 
(Fig. 19-21). I also analyzed the gene regulation of DC maturation markers, cytokines, 
and crem in infected BMDCs using quantitative PCR (Fig. 9, S4, and S6). For in vivo 
experiments, I first sequenced the B. taylorii, its virB2-11, virD4 and beps loci (Fig. 
S9 and S10), and established the Bta infection model in mice (Fig. 22). Following, I 
generated and examined the Bta deletion mutants for bacteremia development in mice 
(Fig. 23 and 24). 
This study was done with the great support by Dr. C. Schmutz, Dr. R. Okujava, and C. 
Mistl. Particularly, Christoph identified the interaction partners of BepD by the 
quantitative interactomic screen (Fig. 16), phospho-proteomic screen (Fig. 17), and 
co-immunoprecipitation (Fig. 15 and 18).  
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3.2.1 Summary   
In contrast to bacterial pathogens that cause acute diseases but rapidly cleared by host 
immune response, Bartonella infection in the natural reservoir host leads to long 
lasting bacteremia. A pre-requisite for this stealth-infection strategy is immune 
evasion. Dendritic cells (DCs), professional antigen-presenting cells, represent a cell 
type potentially relevant to the dermal stage of early Bartonella infection. To gain 
better understandings of immune evasion mediated by Bartonella immunomodulatory 
effectors, the murine bone marrow-derived DCs (BMDCs) were used as a model 
system. In response to Bartonella infection, BMDCs failed to fully mature. Impaired 
DC maturation was characterized by reduced surface expression of MHC class II 
complex and the co-stimulatory receptors CD40 and CD86, as well as strongly 
diminished secretion of the pro-inflammatory cytokines TNF-α and interleukin-6. 
These phenotypic changes were dependent on Bartonella effector proteins BepA and 
BepD, secreted via the type IV secretion system. The effect of BepA was narrowed 
down to its BID domain in association with elevations of intracellular cAMP level. 
BepD harbors an N-terminal array of tyrosine-phosphorylation motifs. Mutagenic 
analysis revealed the contribution of individual phospho-tyrosine residues to the 
impaired maturation phenotype. Several SH2 domain containing proteins were 
identified as interaction partners of BepD in dependence of its 
tyrosine-phosphorylation. Among them, STAT3 became significantly 
hyper-phosphorylated. STAT3 activation strongly correlated with the impaired DC 
maturation phenotype suggesting that it represents a key pathway hijacked by BepD 
to prevent DC maturation. These results showed that Bartonella was able to attenuate 
DC functions which may critically contribute to the modulation of T-cell mediated 
adaptive immunity. To further uncover the relevance of BepA and BepD in 
modulation of host immune response in vivo, a murine model with B. taylorii (Bta) 
infection was established. Through intradermal infection, Bta strains with deletion of 
bepA or/and bepD seemed to lose the fitness of bacteremia development. However, 
further optimizations and investigations are needed for a more sensitive in vivo system 
to study the function of Beps. Taken in vitro and in vivo data, we propose that 
Bartonella utilizes BepA and BepD as immnuomodulatory factors to mediate immune 
evasion and promote chronic bartonellosis.  
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3.2.2 Introduction 
The host immune response eliminating bacterial infection is based on a combination 
of both innate and adaptive immune systems. The orchestration of the immune 
response strictly relies on the interaction of pathogens with professional 
antigen-presenting cells (APCs). Among APCs, dendritic cells (DCs) have the unique 
ability to induce a potent antigen-dependent stimulation and play a central role in the 
initiation of the primary immune response. DCs are strategically located in the 
peripheral tissues where they reside in an immature state to exert a sentinel function 
for detecting foreign agents. Microbial stimuli trigger DC “maturation” describing the 
changes from immature antigen-capturing cells to mature antigen-presenting cells. 
These significant phenotypes of DC maturation include increased surface expression 
of co-stimulatory molecules (e.g., CD40, CD80, and CD86) and major 
histocompatibility complex class II (MHCII), as well as pro-inflammatory cytokine 
secretion (e.g., IL-6 and TNF-α). Furthermore, modified expression of chemokine 
receptors and adhesion molecules leads matured DCs migrating from peripheral 
tissues to the T cell zone of secondary lymphoid organs. Subsequently, activated DCs 
display pathogen-encoded antigens to naïve T cells and initiate the adaptive immunity 
[1, 2]. Early recognition of the pathogen-associated molecular patterns (PAMPs), e.g., 
bacterial lipopolysaccharide (LPS), peptidoglycan (PG), and lipopeptides, plays an 
essential role in DC maturation through germline-encoded pattern recognition 
receptors (PRRs). Among PRRs, the family of Toll-like receptors (TLRs) is the most 
extensively studied. Different TLRs are coupled to distinct downstream signaling 
pathways by the selective use of different TIR‐domain signaling adaptor molecules: 
MyD88, TRIF, TRAM, and TIRAP (Mal). In the following, three major signaling 
pathways are able to be activated by TLRs: mitogen‐activated protein kinase (MAPK), 
nuclear factor ‐ κB (NF ‐ κB), and interferon regulatory factors (IRFs), thereby 
cooperatively mediating pro‐inflammatory cytokine production [3, 4]. 
In recent times it has become clear that DCs are not only immune response initiators 
for T cell activation but also central inducers in the development of T cell tolerance. 
The particular immunological outcomes appear to be determined by the maturation 
state of DCs. Only the mature form promotes full blown T cell responses. In the 
steady state, immature DCs maintain T cell anergy to prevent self-destruction. More 
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than a simple “on/off” switch of DC activation, a semi-mature developmental stage of 
DCs is described in T cell tolerance mechanism. Inducible tolerance is believed to be 
generally attributed to semi-mature DCs, which are characterized by high levels of 
MHCII, but low or no expression of co-stimulatory molecules or pro-inflammatory 
cytokines. Such tolerogenic DCs can convert naïve T cells into regulatory T cells 
(Treg), which in turn suppress immune responses [5, 6]. 
Increasing evidence reveals that several bacterial pathogens develop unique 
mechanisms to subvert DC functions, thereby evading from host immune recognition. 
For example, Francisella tularensis exploits DCs not only as their replicative niches, 
but also for immune evasion. An attenuated type B strain of F. tularensis known as 
live vaccine strain (LVS) induces phenotypic activation with increased expression of 
MHCII and CD86 on the surface of DC. In the meanwhile, LVS inhibits the 
pro-inflammatory cytokines IL-12 and TNF-α secretion to facilitate pulmonary 
infection [7]. In addition, a virulent type A strain of F. tularensis Schu4 prevents the 
phenotypic activation of pulmonary DCs and macrophages as well as the secretion of 
pro-inflammatory cytokines [8, 9]. Similarly, other bacterial pathogens (e.g., 
Bordetella pertussis and Salmonella Typhimurium) also cause aberrant activation of 
DC but with limited bacterial growth in DCs. Bordetella infection causes phenotypic 
but not functional maturated DCs which secrete anti-inflammatory cytokine IL-10 and 
trigger activation of Treg cells [10, 11]. Although S. Typhimurium cannot prevent the 
induction co-stimulatory molecules and cytokine secretion, it is able to interfere with 
MHCII antigen presentation [12]. Additionally, other studies showed that 
Mycobacterium tuberculosis and Brucella abortus share similar profiles to 
comprehensively inhibit DC maturation. M. tuberculosis blocks NF-κB activation via 
the C-type lectin DC-SIGN, preventing DC maturation and reducing secretion of 
IL-12 [13-15]. As exemplified by B. abortus, its TIR-containing protein Btp1 
interferes with TLR2 signaling pathway to inhibit DC maturation [16]. Overall, the 
manipulation of DC maturation by bacterial pathogens constitutes an effective and 
powerful strategy for immune evasion. 
Bartonella transmission mainly replies on bloodsucking arthropods that initially 
inoculate bartonellae into the dermis. Bartonella infection results in a long-lasting 
bacteremia where erythrocytes serve as the immune-privileged niche. Little evidence 
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is available to understand precisely Bartonella infection stages from the intradermal 
inoculation to the bacteremic phase. A murine model of B. henselae infection revealed 
that bacterial DNA were detectable in liver and lymph nodes at 6 hours post 
intraperitoneal injection, proposing that lymphocytes or mononuclear phagocytes may 
be the vehicles of Bartonella transport [17]. A recent publication showed that 
Bartonella was capable of translocating bacterial effectors into DCs, thereby affecting 
cell migration [18]. Taken altogether, present evidences strongly suggest that DCs 
may constitute an important cellular niche to promote Bartonella dissemination from 
the dermis to the lymphatic system. Besides the migratory properties of DCs, we 
sought to understand consequences of Bartonella infection on the immune functions. 
Several virulence factors allow bartonellae to adhere, invade, proliferate, and persist 
within various host-cell types. Particularly, the VirB/D4 type IV secretion system 
(T4SS) represents an essential virulence factor which is likely required for the initial 
colonization rather than for the subsequent blood-stage infection [19]. Seven distinct 
Bartonella effector proteins (BepA-G) of B. henselae have been identiﬁed as 
conjugative substrates through VirB/D4 T4SS. Evolutionally, Beps maintain their 
ancestral domain constitution with at least one Bartonella intracellular delivery (BID) 
domain and a positively-charged tail in the C-terminus together as the translocation 
signal [20]. To date, most studies of T4SS-dependent phenotypes mainly focus on the 
subversion of various endothelial cell (EC) functions, including massive 
rearrangements of the actin cytoskeleton (known as invasome structures), activation 
of the NF-κB-dependent pro-inflammatory response, anti-apoptotic protection, 
capillary-like sprout formation, and prevention of cell fragmentation [21-26].  
Unlike bacterial pathogens which lead to acute infection and induce pro-inflammatory 
responses, Bartonella infection (e.g. B. bacilliformis, B. quintana, and B. henselae) 
elevates the levels of the anti-inflammatory cytokine IL-10 in human patients and 
various experimental models [27-30]. Though phenotypic descriptions on 
immunological attenuation by Bartonella infection, it is still unclear how Bartonella 
interferes with functions of the host immune system. Thus, we sought to explore 
whether Bartonella infection subverts DC functions for immune evasion, a strategy 
shared by other bacteria causing chronic diseases. In this study, we characterized the 
consequences of Bartonella infection on the inhibition of DC maturation, including 
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downregulation of MHCII, CD40, and CD86 surface expression as well as reduction 
of pro-inflammatory cytokine secretion, IL-6 and TNF-α. These specific 
immunosuppression phenotypes were assigned to BepA and BepD. The effect of 
BepA in DCs was associated with elevation of host cell cyclic adenosine 
monophosphate (cAMP) concentration. Furthermore, activated STAT3 strongly 
correlated with the impaired DC maturation phenotype caused by BepD. Thus, this 
article describes the remarkable features of these two Beps into a new perspective, 
highlighting the mechanisms they use to hijack host signaling pathways as 
stealth-attack strategies to evade the host immune responses. 
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3.2.3 Materials and Methods 
Bacterial strains, growth conditions and conjugations 
All bacterial strains used in this study were listed in the supplementary table S1.  
Bartonella strains were grown on Columbia base agar plates supplemented with 5% 
sheep blood (CBA) or cultured in medium M199 (Gibco) with 10% fetal calf serum 
(FCS) (Gibco) and appropriate antibiotics at 37°C and 5% CO2 for 2-4 days. E. coli 
strains were cultivated in Luria-Bertani liquid broth (LB) or on solid agar plates (LA) 
supplemented with appropriate antibiotics at 37°C overnight. When indicated, 
antibiotics or supplements were used in the following concentrations: kanamycin 30 
µg ml
-1
, gentamycin 10 µg ml
-1
, streptomycin 100 µg ml
-1
, 
isopropyl-β-D-thiogalactoside (IPTG) 500 µM and diaminopimelic acid (DAP) 1 mM. 
Constructed plasmids were introduced into Bartonella strains by conjugation from 
E. coli strain β2150 using three-parental mating as described previously by Dehio et 
al., 1998 [31] 
Cell lines and culture conditions 
Mouse bone marrow-derived dendritic cells (BMDCs) were differentiated in vitro 
using standard protocol [32]. Briefly, bone marrow cells were flushed from the tibias 
and femurs of Balb/c mice with culture medium composed of GlutaMAX DMEM 
(Gibco) supplemented with 10% FCS, 10mM HEPES, 1mM sodium pyruvate, and 0.5 
mM β-ME. After one centrifugation, BM cells were resuspended in RBC lysis buffer 
(Biolegend) for 2 min to lyse RBC. After one more centrifugation, BM cells were 
cultured at 1 × 10
6
 cells/ml in culture medium supplemented with 200 ng/ml 
recombinant human Flt3L (produced by 40E1 hybridoma cells, kind gift from Prof. A. 
Rolink). Cultures were incubated at 37°C in 5% CO2 for 8-10 days. 
JAWSII cell line (ATCC CRL-11904™, kindly provided from Prof. P. Broz) is a 
GM-CSF-dependent DC line established from bone marrow cells of a p53-knockout 
C57BL/6 mouse [33]. JAWSII cells were cultured at 37°C in 5% CO2 in complete 
culture medium consisting of MDM (Sigma-Aldrich) with 10% FCS, 4 mM 
l-glutamine, 1 mM sodium pyruvate, and 5 ng/ml GM-CSF (produced by X63 
hybridoma cells, kind gift from Prof. A. Rolink).  
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Construction of strains and plasmids 
DNA manipulations were performed according to standard techniques and all cloned 
inserts were DNA sequenced to confirm sequence integrity. Chromosomal deletions 
of B. taylorii were generated by a two-step gene replacement procedure as described 
previously by Schulein et al., 2002 [19]. For protein complementation/overexpression 
in B. henselae and B. taylorii, selected genes were cloned into the plasmid pPG100 or 
pPG180 under the control of the taclac promoter [20]. For protein overexpression in 
JAWSII cells, interest genes were cloned into the plasmid 
pCLX-pTF-R1-DEST-R2-EBR65, which is a lentivector, under the TET-inducible 
promoter pTF [34] through standard gateway cloning strategy (Gateway system, 
Invitrogen). TET-modified pTF promoter was induced by adding doxycycline (DOX) 
to a final concentration of 1 μg/ml. Detailed description for the construction of each 
plasmid is presented in supporting information. The sequence of all oligonucleotide 
primers used in this study is listed in table S2. 
Infection of BMDCs 
For Bartonella infection of BMDCs, bacterial strains were cultured in medium 
M199/10% FCS for 2 days. One day before infection, BMDCs were seeded at 2 × 
10
6
/well in 6-well plates. Next day, cells were washed once with M199 supplemented 
with 10% FCS and infected with a multiplicity of infection (MOI) of 25 bacteria per 
cell in M199/10% FCS/500 µM IPTG. Unless stated differently, infected BMDCs 
were harvested at 24 hours post-infection for following immunoblot analysis and flow 
cytometry. The supernatants were collected for cytokine detection.  
Lentiviral transduction of JAWSII cells 
To generate stable cell lines with integrated selected genes, lentiviral transduction was 
performed as previously described by Okujava et al., 2014 [18]. Subconfluent (3 × 
10
6
) HEK 293T cells in 10 cm cell-culture dishes were transfected with a total of 5 µg 
of plasmid DNA following the FuGENE transfection protocol (FuGENE 6 
Transfection Reagent, Roche). After 6 h, the cell culture media was replaced. For viral 
production, the cells were kept in culture for additional 48 h. One day before the viral 
transduction, 5 × 10
4
 JAWSII cells/well was seeded in the 6-well plate. The viral 
supernatant was filtered with the 0.45 µm filter and transferred onto the JAWSII cells, 
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3 ml of viral supernatant in presence of 0.5 µg/ml Polybrene (Sigma) was applied on 
each well. After 6 h, the cell culture media was replaced by the complete growth 
media for JWASII cells. Two days after transduction, blasticidin selection (5 µg/ml, 
Gibco) was performed for additional one week to enrich transduced JAWSII cells.  
Determination of cell surface markers by flow cytometry 
The following staining reagents from Biolegend were used: PE anti-mouse MHCII 
(M5/114.15.2), APC anti-mouse MHCII (M5/114.15.2), PE anti-mouse CD40 (3/23), 
PE anti-mouse CD80 (16-10A1), PE anti-mouse CD86 (GL-1), APC anti-mouse 
CD86 (GL-1), and APC anti-mouse CD11c (N418). Cell suspensions of BMDCs or 
JAWSII cells were stained at 4
o
C with the appropriate antibodies in PBS containing 
2% FCS. Surface markers MHCII, CD40, CD80, and CD86 were measured using a 
FACSCalibur flow cytometer (Becton Dickinson). Dead cells were excluded through 
the use of propidium iodide. Data were analyzed with FlowJo software (TreeStar). 
Expression levels of the maturation markers were given as the geometric mean of the 
fluorescence intensities (GMFI) normalized to samples of Bhe ΔbepA-G infection. 
Determination of cytokine secretion  
After 24 hours post-infection, cytokine production was measured in the medium of 
infected BMDCs with ELISA. All ELISA kits specific to mouse IL-6, IL-12p40, and 
TNF-α were from eBioscience. The assay was performed following the 
manufacturers' guidelines. 
Immunoblot analysis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
immunoblotting for the detection of the expressed proteins in Bartonella were 
performed as described by Schulein et al., 2005 [20]. Bartonella bacterial culture was 
harvested in PBS after 48 h of growth on CBA plates supplemented with appropriate 
antibiotics and IPTG. After centrifugation, bacterial cell pellets were directly 
resuspended in 1x Laemmli sample buffer to final OD600 of 4. To verify the interest 
protein expression levels, infected BMDCs or JAWSII cells were collected and 
washed twice with 2ml ice-cold PBS. Cell pellets were lyzed by adding 100 µl 
PhosphoSafe reagent (Novagen) containing 1x protease inhibitor (Roche). Protein 
concentrations of the cleared lysates were quantified using BCA kit (Thermo 
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Scientific) and diluted to final 1× Laemmli sample buffer. Immunoblots were 
examined by the specific primary antibody to the target protein and followed by a 
1:5000 dilution of secondary horseradish peroxidase-conjugated antibody (GE 
Healthcare). In all experiments, immunoblots were developed using LumiGLO 
chemiluminescent substrate (KPL) and imaged using an ImageQuant LAS 4000 (GE 
Healthcare). Supplementary material Table S3 lists all primary antibodies used in this 
study. 
Quantitative RT-PCR 
RNA manipulation and real-time PCR was performed as previously described by 
Dehio et al., 2005 [35]. RNA extracts were purified with the RNeasy mini kit (Qiagen) 
and treated with DNase (RNase-Free DNase Set, Qiagen) to digest contaminating 
genomic DNA. Reverse transcription was performed using the SuperScript II Reverse 
Transcriptase (Invitrogen) according to the manufacturer's instructions. cDNA (5 µl of 
a 1:200 dilution) was subjected to real-time PCR on an ABI PRISM 7000 Sequence 
Detection System (Applied Biosystems) using a Power SYBR Green PCR Master 
Mix (Applied Biosystems). qPCRs were set up as follows: one cycle of 95°C for 
10 min, followed by 45 cycles of 95°C for 15 sec and 60°C for 1 min. All samples 
were normalized to GAPDH signal and relative changes in gene expression were 
determined using the comparative CT method [36]. Table S2 in the supplemental 
material lists all primers used for quantitative PCR in this study.  
GFP-Trap® _A for Immunoprecipitation 
24 hours after seeding JawsII cells, expression of GFP-fused BepD constructs was 
induced by the addition of 1µg/ml doxycycline for further 24 hours. Cells were put on 
ice and the supernatant containing cells in dispersion, as well as adherent cells were 
collected and washed twice with ice-cold PBS. Cells were resuspended in ice-cold 
lysis buffer (10 mM Tris/Cl pH 7.5; 150 mM NaCl; 0.5 mM EDTA; 0.5% NP-40, 1x 
PhosSTOP, 1x, 1x cOmplete, Mini, EDTA-free) and incubated for 30 minutes on ice. 
The cell lysate was centrifuged and the supernatant transferred to a new tube. The 
sample was subsequently diluted with 1.5x amount of dilution buffer (10 mM Tris/Cl 
pH 7.5; 150 mM NaCl; 0.5 mM EDTA). Meanwhile GFP-Trap® _A beads were taken 
and washed twice with ice-cold dilution buffer. The diluted cell lysate was then added 
to the GFP-Trap® _A beads and incubated for 1h at 4°C tumbled end-over end. 
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Afterwards, the mixture was washed 4 times with ice-cold dilution buffer and eluted 3 
times with ice-cold 0.2M glycine pH 2.5. The eluate was neutralized with 
Ammoniumbicarbonate to a pH > 8. 
Preparation of immunoprecipitated samples for mass spectrometry 
Disulfide bonds were reduced with tris (2-carboxyethyl) phosphine at a final 
concentration of 10 mM at 37 °C for 1 h. Free thiols were alkylated with 20 mM 
iodoacetamide at room temperature for 30 min in the dark. The excess of 
iodoacetamide was quenched with N-acetyl cysteine at a final concentration of 25 
mM for 10 min at room temperature. The proteins were digested overnight at 37 °C 
with sequencing-grade modified trypsin at a protein-to-enzyme ratio of 50:1. Peptides 
were desalted on a C18 Sep-Pak cartridge and dried under vacuum. 
Sample preparation for phosphoproteomics 
24 hours after seeding JawsII cells, expression of GFP-fused BepD constructs was 
induced by the addition of 1µg/ml doxycycline for further 24 hours. The plates were 
put on ice and washed twice with ice-cold PBS. Samples were then collected in urea 
solution [8 M Urea, 0.1 m Ammoniumbicarbonate, 1× PhosSTOP]. The samples were 
briefly vortexed, sonicated at 4 °C, shaked for 5 min on a thermomixer and 
centrifuged for 20 min at 4 °C and 16′000g. Supernatants were collected and stored 
at −80 °C for further processing. BCA Protein Assay was used to measure protein 
concentration. 
Phosphopeptide enrichment 
Disulfide bonds were reduced with tris (2-carboxyethyl) phosphine at a final 
concentration of 10 mM at 37 °C for 1 h. Free thiols were alkylated with 20 mM 
iodoacetamide at room temperature for 30 min in the dark. The excess of 
iodoacetamide was quenched with N-acetyl cysteine at a final concentration of 25 
mM for 10 min at room temperature. Lys-C endopeptidase was added to a final 
enzyme/protein ratio of 1:200 (w/w) and incubated for 4 h at 37 °C. The solution was 
subsequently diluted with 0.1 M ammoniumbicarbonate to a final concentration below 
2 M urea and digested overnight at 37 °C with sequencing-grade modified trypsin at a 
protein-to-enzyme ratio of 50:1. Peptides were desalted on a C18 Sep-Pak cartridge 
and dried under vacuum. Phosphopeptides were isolated from 2 mg of total peptide 
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mass with TiO2 as described previously [46]. Briefly, dried peptides were dissolved in 
an 80% acetonitrile (ACN)–2.5% trifluoroacetic acid (TFA) solution saturated with 
phthalic acid. Peptides were added to the same amount of equilibrated TiO2 (5-μm 
bead size, GL Sciences) in a blocked Mobicol spin column that was incubated for 30 
min with end-over-end rotation. The column was washed twice with the saturated 
phthalic acid solution, twice with 80% ACN and 0.1% TFA, and finally twice with 
0.1% TFA. The peptides were eluted with a 0.3 M NH4OH solution. The pH of the 
eluates was adjusted to be below 2.5 with 5% TFA solution and 2 M HCl. 
Phosphopeptides were again desalted with microspin C18 cartridges. 
LC-MS/MS analysis 
Chromatographic separation of peptides was carried out using an EASY nano-LC 
system (Thermo Fisher Scientific), equipped with a heated 30cm RP-HPLC column 
(75 μm x 45 cm) packed in-house with 1.9 µm C18 resin (Reprosil-AQ Pur, Dr. 
Maisch). Phosphopeptide samples were analyzed per LC-MS/MS run using a linear 
gradient ranging from 98% solvent A (0.15% formic acid) and 2% solvent B (98% 
acetonitrile, 2% water, 0.15% formic acid) to 30% solvent B over 120 minutes at a 
flow rate of 200 nl/min. Peptides derived from immunoprecipitation experiments were 
analyzed separated on a 60 min gradient. Mass spectrometry analysis was performed 
on a dual pressure LTQ-Orbitrap mass spectrometer equipped with a nanoelectrospray 
ion source (both Thermo Fisher Scientific). Each MS1 scan (acquired with the 
Orbitrap) was followed by collision-induced dissociation (CID, acquired in the LTQ) 
of the 10 most abundant precursor ions with dynamic exclusion for 30 seconds. For 
phosphopeptide analysis, the 10 most abundant precursor ions were subjected to CID 
with enabled multistage activation. Total cycle time was approximately 2 s. For MS1, 
106 ions were accumulated in the Orbitrap cell over a maximum time of 300 ms and 
scanned at a resolution of 240,000 FWHM (at 400 m/z). MS2 scans were acquired 
using the rapid scan mode, a target setting of 104 ions, and accumulation time of 25 
ms. Single charged ions and ions with unassigned charge state were excluded from 
triggering MS2 events. The normalized collision energy was set to 35%, and one 
microscan was acquired for each spectrum. 
Label-free Quantification and Database Searching 
The acquired raw-files were imported into the Progenesis software tool (Nonlinear 
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Dynamics) for label-free quantification using the default parameters. MS2 spectra 
were exported directly from Progenesis in mgf format and searched using the 
MASCOT algorithm (Matrix Science) against a decoy database containing normal 
and reverse sequences of the predicted SwissProt entries of Mus musculus 
(www.ebi.ac.uk) and commonly observed contaminants generated using the 
SequenceReverser tool from the MaxQuant software. The precursor ion tolerance was 
set to 10 ppm and fragment ion tolerance was set to 0.6 Da. The search criteria were 
set as follows: full tryptic specificity was required (cleavage after lysine or arginine 
residues unless followed by proline), 2 missed cleavages were allowed, 
carbamidomethylation (C) was set as fixed modification and phosphorylation (S,T,Y) 
or oxidation (M) as a variable modification for TiO2 enriched or not enriched samples, 
respectively. Finally, the database search results were exported as a xml-file and 
imported back to the Progenesis software for MS1 feature assignment. For 
phosphopeptide quantification, a csv-file containing the MS1 peak abundances of all 
detected features was exported and for not enriched samples, a csv-file containing all 
protein measurements based on the summed feature intensities of all identified 
peptides per protein was created. Importantly, the Progenesis software was set that 
proteins identified by similar sets of peptides are grouped together and that only 
non-conflicting peptides with specific sequences for single proteins in the database 
were employed for protein quantification. Both files were further processed using the 
in-house developed SafeQuant R script [74]. In brief, the software sets the 
identification level False Discovery Rate to 1% (based on the number of decoy 
protein sequence database hits) and normalizes the identified MS1 peak abundances 
(extracted ion chromatogram, XIC) across all samples, i.e. the summed XIC of all 
confidently identified peptide features is scaled to be equal for all LC-MS runs. In the 
case of the IP experiments, the summed XIC confidently identified peptide features, 
matching the bait proteins, were used for normalization. In the case of 
phosphoproteomoics, all quantified phosphopeptides/proteins are assigned an 
abundance ratio for each time point, based on the median XIC per time point. The 
statistical significance of each ratio is given by its q-value (false discovery rate 
adjusted p values), obtained by calculating modified t-statistic p values and adjusting 
for multiple testing. The location of the phosphorylated residues was automatically 
assigned by MASCOT (score >10). 
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Ethics statement 
Animals were handled in strict accordance with good animal practice as defined by 
the relevant European (European standards of welfare for animals in research), 
national (Information and guidelines for animal experiments and alternative methods, 
Federal Veterinary Office of Switzerland) and/or local animal welfare bodies. Animal 
work was approved by the Veterinary Office of the Canton Basel City on June 2003 
(licence no. 1741). 
Infection of mice 
Female BALB/cJRj mice were obtained at the age of 6-8 weeks from Janvier Labs. 
All animal studies were approved by the authors' institutional review boards. After 
one week of adaptation, the mice were infected with B. taylorii through the 
intradermal route. Bacterial strains were grown as described above, harvested in PBS, 
and diluted to OD600 = 0.01. Mice were infected with 10 µl of the bacterial suspension 
in the dermis of the right ear. Blood samples were taken from the tail vein and 
immediately mixed with PBS containing 3.8% sodium-citrate to avoid coagulation. 
After freezing at -70°C and subsequent thawing, undiluted and diluted blood samples 
were plated on CBA plates at 35°C and 5% CO2. After 7-10 days of growth, colony 
forming units (CFU) were counted. 
Statistical analysis 
Statistical analyses were performed using Student's t test (two-tailed): p<0.05 was 
considered to be statistically significant. 
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Materials and Methods S1 
DNA manipulations 
Plasmids for expression of Flag-Beps.  
The vector expressing the BepD-BXBIDBhe was constructed by PCR amplifying a 
fragment of 1104 bp from boiled colony of B. henselae RSE247 with the primers 
prLU174 and prLU175. After digesting the PCR product with NdeI, it was inserted in 
the respective site of the flag-tag expression vector pPG100, yielding pLU030. 
The vector expressing the BepABgr was constructed by PCR amplifying a fragment of 
1657 bp from boiled colony of B. grahamii CHDE142 with the primers prLU259 and 
prLU260. After digesting the PCR product with NdeI, it was inserted in the respective 
site of the flag-tag expression vector pPG100, yielding pLU054. 
The vector expressing the BepA-BIDBbi was constructed by PCR amplifying a 
fragment of 748 bp from boiled colony of B. birtlesii PEE0249 with the primers 
prLU283 and prLU284. After digesting the PCR product with NdeI, it was inserted in 
the respective site of the flag-tag expression vector pPG100, yielding pLU065. 
The vector expressing the BepA-BIDBta was constructed by PCR amplifying a 
fragment of 748 bp from boiled colony of B. taylorii LUB046 with the primers 
prLU285 and prLU286. After digesting the PCR product with NdeI, it was inserted in 
the respective site of the flag-tag expression vector pPG100, yielding pLU064. 
The vector expressing the BepDBtr was constructed by PCR amplifying a fragment of 
1597 bp from boiled colony of B. tribocorum RSE149 with the primers prLU265 and 
prLU266. After digesting the PCR product with NdeI, it was inserted in the respective 
site of the flag-tag expression vector pPG100, yielding pLU053. 
The vector expressing the BepDBgr was constructed by PCR amplifying a fragment of 
1192 bp from boiled colony of B. grahamii CHDE142 with the primers prLU281 and 
prLU282. After digesting the PCR product with NdeI, it was inserted in the respective 
site of the flag-tag expression vector pPG100, yielding pLU061. 
The vector expressing the BepDBbi was constructed by PCR amplifying a fragment of 
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1078 bp from boiled colony of B. birtlesii PEE0249  with the primers prLU234 and 
prLU235. After digesting the PCR product with NdeI, it was inserted in the respective 
site of the flag-tag expression vector pPG100, yielding pLU060. 
The vector expressing the BepDBta was constructed by PCR amplifying a fragment of 
1063 bp from boiled colony of B. taylorii LUB046 with the primers prLU074 and 
prLU075. After digesting the PCR product with NdeI, it was inserted in the respective 
site of the flag-tag expression vector pPG100, yielding pLU058. 
Tyrosine to phenylalanine exchange mutant in BepDBhe.  
To exchange the putatively phosphorylated tyrosines to phenylalanines in the 
N-terminus of BepD, we re-amplified the entire plasmid pLU030 containing the 
sequence coding for BepD-BXBID for site-directed mutagenesis. The template DNA 
was eliminated by DpnI digestion which specifically targets the methylated DNA. The 
mutated plasmid generated in vitro is unmethylated; thus it was left undigested. To 
avoid any unexpected mutation generated in the plasmid, the mutated bepD-BXBID 
fragment was cut and inserted into the parental pPG100 vector through the NdeI 
ligation. The Y32F; Y72F; Y92F; Y114F; Y134F (BepD-BXBIDBhe YF) mutant 
was generated after sequential mutation rounds.  
Construction of in-frame deletions.  
In-frame deletion mutants of Bta LUB046 were generated by a two-step gene 
replacement procedure as described [19, 37]. All mutagenesis plasmids derived from 
the mutagenesis vector pTR1000 harbor a cassette with the flanking regions of the 
in-frame deletion in the genes of interest. This cassette was generated from two PCR 
fragments amplified from chromosomal DNA of Bta LUB046 as template by 
conventional cloning. 
pLU068 used for generating a Bhe ΔbepA mutant was constructed as follows. 
Oligonucleotide primers prLU299 and prLU318 amplified fragment 1 (1000 bp) and 
prLU319 and prLU302 amplified fragment 2 (1000 bp). Both fragments were 
combined by SOEing PCR with oligonucleotide primers prLU299 and prLU302, 
resulting in a fragment of 2 kb carrying an in-frame deletion in bepABta. By using 
flanking XbaI sites, the fragment was inserted into the corresponding site of pTR1000, 
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yielding pLU068. The use of pLU068 for gene replacement in Bta LUB046 resulted 
in the Bta ΔbepA mutant LUB291. 
pLU069 used for generating a Bhe ΔbepD mutant was constructed as follows. 
Oligonucleotide primers prLU063 and prLU320 amplified fragment 1 (750 bp) and 
prLU304 and prLU305 amplified fragment 2 (750 bp). Both fragments were 
combined by SOEing PCR with oligonucleotide primers prLU063 and prLU305, 
resulting in a fragment of 1.5 kb carrying an in-frame deletion in bepDBta. By using 
flanking XbaI sites, the fragment was inserted into the corresponding site of pTR1000, 
yielding pLU069. The use of pLU069 for gene replacement in Bta LUB046 resulted 
in the Bta ΔbepD mutant LUB293. Next, the use of pLU069 for gene replacement in 
Bta ΔbepA LUB291 resulted in the Bta ΔbepAD mutant LUB297. 
pLU072 used for generating a Bta ΔvirD4 in-frame mutant was constructed as follows. 
Oligonucleotide primers prLU059 and prLU060 amplified fragment 1 (753 bp) and 
prLU061 and prLU062 amplified fragment 2 (790 bp). Both fragments were 
combined by SOEing PCR with oligonucleotide primers prLU059 and prLU062, 
resulting in a fragment of 1.54 kb carrying an in-frame deletion in virD4Bta. By using 
flanking XbaI sites, the fragment was inserted into the corresponding site of pTR1000, 
yielding pLU072. The use of pLU072 for gene replacement in LUB046 resulted in the 
Bta ΔvirD4 mutant LUB163. 
Plasmids for doxycycline-inducible lentiviral expression. The lentiviral 
doxycycline-inducible vector pCLX-pTF-R1-DEST-R2-EBR65 was constructed with 
the TET-inducible promoter pTF [34]. The GFP fragment of 796 bp was amplified by 
PCR from pRO300 using prLU276 and prLU277. The GFP fragment was recombined 
to pDONR by gateway BP clonase reaction (Life Technologies), yielding an entry 
clone pLU073. The GFP fragment in pLU073 was recombined into the destination 
vector pCLX-pTF-R1-DEST-R2-EBR65 by gateway LR clonase reaction (Life 
Technologies), yielding pLU077. 
The vector expressing GFP-BepD-BXBIDBhe, pLU078, was constructed by two steps 
of PCR. First, the GFP fragment of 778 bp was amplified from pRO300 using 
prLU276 and prRO90. The BepD-BXBIDBhe fragment of 1113 bp was amplified from 
pLU030 using prLU199 and prLU278. Second, SOEing PCR amplifying an extended 
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GFP-BepD-BXBIDBhe fragment of 1876 bp using the primers prLU276 and prLU278. 
Two steps of gateway cloning brought this GFP-BepD-BXBIDBhe fragment first into 
pDONR, yielding an entry clone pLU074. Subsequently, second reaction into the 
destination vector resulted in the pLU078. 
The vector expressing GFP-BepD-BIDBhe, pLU079, was constructed by two steps of 
PCR. First, the GFP fragment of 778 bp was amplified from pRO300 using prLU276 
and prRO90. The BepD-BIDBhe fragment of 576 bp was amplified from pLU030 
using prLU197 and prLU278. Second, SOEing PCR amplifying an extended 
GFP-BepD-BIDBhe fragment of 1339 bp using the primers prLU276 and prLU278. 
Two steps of gateway cloning brought this GFP-BepD-BIDBhe fragment first into 
pDONR, yielding an entry clone pLU075. Subsequently, second reaction into the 
destination vector resulted in the pLU079. 
The vector expressing GFP-BepD-BXBIDBhe 5Ymuts (Y32/72/92/114/134F), pLU080, 
was constructed by two steps of PCR. First, the GFP fragment of 778 bp was 
amplified from pRO300 using prLU276 and prRO90. The BepD-BXBIDBhe 5Ymuts 
fragment of 1113 bp was amplified from pLU044 using prLU199 and prLU278. 
Second, SOEing PCR amplifying an extended GFP-BepD-BXBIDBhe fragment of 
1876 bp using the primers prLU276 and prLU278. Two steps of gateway cloning 
brought this GFP-BepD-BXBIDBhe 5Ymuts fragment first into pDONR, yielding an 
entry clone pLU076. Subsequently, second reaction into the destination vector 
resulted in the pLU080. 
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3.2.4 Results 
Bartonella inhibits a full maturation of infected BMDCs through 
T4SS dependent manner 
Based on the current infection cycle of Bartonella, DCs represent one of the candidate 
cell types for the “dermal niche” and may serve as transporters of bacterial cargo to 
the lymph nodes [18]. However, it is still not fully understood how Bartonella is 
capable of exploiting these professional antigen presenting cells for pathogenicity. To 
better understand the consequences of Bartonella infection on the immune functions 
of DCs, we used murine bone marrow derived DCs (BMDCs) by Flt3-ligand (Flt3L) 
stimulation as a model in vitro system. Flt3L-dependent differentiation of DCs allows 
the generation of plasmacytoid (pDCs) and conventional (cDCs) dendritic cells from 
bone marrow precursors [32]. An anti-CD11c staining confirmed that a mixed culture 
of BMDCs contained 70% CD11c
+
 differentiated DCs. Within the CD11c
+
 DCs, 60% 
of cells were cDCs (CD11b
+
) and 30% were pCDs (B220
+
). Furthermore, 60% of 
CD11c
+
 DCs were expressing MHCII, indicating that these BMDCs were partially 
activated during Flt3L differentiation (Fig. S1). Following experiments were 
performed using the described mixture of BMDCs. To further characterize the 
properties of Flt3L derived BMDCs, maturation patterns were monitored by the 
regulation of surface co-stimulatory (CD40, CD80, and CD86) and MHCII molecules 
using flow cytometry analysis (Fig. 1A). Expression levels of the maturation markers 
were presented as the geometric mean of the fluorescence intensities (GMFI). Flow 
cytometric analysis showed that BMDCs were able to fully maturate characterized by 
upregulation of MHCII, CD40, CD80, and CD86 on the cell surface upon E. coli LPS 
stimulation.  
To study the role of Bartonella type IV secretion system (T4SS) in DC maturation, we 
used B. birtlesii (Bbi), a murine-specific strain, to infect murine BMDCs [38]. At 24 
hours post-infection (hpi), infection of BMDCs with Bbi wild-type resulted in 
upregulation of all tested surface makers (MHCII, CD40, CD80, and CD86) 
compared to uninfected condition. Interestingly, Bbi wild-type caused significantly 
lower expression of MHCII, CD40, and CD86 than Bbi Tn-virD4, a T4SS secretion 
deficient strain. However, a converse effect was observed on the expression of CD80 
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(Fig. 1B). In addition, the culture medium of infected BMDCs was analyzed for 
detection of pro-inflammatory cytokines (TNF-α, IL-6, and IL-12p40) by ELISA. As 
compared to Bbi Tn-virD4, Bbi wild-type infection induced dramatically low TNF-α 
and slightly lowered IL-6 secretion by BMDCs. However, no difference in IL-12p40 
secretion was observed (Fig. 2). Thus, analysis of maturation makers and cytokines 
revealed that Bartonella infection leads to semi-maturation of DCs in a T4SS 
dependent manner.   
BepABhe and BepDBhe display immunomodulatory effects on DCs 
To further dissect which Bartonella effector protein (Bep) is involved in interfering 
with maturation of DCs, investigations with mutant strains of Bartonella are needed. 
However, due to the difficulty of genetic modification on Bbi, we had to switch to a 
well characterized strain - B. henselae (Bhe) [39]. First, experiments were performed 
to confirm that Bhe has a similar effect on DC maturation as Bbi. Indeed, compared to 
an effector-free mutant (Bhe ΔbepA-G), infection with Bhe wild-type induced lower 
MHCII, CD40, and CD86 but higher CD80 expression (Fig. 1A and 1B). The 
regulation of co-stimulatory molecules caused by Bhe infection was comparable to 
Bbi infection. Consistently, cytokine secretion (TNF-α and IL-6) was reduced upon 
Bhe wild-type infection. Even more, IL-12p40 suppression was observed with Bhe 
infection but not with Bbi infection (Fig. 2). All of the results from two different 
strains strongly indicate that Beps are capable of modulating the maturation state of 
infected BMDCs. 
To identify which Bep contributes to the semi-maturation phenotype of BMDCs and 
potential modulation of the host immune system, infections with 
effector-complemented strains expressing individual Beps (BepA-GBhe) in the 
substrate-free background (Bhe ΔbepA-G) were analyzed (Fig. S2A). Strikingly, two 
Beps, BepABhe and BepDBhe, interfered with full maturation of infected BMDCs. 
BepABhe mainly affected MHCII and CD40 repression, while BepDBhe inhibited 
MHCII and CD86 upregulation but induced CD80 expression (Fig. 3). Furthermore, 
both BepABhe and BepDBhe reduced IL-6 and TNF-α secretion. However, BepDBhe was 
more potent in TNF-α inhibition than BepABhe (Fig. 4). These differences of inhibition 
level imply that the two effectors might interfere differently with cellular signaling 
pathways. 
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The functions of BepABhe and BepDBhe are related to its BID domain 
and the N-terminal fragment, respectively 
As indicated earlier, both BepABhe and BepDBhe contain one BID domain as the 
intracellular delivery signal at the C-terminus. In Bartonella infection models, the 
BID domain was indispensable for Bep translocation into host cells. At the N-terminal 
region, BepABhe carries a FIC domain and BepDBhe several tandem-repeated 
tyrosine-containing peptide sequences [40, 41]. The tyrosine-phosphorylation sites of 
BepDBhe were characterized by the presence of the Glu-Pro-Ile-Tyr-Ala (EPIYA) 
closely related sequences (referred to EPIYA-related motifs) [42]. To narrow down 
which domain is responsible for the effects of BepABhe and BepDBhe, strains 
expressing only BID domain of BepABhe or BepDBhe were used to infect BMDCs (Fig. 
S2B). Interestingly, the results showed that the BID domain of BepABhe behaved 
comparably as the full length of BepABhe towards inhibition of the MHCII and CD40 
expression as well as secretion of the cytokine TNF-α, IL-6, and IL-12p40 (Fig. 5 and 
6). However, the BID domain of BepDBhe lost its ability to trigger the DC phenotypes 
as observed by the full length protein (Fig. 5 and 6). It implies that the N-terminal 
region carrying the tandem EPIYA-related motifs is essential to interfere with DC 
maturation. 
CD40 expression and inflammatory cytokine secretion are negatively 
regulated by BepABhe homologs 
Based on the significant similarity of BepA homologs from the Bartonella lineage 4 
species (Fig. S3), the functional conservation of BepA homologs from different 
Bartonella species (BepABtr from B. tribocorum, BepABgr from B. grahamii, 
BepA-BIDBbi from B. birtlesii, and BepA-BIDBta from B. taylorii) on BMDCs was 
analyzed. However, due to the difficulty in cloning, only the BID domains of BepA 
from B. birtlesii and B. taylorii were constructed instead of the full length (Fig. S2C). 
Although the BID domains of BepA homologs share more than 50% amino acids (aa) 
identity, the activity among BepA homologs was discordant. Indeed, BepABtr and 
BepA-BIDBbi interfered with the MHCII and CD40 expression as well as TNF-α and 
IL-6 secretion to a similar extend as BepABhe. However, BepA-BIDBta led to weaker 
inhibition of DC maturation and no significant activity was observed by BepABgr (Fig. 
7 and 8).  
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The effects of BepABhe homologs are in association with the 
acceleration of cellular cyclic AMP level 
According to previous studies, the BID domain of BepA protects infected human ECs 
against apoptotic stimuli by elevation of cellular cAMP levels [43, 44]. Moreover, an 
artificial increase of cAMP by forskolin in DCs leads to reduced antigen uptake, 
lower surface expression of MHCII and CD40 [45]. Taken these results together, we 
suspected that the phenotypic changes of DC maturation caused by BepA might be 
due to stimulating intracellular cAMP level. To address this question, we tested 
whether BepA homologs activated the cAMP-dependent CREM/CREB pathway in 
BMDCs by quantitative real-time PCR of the cAMP-inducible gene, crem. At 24 hpi, 
RNA samples of infected BMDCs were extracted to monitor the transciptional 
regulation of CD40 and crem. Strikingly, the repression of CD40 by BepA homologs 
significantly correlated with upregulation of crem (Fig. 9). Similar to BepABhe and 
BepA-BIDBhe, BepABtr and BepA-BIDBbi showed strong activities on CD40 inhibition 
in association with high level of crem gene activation. Consistently, BepABgr led to an 
increase of CD40 mRNA expression but no induction of crem gene. Besides, 
quantitative PCR analysis revealed that BepA also transcriptionally inhibited the 
genes of inflammatory cytokines (TNF-α, IL-6, and IL-12) regulation (Fig. S4). In 
summary, these findings indicate that BepA acts as a potent negative regulator in DC 
maturation in association with an acceleration of intracellular cAMP level. 
BepDBhe homologs possess conserved activities on inhibition of 
MHCII and CD86 expression, as well as pro-inflammatory cytokine 
secretion 
To study whether BepD homologs trigger similar phenotypes of interference with DC 
maturation, we first aligned the sequence of BepD homologs from the Bartonella 
lineage 4 species (e.g. B. tribocorum, B. grahamii, B. birtlesii and B. taylorii). 
Similarly as BepDBhe, BepDBtr contains duplicate fragments (refer to AX and BX) at 
its N-terminal region sharing 90% aa identity. Corresponding to BepD-BXBhe, the 
N-terminal fragments of BepD homologs showed pair-wise aa identity of 35-50% 
with conserved tyrosines in the putative phosphorylation motifs (Fig. S5). Various 
Bhe strains were constructed by heterologous complementation with BepDBhe 
homologs (BepDBtr, BepDBgr, BepDBbi, and BepDBta) in Bhe ΔbepA-G background 
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(Fig. S2C). At 24 hpi, FACS analysis showed that all tested BepDBhe homologs 
resulted in inhibition of MHCII and CD86 but induction of CD80 expression (Fig. 10). 
Furthermore, BepDBtr and BepDBta had a strong effect on TNF-α and IL-6 repression 
like BepDBhe. However, weak cytokine suppression was observed by BepDBgr and 
BepDBbi (Fig. 11). 
The functional EPIYA-related motifs are delineated in 
BepD-BXBIDBhe by tyrosine to phenylalanine exchanges 
Next, we sought to characterize which EPIYA-related motif in BepDBhe contributes to 
the impaired DC maturation phenotype. A truncated mutant (refer to BepD-BXBIDBhe) 
was generated to reduce the complexity of potential redundant effects by duplication 
of N-terminal fragments. The inhibition level of MHCII and CD86 in BMDCs was 
comparable between the full length of BepDBhe and BepD-BXBIDBhe (Fig. 12). 
However, compared to BepD-BXBIDBhe, the full length of BepDBhe gave an additive 
effect on TNF-α and IL-6 repression (Fig. 13). Nine putative tyrosine-phosphorylation 
motifs are located in the BepD-BXBhe. To assess which tyrosine is critical for the 
immunomodulatory activity of BepD-BXBIDBhe in DCs, we performed a systematic 
mutagenesis to exchange the tyrosines to phenylalanines (Y32F, Y52F, Y62F, Y72F, 
Y92F, Y114F, Y134F, Y155F, and Y176F) (Fig. S2D). Strikingly, flow cytometric 
analysis of DC maturation markers revealed that three tyrosine-substitution mutants 
(Y92F, Y114F, and Y134F) significantly attenuated the phenotype caused by 
BepD-BXBIDBhe (Fig. 12). Consistent with flow cytometric results, these mutants 
(Y92F, Y114F, and Y134F) induced high level of TNF-α and IL-6 secretion. Two 
mutants (Y32F and Y72F) slightly lost the activity on cytokine suppression (Fig. 13). 
Additionally, two multi-tyrosine substitution mutants (Y32/114/134F and 
Y32/72/92/114/134F) were constructed by sequential mutation cloning rounds. Indeed, 
these two mutants did not interfere with DC maturation state infection with the 
effector-free strain Bhe ΔbepA-G (Fig. 12 and 13). In the following experiments, this 
multi-tyrosine substitution mutant (Y32/72/92/114/134F) was used as a 
loss-of-function mutant (refer to BepD-BXBIDBhe 5Ymuts).  
Ectopic expression of BepD-BXBIDBhe actively suppresses JAWSII 
responses to E. coli LPS stimuli 
Based on the solid phenotypes of impaired DC maturation, we became interested in 
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understanding the underlying mechanisms of BepD. Preliminary results of 
quantitative real-time PCR revealed that BepD transcriptionally interfered with 
cytokine regulation of TNF-α, IL-6, and IL-12p40, but not clearly influenced MHCII, 
CD80 and CD86 regulation (Fig. S6). To further uncover the molecular bases of BepD, 
we set up an in vitro model using the JAWSII cell line, a DC line established from 
bone marrow cells of a p53-knockout C57BL/6 mouse [33]. Anti-CD11c staining 
confirmed that more than 90% cells are CD11c
+
. Moreover, JAWSII cells are 
identified as cDCs (CD11b
+
/B220
-
) (Fig. S7A). Upon E. coli LPS treatment, 
maturation patterns were monitored by the regulation of surface co-stimulatory (CD40, 
CD80, and CD86) and MHCII molecules to characterize DC properties of JAWSII 
cells. Compared to untreated JAWSII cells, E. coli LPS stimulated MHCII and CD86 
upregulation, but not CD40 and CD80 (Fig. S7B). Since our results showed that 
BepDBhe interfered with DC maturation, especially on MHCII and CD86 inhibition, 
JAWSII cells were suitable to be used for BepD study.  
A lentiviral transduction system was used to ectopically express GFP or GFP-fusion 
proteins (GFP-BepD-BXBIDBhe, GFP-BepD-BIDBhe, and GFP-BepD-BXBIDBhe 
5Ymuts) in JAWSII cells. Under the TET-inducible promoter pTF, these GFP and 
GFP-fusion proteins were easily induced by doxycycline treatment (Fig. S8). Upon 
challenging by E. coli LPS for 24 hours, only DOX-induced BepD-BXBIDBhe 
prevented the JAWSII cells from MHCII and CD86 upregulation. The BID domain 
alone and the tyrosine-substitution mutant (BepD-BXBIDBhe 5Ymuts) abolished the 
effect of BepD-BXBIDBhe (Fig 14). 
BepD-BXBIDBhe co-immunoprecipitates with SHP2 and STAT3 in a 
phosphorylation-dependent manner 
A previous study on the interactome of BepDBhe revealed that several SH2 
domain-containing signaling proteins (e.g. Csk and SHP-2) interact with BepDBhe 
upon phosphorylation of specific tyrosines within the motifs [40]. To further 
investigate the potential intracellular targets of BepDBhe, GFP nanobodies coupled to 
agarose beads were used to pull down specific interaction partners of 
GFP-BepD-BXBIDBhe from lysates of JAWSII cells. Cells expressing the BID domain 
of BepDBhe (GFP-BepD-BIDBhe) or the tyrosine-substitution mutant 
(GFP-BepD-BXBIDBhe 5Ymuts) were employed as the negative controls to 
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distinguish between specific interaction partners and nonspecific contaminants. Upon 
immunoprecipitation with the GFP nanobodies, staining with anti-GFP and 
anti-phosphotyrosine antibodies confirmed that only BepD-BXBIDBhe as “wild-type” 
was tyrosine-phosphorylated by the endogenous levels of tyrosine kinases in the 
JAWSII cells. However, BepD-BIDBhe and BepD-BXBIDBhe 5Ymuts did not show any 
detectable tyrosine-phosphorylation (Fig. 15).  
A quantitative interactomic screen showed that 12 candidates significantly interacted 
with BepD-BXBIDBhe (Fig. 16A). Significant changes of the BepD-BXBIDBhe versus 
BepD-BXBIDBhe 5Ymuts were defined by a q-value cutoff of < 0.01. The interactome 
was graphically illustrated based on the STRING database. Only proteins with at least 
one connection in STRING were represented. Data showed a complex network with 
several distinct functional modules (Fig. 16B). The top three potential interaction 
partners of BepD-BXBIDBhe were PTPN11 (SHP-2, a tyrosine phosphatase), STAT3 
(a transcription factor), and Abl (a tyrosine kinase) (Fig. 16C). To obtain a 
systems-level overview of host signaling with BepD expression, we further analyzed 
the global dynamics of protein phosphorylation using a phosphoproteomics strategy 
combining with phosphopeptide enrichment [46] (Fig. 17A). For simplification, 27 
proteins were identified undergoing a significant change of phosphorylation in 
dependence of BepD-BXBIDBhe, 19 proteins with increase and 8 proteins with 
decrease in phosphorylation (Fig. 17B and 17C). Significant phosphorylation changes 
were defined by a q-value cutoff of < 0.01. Interestingly, the top candidate was STAT3 
undergoing to be hyper-phosphorylated.  
To examine the interaction between potential partners (e.g., SHP2 and STAT3) and 
BepD-BXBIDBhe, upon immunoprecipitation with the GFP nanobodies, we probed the 
precipitate with anti-SHP2 and anti-STAT3 antibodies. In contrast to the 
tyrosine-substitution mutant (BepD-BXBIDBhe 5Ymuts), SHP-2 and STAT3 
specifically co-immunoprecipitated with BepD-BXBIDBhe, demonstrating that 
Y32/72/92/114/134 mediate the interaction of SHP2 and STAT3 to BepD-BXBIDBhe 
in dependence of its tyrosine-phosphorylation (Fig 18). Strikingly, staining with an 
anti-phosphoSTAT3 (Y705) antibody showed that the pulled down STAT3 by 
BepD-BXBIDBhe was in a activate form (Fig. 18). Together with the interactomic 
screen data, we suspected that BepD might provide a platform to recruit STAT3 and 
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tyrosine kinases (likely Abl), to subsequently activate STAT3 signaling.  
Phosphorylation of STAT3 strongly correlates with semi-maturation 
phenotype of BMDCs 
In order to determine whether inhibition of DC maturation by BepD relates with 
STAT3 activation, various Bhe strains expressing BepDBhe homologs or 
BepD-BXBIDBhe tyrosine-substitution mutants were used for infection of BMDCs. At 
24 hpi, the cell lysates of infected BMDCs were analyzed by western blotting using 
anti-STAT3 and anti-phosphoSTAT3 (Y705) antibodies. STAT3 activation was 
quantified by the ratio of phospho-STAT3 to total STAT3. Interestingly, only BepDBhe 
led to hyper-phosphorylation of STAT3 but not BepEBhe and BepFBhe even though they 
also contain EPIYA-related motifs, indicating that STAT3 activation is specific in 
response to BepDBhe. Furthermore, BepDBhe homologs (BepDBtr, BepDBgr, BepDBbi, 
and BepDBta) shared similar properties like BepDBhe to enhance cellular 
phospho-STAT3 level (Fig. 19). Consistently, analyses of BepD-BXBIDBhe 
tyrosine-substitution mutants showed that three individual-tyrosine substitution 
mutants (Y92F, Y114F, and Y134F) significantly diminished the upregulation of 
phospho-STAT3. A multi-tyrosine substitution mutant (Y32/72/92/114/134F) which 
was proved to no longer inhibit DC maturation failed in STAT3 activation (Fig. 20). 
Overall, quantification of STAT3 activation revealed that the level of phospho-STAT3 
strongly correlated with phenotypes of impaired DC maturation caused by BepD. 
The prolonged STAT3 activation is known to be essential for the anti-inflammatory 
signals mediated by IL-10 and subsequently inhibits LPS-triggered signaling [47]. To 
determine whether STAT3 phosphorylation caused by BepD is sustained, we 
performed a time course analysis. BMDCs were infected with strains expressing 
BepD-BXBIDBhe or BepD-BXBIDBhe 5Ymuts. Cell lysates were collected over a time 
course (1 h, 3 h, 6 h, 9 h, 12 h, and 24 h post-infection). Western blotting showed that 
compared to BepD-BXBIDBhe 5Ymuts, BepD-BXBIDBhe clearly enhanced STAT3 
phosphorylation starting at 9 hpi. Furthermore, the accumulation of phsopho-STAT3 
expression was sustained till 24 hpi (Fig. 21). 
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A murine model with B. taylorii intradermal infection is established 
for functional analysis of Beps in vivo 
Next, we sought to explore the role of BepD in an in vivo establishment of Bartonella 
infection. However, Bhe causes intraerythrocytic bacteremia as a hallmark of 
infection in its feline natural reservoir host only, which for ethical reasons is not an 
accessible experimental model. To establish an optimal murine model for functional 
analysis of Beps in vivo, B. taylorii (Bta) a murine-specific strain was introduced. 
Based on its high conjugation efficiency, this strain was able to uptake the suicide 
mutagenesis plasmid for genetic manipulations. To gain more information about the 
VirB/D4 T4SS in Bta, we sequenced the respective genomic region including the virB 
operon, virD4 and the bep genes. For sequencing purposes, primers for creating 
overlapping PCR fragments were deduced from the published Bhe strain Houston-1 
genome (Accession No. NC_005956.1) [48] and fragments were subsequently 
sequenced. Annotation of the Bta genomic fragment revealed that open reading 
frames encoding for VirB2-11 and VirD4 show high similarities to Bhe. However, 
only five effector proteins were annotated in Bta instead of seven Beps (BepA-G) in 
Bhe (Fig. S9). Among them, two Beps of Bta, BepDBta and BepEBta contained putative 
tyrosine-phosphorylation motifs as homologs of BepDBhe (identity of the N-terminal 
fragment: 53%) and BepEBhe (identity of the N-terminal fragment: 24%), respectively. 
The in vitro data revealed that BepDBta but not BepEBta showed the 
immunomodulatory activity which was comparable to BepDBhe in BMDCs. Thus, we 
reasoned that Bta could be used as an appropriate species to study BepD functions in 
vivo.  
Mutations associated with streptomycin resistance have been identified in the genes 
encoding 16S rRNA (rrs) and ribosomal protein S12 (rpsL) [49]. For in-frame 
deletion mutagenesis, a spontaneous streptomycin-resistant (Sm
R
) variant of Bta was 
selected serving as the “wild-type” in which rpsL changed with codon 43 mutation 
(AAGAGG; K43R). Recently, an intradermal (i.d.) infection model of B. birtlesii 
(Bbi) has been introduced by Marignac et al [50], where the bacteria are inoculated in 
the derma on the ear pinnae of mice. This model likely reflects the natural route of 
infection, mimicking the infectious bacteria transmitted by the arthropod vector. 
Through i.d. infection, the Sm
R
 Bta wild-type was examined with different doses 
inoculum (1 × 10
7
, 1 × 10
5
, or 1 × 10
3
 CFU/mouse) in Balb/c mice. Bacteremia was 
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monitored over time as CFU per ml of blood. Five out of five (100%) mice showed 
bacteremia with 1 × 10
7
 CFU inoculum, four out of five (80%) with 1 × 10
5
 CFU 
inoculum and four out of five (80%) with 1 × 10
3
 CFU inoculum. The course of 
bacteremia revealed that Bta tended to develop higher bacteremia and delay of 
clearance with lower doses inoculum. However, the bacteremia establishment became 
lesser synchronized with lower doses inoculum (Fig. 22). It might reflect that high 
doses inoculum of bacteria may prime an efficient immune response for bacterial 
elimination. Thus, instead of 1 × 10
7
 CFU/mouse which was used in most pervious 
Bartonella studies, bacterial inoculum of 1 × 10
5
 CFU was used for i.d. infection in 
the following mice experiments. 
Through intradermal infection, Bta ΔbepAD seems to lose the fitness 
of bacteremia development 
To study the immnuomodulatory effect of Bartonella infection in vivo, several mutant 
strains derived from Sm
R
 Bta wild-type were made with in-frame deletion of virD4, 
bepA, or bepD (referred to Bta ΔvirD4, Bta ΔbepA, and Bta ΔbepD, respectively). 
Both BepABta and BepDBta showed inhibitory effects on DC maturation. To reduce 
their redundant functions, a mutant strain with deletions of both genes bepA and bepD 
was constructed (referred to Bta ΔbepAD). To analyze the relevance of VirD4, BepA, 
and BepD in bacteremia development, mice were infected with Bta wild-type, Bta 
ΔvirD4, Bta ΔbepA, Bta ΔbepD, or Bta ΔbepAD (1x 105 CFU/mouse; five mice per 
group). Blood samples were collected from each mouse until up to 8 weeks (Fig. 23). 
Infection with Bta ΔvirD4 completely lost the ability to establish the bacteremia in 
mice, indicating that the VirB/D4 T4SS is an indispensable virulence factor for Bta 
pathogenicity. Except Bta ΔvirD4, all of mice infected with Bta wild-type, Bta ΔbepA, 
Bta ΔbepD, or Bta ΔbepAD were bacteremic. The highest peak of each bacteremia 
from all the groups was reached at 14 dpi (Fig. 24). In the previous experiment, the 
infection with 1 × 10
5
 CFU inoculum of Bta wild-type resulted in 100% bacteremic 
mice with similar kinetics of bacteremia (reaching to 1 × 10
6
 CFU/ml blood) (Fig 22). 
However, in this experiment, four out of five mice infected with Bta wild-type 
developed expected course of bacteremia but one was only reaching to 5 × 10
3
 
CFU/ml blood. In the groups inoculated with mutants Bta ΔbepA, Bta ΔbepD, or Bta 
ΔbepAD, the bacteremia development showed a trend towards lower peak and shorter 
duration. More replicates are needed to gain statistically significance of the difference 
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between wild-type and mutant infections. 
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3.2.5 Discussion  
Impaired DC maturation by Bartonella infection 
In the arms race of host-microbe coevolution, successful microbial pathogens have 
evolved ingenious ways to evade, neutralize, or subvert host immunity. Interference 
with DC maturation is an example of a powerful mechanism used by various bacterial 
pathogens for host immune evasion. Since DCs are one of the potential vehicles for 
Bartonella transport in the host organism, we sought to examine the interaction 
between Bartonella and professional antigen-presenting DCs. Our data disclose 
immunosuppressive properties of Bartonella virulence factors, which are utilized to 
interfere with DC maturation. In response to Bartonella infection, murine BMDCs 
failed to fully mature and remained in a semi-developed stage. This impaired DC 
maturation was characterized by reduced surface expression of the MHCII complex 
and the co-stimulatory receptors CD40 and CD86, as well as strongly diminished 
secretion of the pro-inflammatory cytokines TNF-α and IL-6. Reminiscent of what is 
observed in Bartonella, also H. pylori-experienced DCs reach only a semi-mature 
state. These tolerogenic DCs secrete IL-18 and efficiently induce Foxp3
+
 Treg 
response in favor of H. pylori persistence [51]. In accordance with this, our findings 
support the idea that by induction of semi-maturation and thus tolerogenic properties 
of DCs, Bartonella may subvert the host immune response to develop and sustain a 
chronic bartonellosis.  
The impaired maturation of murine BMDCs was observed with both Bbi (a 
murine-specific strain) and Bhe (a feline-specific strain) infections in this study. This 
is contradictory to a previous publication, in which Bhe infection of human 
monocyte-derived DCs showed classical phenotypic changes of Bhe-driven DC 
activation including the increase of surface expression of co-stimulatory molecules 
(CD83 and CD86) and MHCII, as well as the release of cytokines (e.g., TNF-α, IL-6, 
IL-10, and CXCL13) [30]. These contradicting outcomes may be due to different host 
species, although Bhe infection in either murine or human DCs is heterogonous. 
Further, the experimental conditions diverge. Different from the RPMI medium used 
in [30], we took M199 medium for culturing bartonellae and for performing the 
bacterial infection in BMDCs. The latter may be a preferable condition to study the 
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function of T4SS because it was proven that regulation of VirB/D4 T4SS-related 
genes (e.g., virB and bepD), which is required for Bartonella virulence in DCs, is 
prominently induced in M199 medium [52].  
cAMP in Bartonella pathogenicity 
Interestingly, the induction of the phenotypic changes observed in DCs upon 
Bartonella infection could be attributed to two effector proteins, BepA and BepD. In 
particular, the BID domain of BepA strongly affected the downregulation of CD40 
expression and TNF-α production. In fact, our findings in this study are not the first 
ones to describe a role for BepA in Bartonella pathogenicity. It was shown that the 
BepA-mediated elevation of cAMP levels is linked to reduced caspase-3 activation 
and prevents infected ECs from apoptosis [24]. A recent publication of our lab 
demonstrated that the enhanced cAMP production is due to a BepA interaction with 
the host cell adenylyl cyclase Gαs [53]. The cAMP signaling has been extensively 
studied in context of either inhibiting or stimulating apoptosis [54]. These adverse 
phenotypes are attributed to the antagonistic interaction of protein kinase A (PKA) 
and Exchange protein activated by cAMP (Epac-1), a guanine nucleotide exchange 
factor (GEF) for Ras-like small GTPases downstream of cAMP signaling [55, 56]. 
Remarkably, BepABhe-mediated anti-apoptosis was cell type dependent. While BepA 
inhibited apoptosis in human umbilical vein ECs (HUVECs), it acted 
pro-apoptotically in the endothelial hybrid cell line (Ea.hy926) (Dr. A. Pulliainen, data 
unpublished). Both in vitro phenotypes of BepA described in different cell types were 
closely related to its BID domain and associated with cAMP elevation, likely through 
the same molecular mechanism. The cAMP signaling is known to influence a plethora 
of cellular functions based on its broad modulatory capabilities. We thus investigated 
the involvement of cAMP in the DC phenotype. The activation of cAMP-dependent 
CREM/CREB pathway in BMDCs was determined by quantitative real-time PCR of 
the cAMP-inducible gene, crem. It showed that this effect of BepA on BMDCs was 
associated with induction of intracellular cAMP levels. 
The inhibitory effects of BepA on DC maturation are in line with the general concept 
of cellular cAMP as a negative regulator of immune stimulation in phagocytes (e.g., 
macrophages and DCs). Bartonella BepA provides an intriguing example of cAMP 
level control by one single bacterial effector leading to a multifaceted manipulation in 
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different host cell types. Besides Bartonella, several other pathogenic bacteria (e.g., B. 
pertussis and Vibrio cholerae) have evolved mechanisms to exploit host cell cAMP 
signaling by virulence factors, such as pertussis toxin (PT) and AC toxin (CyaA) of B. 
pertussis, and the cholera toxin (CT) of V. cholerae. Though by distinct mechanisms, 
these toxins ultimately lead to a sustained increase of intracellular cAMP in target 
cells. Moreover, they share similar negative effects on phagocyte activation, including 
phagocytosis, cytokine production, chemotaxis, and superoxide production [57].  
In addition to BepABhe, we analyzed the effect of several BepA homologs on DC 
maturation: BepABtr, BepABgr, BepA-BIDBbi, and BepA-BIDBta. Although BepA 
homologs share high sequence identity, the functional readouts of them were not 
congruent. Particularly, BepABgr showed hardly any immunosuppressive activity in 
BMDCs. Additionally, it is interesting to note that BepABtr displayed opposing actions 
in different cells. A previous publication of our lab revealed that BepABtr failed to 
inhibit apoptosis of human ECs. However, BepABtr in this study strongly repressed 
CD40 expression and TNF-α production in BMDCs. Further investigations are needed 
to elucidate a potential cell type or host species specificity of BepA. 
Impact of BepD and STAT3 interaction of DC function  
Tyrosine-phosphorylation of proteins plays a central role during signal transduction in 
eukaryotes. Recent progress in the description of several bacterial effectors has shown 
that tyrosine-phosphorylation is a common feature on these proteins, which 
capacitates them for recruiting and binding host cellular interaction partners, thereby 
manipulating signaling pathways. To date, nine effectors displaying phosphorylated 
EPIYA-motifs have been identified in various bacteria, including Bartonella BepD-F 
[58]. Although these bacterial effectors are capable of undergoing versatile 
interactions with mammalian SH2 domain-containing proteins, only a few of them 
(e.g., CagA of H. pylori and Tir of enteropathogenic E. coli (EPEC)) have been 
proved so far to display pathogenic functions upon delivery into mammalian host cells. 
Most previous evidence relates to actin-cytoskeletal rearrangements influenced by 
EPIYA effectors. CagA for instance was found to be involved in cell scattering and Tir 
in pedestal formation [59, 60]. Recently, a second function of Tir in association with 
SHP-1 and SHP-2 has been discovered in the anti-inflammatory response [61, 62]. 
Here we demonstrate that another bacterial EPIYA effector, Bartonella BepD, 
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displays immunomodulatory properties similarly to EPEC Tir, but likely through a 
distinct mechanism. The phenotypic changes of infected DCs triggered by Bartonella 
BepD were represented by a downregulation of surface MHCII and CD86 expression, 
as well as by the repression of TNF-α and IL-6 production. Strikingly, analyses of 
tyrosine-substitution mutants showed that the effects of BepD are strongly linked to 
its EPIYA-related motifs (in particular Y92, Y114, and Y134). A loss-of-function 
mutant of BepD (Y32/72/92/114/134F) did not show any detectable 
tyrosine-phosphorylation and consequently no effect on DC maturation. Taken 
together, these findings indicate that the phosphorylation of certain EPIYA-related 
motifs is critical for the immunosuppressive activity of BepD. In fact, BepD was 
highly tyrosine-phosphorylated by endogenous tyrosine kinases in JAWSII cells. 
However, phosphorylation of BepD in HeLa cells was only observed by pre-treatment 
with vanadate to inhibit protein tyrosine phosphatases (data not shown), indicating 
that phosphorylation-based interaction of BepD with host factors may be cell 
type-specific. 
E. coli LPS is a well-known TLR4 agonist to induce massive inflammation [3]. 
Interestingly, ectopic expression of BepD in JAWSII cells prevented DC activation by 
E. coli LPS stimulation, strongly suggesting antagonistic effects of BepD on 
LPS-dependent TLR signaling. Based on a quantitative proteomic screen in JAWSII 
cells, several SH2 domain-containing eukaryotic interaction partners were identified 
for differentially tyrosine-phosphorylated forms of BepD. Among them were SHP-2 
and STAT3 whose interaction with a GFP-fusion of BepD-BXBIDBhe could be 
verified by co-immunopercipitation. SHP-2, as described above, is exploited by EPEC 
Tir as one of the interaction partners for its anti-inflammatory activity. The 
phosphorylation of Tir promotes the formation of the Tir/SHP-2/TRAF6 complex to 
prevent the ubiquitination of TRAF6, and that subsequently inhibits the MAP kinase 
and NF-κB pathways [62]. This molecular basis of Tir provides a potential working 
model for BepD signaling. Further experiments are needed to seek for evidence of 
such a mechanism utilized by BepD.  
Besides the potential mechanism associated with SHP-2, we found another intriguing 
pathway to be connected with the immunomodulatory activity of BepD. A pull down 
assay with a GFP-fusion of BepD-BXBIDBhe showed on an immunoblot a 
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hyper-phosphorylated form of STAT3. The STAT3 activation strongly correlated with 
the impaired DC maturation phenotypes caused by infection with various Bartonella 
strains. It suggests that STAT3 signaling represents a key pathway hijacked by BepD 
in DCs. Although BepE and BepF, themselves containing several EPIYA-related 
motifs, were also tyrosine-phosphorylated in host cells [40], STAT3 activation was 
specific for BepD. Based on the proteomic data, we propose that BepD may serve as a 
platform to recruit host kinases (such as Abl and c-Src) and STAT3, thereby preparing 
for a subsequent activation of STAT3 signaling. 
Numerous studies illustrate the important role of STAT3 in DC differentiation and 
function in cancer [63]. STAT3 signaling has been well-studied in connection with 
tumor-related factors, such as the pro-inflammatory cytokine IL-6 and the 
anti-inflammatory cytokine IL-10. Although IL-6 and IL-10 generate nearly opposing 
cellular responses, both cytokines activate STAT3 signaling and subsequently induce 
SOCS3 expression. The divergent actions of these two cytokines are based on the 
kinetics of STAT3 activation. In contrast to transient STAT3 activation by IL-6, 
stimulated IL-10 signaling leads to sustained STAT3 activation and results in an 
anti-inflammatory response [64, 65]. Similar to the effect of IL-10, also Bartonella 
BepD leads to a prolonged STAT3 phosphorylation and activation, which may explain 
the anti-inflammatory properties of BepD. Although H. pylori was described to induce 
phosphorylation of STAT3 in gastric cancer cells [66], a recent publication revealed 
that the STAT3 signaling is indirectly activated by the H. pylori effector protein CagA. 
In other words, CagA-secreting H. pylori induces a predominant secretion of IL-10, 
what in turn leads to enhanced STAT3 phosphorylation as required for induction of 
tolerogenic DCs [67]. These immunosuppressive properties of IL-10 are markedly 
exploited by many bacterial pathogens (e.g., B. pertussis and M. tuberculosis) with a 
stealth-infection strategy to shut off the host inflammatory responses [68, 69]. In 
contrast to the manipulation of IL-10 production, our findings shed light on a 
previously unknown mechanism, in which Bartonella BepD acts as a signaling hub 
and recruits host kinases together with STAT3. Subsequently, prolonged STAT3 
phosphorylation is triggered and eventually results in inhibition of DC maturation. 
Relevance of Beps’ function in vivo 
The phenotypes of BepA and BepD were majorly described in the in vitro model. To 
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translate our findings and put them into an in vivo context, we analyzed the 
bacteremia as a hallmark of Bartonella infection in mice. A minor impairment of 
bacteremia development was observed after infection with Bta strains harboring 
deletions of bepA or/and bepD, indicating that BepA and BepD contribute to the 
fitness of bacteremia. It is important to take into account that the inoculum of 1 x10
5
 
CFU/mouse used for i.d. infection may be still much higher than the dose occurring in 
natural infections. With high doses inoculum of bacteria, we might saturate our in vivo 
system, likely by priming an efficient immune response. Based on the results of 
bacterial inoculum titrations, we concluded that 80% mice infected with Bta wild-type 
1 × 10
3
 CFU/mouse led to stable bacteremia, yet its development was less 
synchronized. To sensitize our murine model, lower doses of inoculum (<10
3
 
CFU/mouse) will be tested in the next experiment.  
Although Bartonella harbors an atypical LPS with low endotoxic activities, which 
enables these bacteria to be less noticeable for host immune recognition, it is 
interesting that Bartonella develops two effector proteins, BepA and BepD, to 
interfere with DC maturation and particularly with the production of 
pro-inflammatory cytokines. Thus, we speculate that BepA and BepD may contribute 
to establishing chronic infection by evading from host immune surveillance within 
specific tissues. Further investigations are needed to uncover the local inflammation 
of Bartonella infection. 
Perspective in immune-attenuation by Bartonella infection 
In summary, our findings demonstrate that two immnunomodulatory Bartonella 
effectors, BepA and BepD, both have a role in generating a “semi-mature” state of 
DCs through independent mechanisms. BepA may take advantage of the regulation of 
host cAMP levels to repress upregulation of surface CD40 expression and TNF-α 
production. BepD instead may work as a signaling hub for triggering prolonged 
STAT3 activation to suppress certain consequences of an immune response, in 
particular the inhibition of MHCII and CD86 expression and the secretion of 
pro-inflammatory cytokines. Overall, these “semi-mature” DCs may display 
tolerogenic properties to convert the T cell response into Treg immunotolerance 
reflecting part of the Bartonella stealth-infection strategy.  
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3.2.6 Figure Legends 
Figure 1. DC maturation is impaired by Bartonella infection in a VirB/D4 T4SS 
dependent manner. (A) E. Coli LPS treatment (1 μg/ml) triggered DC maturation as 
the positive control. The BMDCs were infected with Bhe wild-type or Bhe ΔbepA-G 
(MOI = 25). After 24 hpi, maturation patterns were monitored by the regulation of 
surface co-stimulatory (CD40, CD80, and CD86) and MHCII molecules using flow 
cytometry analysis. Expression levels of the maturation markers were presented as the 
geometric mean of the fluorescence intensities (GMFI). One representative histogram 
image is displayed from three independent experiments. (B) The BMDCs were 
infected with Bbi wild-type, Bbi Tn-virD4, Bhe wild-type or Bhe ΔbepA-G (MOI = 25) 
for 24 h. Expression levels of MHCII, CD40, CD80, and CD86 were presented as 
relative GMFI. All data were normalized to infection with Bhe ΔbepA-G as 1 and 
showed as the mean ± SEM from three independent experiments. Statistical 
significance was determined using Student's t-test. P<0.05 was considered statistically 
significant. 
Figure 2. Pro-inflammatory cytokine secretion is diminished by Bartonella 
infection in a VirB/D4 T4SS dependent manner. The BMDCs were infected with 
Bbi wild-type, Bbi Tn-virD4, Bhe wild-type or Bhe ΔbepA-G (MOI = 25) for 24 h. 
Culture media were collected for cytokine detection (TNF-α, IL-6, and IL-12p40). 
The data showed as the mean ± SEM from three independent experiments. Statistical 
significance was determined using Student's t-test. P<0.05 was considered statistically 
significant. Data from one representative experiment (n = 3) are presented. 
Figure 3. BepABhe and BepDBhe inhibit upregulation of surface receptors of 
infected BMDCs. BMDCs were infected with Bhe ΔbepA-G mutant complemented 
with the indicated Bep-expression plasmids at MOI = 25 for 24 h. The maturation 
markers were monitored by the surface expression of MHCII, CD40, CD80, and 
CD86 using flow cytometry analysis. Expression levels of the maturation markers 
were presented as relative GMFI. All data were normalized to infection with Bhe 
ΔbepA-G as 1 and showed as the mean ± SEM from three independent experiments. 
Statistical significance was determined using Student's t-test. Data marked by an 
asterisk differ statistically significantly (P<0.05) from infection with Bhe ΔbepA-G. 
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Figure 4. Repression of pro-inflammatory cytokine secretion is assigned to 
BepABhe and BepDBhe. BMDCs were infected with Bhe ΔbepA-G mutant 
complemented with the indicated Bep-expression plasmids at MOI = 25. At 24 hpi, 
Culture media were collected for cytokine detection (TNF-α and IL-6) by ELISA. The 
data showed as the mean ± SEM from three independent experiments. Statistical 
significance was determined using Student's t-test. Data marked by an asterisk differ 
statistically significantly (P<0.05) from infection with Bhe ΔbepA-G. Data from one 
representative experiment (n = 3) are presented. 
Figure 5. The functions of BepABhe and BepDBhe on inhibition of DC mutation 
receptors are narrowed down to its BID domain and the N-terminal fragment, 
respectively. BMDCs were infected with Bhe ΔbepA-G mutant complemented with 
the indicated Bep-expression plasmids at MOI = 25 for 24 h. The surface expression 
of MHCII, CD40, CD80, and CD86 was monitored by flow cytometry analysis. 
Expression levels of the maturation markers were presented as relative GMFI. All 
data were normalized to infection with Bhe ΔbepA-G as 1 and showed as the mean ± 
SEM from three independent experiments. Statistical significance was determined 
using Student's t-test. Data marked by an asterisk differ statistically significantly 
(P<0.05) from infection with Bhe ΔbepA-G. 
Figure 6. The effects of BepABhe and BepDBhe on repression of pro-inflammatory 
cytokine secretion are related to its BID domain and the N-terminal fragment, 
respectively. BMDCs were infected with Bhe ΔbepA-G mutant complemented with 
the indicated Bep-expression plasmids at MOI = 25. After 24 hpi, Culture media were 
collected for cytokine detection (TNF-α and IL-6) by ELISA. The data showed as the 
mean ± SEM from three independent experiments. Statistical significance was 
determined using Student's t-test. Data marked by an asterisk differ statistically 
significantly (P<0.05) from infection with Bhe ΔbepA-G. Data from one 
representative experiment (n = 3) are presented. 
Figure 7. Expression of BepABhe homologs in the Bhe ΔbepA-G inhibits DC 
maturation receptors. BMDCs were infected with Bhe ΔbepA-G mutant 
complemented with the indicated Bep-expression plasmids at MOI = 25 for 24 h. The 
surface expression of MHCII, CD40, CD80, and CD86 was monitored by flow 
cytometry analysis. Expression levels of the maturation markers were presented as 
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relative GMFI. All data were normalized to infection with Bhe ΔbepA-G as 1 and 
showed as the mean ± SEM from three independent experiments. Statistical 
significance was determined using Student's t-test. Data marked by an asterisk differ 
statistically significantly (P<0.05) from infection with Bhe ΔbepA-G. 
Figure 8. Expression of BepABhe homologs in the Bhe ΔbepA-G represses 
pro-inflammatory cytokine secretion. BMDCs were infected with Bhe ΔbepA-G 
mutant complemented with the indicated Bep-expression plasmids at MOI = 25. After 
24 hpi, Culture media were collected for cytokine detection (TNF-α and IL-6) by 
ELISA. The data showed as the mean ± SEM from three independent experiments. 
Statistical significance was determined using Student's t-test. Data marked by an 
asterisk differ statistically significantly (P<0.05) from infection with Bhe ΔbepA-G. 
Data from one representative experiment (n = 3) are presented. 
Figure 9. BepA homologs mediate a downregulation of CD40 gene and an 
upregulation of cAMP response gene. BMDCs were infected with Bhe ΔbepA-G 
mutant complemented with the indicated Bep-expression plasmids at MOI = 25. After 
24 hpi, regulations of CD40 and the cAMP-responsive gene crem were determined by 
quantitative real-time PCR. Results were normalized to expression of the 
housekeeping gene GAPDH. The bars represent the mean of triplicate samples ± SEM. 
Statistical significance was determined using Student's t-test. Data marked by an 
asterisk differ statistically significantly (P<0.05) from infection with Bhe ΔbepA-G. 
Data from one representative experiment (n = 3) are presented. 
Figure 10. Expression of BepDBhe homologs in the Bhe ΔbepA-G inhibits DC 
maturation receptors. BMDCs were infected with Bhe ΔbepA-G mutant 
complemented with the indicated Bep-expression plasmids at MOI = 25 for 24 h. The 
surface expression of MHCII, CD40, CD80, and CD86 was monitored by flow 
cytometry analysis. Expression levels of the maturation markers were presented as 
relative GMFI. All data were normalized to infection with Bhe ΔbepA-G as 1 and 
showed as the mean ± SEM from three independent experiments. Statistical 
significance was determined using Student's t-test. Data marked by an asterisk differ 
statistically significantly (P<0.05) from infection with Bhe ΔbepA-G. 
Figure 11. Expression of BepDBhe homologs in the Bhe ΔbepA-G represses 
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pro-inflammatory cytokine secretion. BMDCs were infected with Bhe ΔbepA-G 
mutant complemented with the indicated Bep-expression plasmids at MOI = 25. At 24 
hpi, culture media were collected for cytokine detection (TNF-α and IL-6) by ELISA. 
The data showed as the mean ± SEM from three independent experiments. Statistical 
significance was determined using Student's t-test. Data marked by an asterisk differ 
statistically significantly (P<0.05) from infection with Bhe ΔbepA-G. Data from one 
representative experiment (n = 3) are presented. 
Figure 12. The functional tyrosine residue in BepD-BXBIDBhe is delineated for 
the inhibition of DC maturation receptors. BMDCs were infected with Bhe 
ΔbepA-G mutant complemented with the indicated tyrosine substitution mutants 
derived from BepD-BXBIDBhe at MOI = 25 for 24 h. The DC surface expression of 
MHCII, CD40, CD80, and CD86 was monitored by flow cytometry analysis. 
Expression levels of the maturation markers were presented as relative GMFI. All 
data were normalized to infection with Bhe ΔbepA-G as 1 and showed as the mean ± 
SEM from three independent experiments. Statistical significance was determined 
using Student's t-test. Data marked by an asterisk differ statistically significantly 
(P<0.05) from infection with the strain expressing BepD-BXBIDBhe. 
Figure 13. The functional tyrosine residue in BepD-BXBIDBhe is delineated for 
the repression of pro-inflammatory cytokine secretion. BMDCs were infected with 
Bhe ΔbepA-G mutant complemented with the indicated tyrosine substitution mutants 
derived from BepD-BXBIDBhe at MOI = 25. At 24 hpi, culture media were collected 
for cytokine detection (TNF-α and IL-6) by ELISA. The data showed as the mean ± 
SEM from three independent experiments. Statistical significance was determined 
using Student's t-test. Data marked by an asterisk differ statistically significantly 
(P<0.05) from infection with the strain expressing BepD-BXBIDBhe. Data from one 
representative experiment (n = 3) are presented. 
Figure 14. Ectopic expression of BepD-BXBIDBhe actively suppresses JAWSII 
responses to E. coli LPS stimuli. The GFP or GFP-fusion protein 
(GFP-BepD-BXBIDBhe, GFP-BepD-BIDBhe, and GFP-BepD-BXBIDBhe 5Ymuts) was 
ectopically expressed in JAWSII cells using the lentiviral transduction system. Under 
the TET-inducible promoter pTF, the GFP or GFP-fusion proteins was induced by 
doxycycline treatment (1 μg/ml) for 24 h. Upon challenging with E. Coli LPS (0.1 
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μg/ml or 1 μg/ml) for 24 h, the DC surface expression of MHCII and CD86 was 
monitored by flow cytometry analysis. Expression levels of the maturation markers 
were presented as relative GMFI. All data were normalized to JAWSII cells without 
treatments as 1 and showed as the mean ± SEM from three independent experiments. 
Statistical significance was determined using Student's t-test. Data marked by an 
asterisk differ statistically significantly (P<0.05) from each constructed cell line 
without doxycycline and E. coli LPS treatments. 
Figure 15. Ectopically expressed BepD-BXBIDBhe is phosphorylated in JAWSII 
cells. Upon immunoprecipitation with GFP nanobodies coupled to agarose beads, 
immunoblot of GFP and tyrosine-phosphorylation were determined from total cell 
lysates (input), the supernatant (flow-through), and the precipitate (IP) of JAWSII 
cells ectopically expressing corresponding BepD constructs depicted in figure. 
Figure 16. Interactomics reveals several putative BepD binding partners. (A) 
Volcano plot representing significance (q-values) versus the BepD-BXBIDBhe 
/BepD-BXBIDBhe 5Ymuts interaction ratio of indicated partners on the y- and x-axes, 
respectively. Interactions showing a q-value <0.01 were considered significantly 
regulated among the two conditions and are represented in red. Underlined proteins 
harbor an SH2 domain. (B) Graphical representation of the interactome using 
STRING (high confidence 0.7). The color indicates the ratio for each interaction 
partner between BepD-BXBIDBhe and BepD-BXBIDBhe 5Ymuts. Only proteins with at 
least one connection in STRING are represented. (C) Table showing all 27 
significantly regulated interaction partners (q-value <0.01) among BepD-BXBIDBhe 
/BepD-BXBIDBhe 5Ymuts.  
Figure 17. Phosphoproteomics reveals STAT3 hyper-phosphorylation in 
dependency of Bep-BXBIDBhe. (A) Diagram of the phosphoproteomics protocol 
applied to BepD-BXBIDBhe expression compared to BepD-BXBIDBhe 5Ymuts in 
JAWSII cells. (B) Volcano plot representing significance (q-values) versus the 
BepD-BXBIDBhe/BepD-BXBIDBhe 5Ymuts phosphorylation ratio on the y- and x-axes, 
respectively. Phosphopeptides showing a q-value <0.01 were considered significantly 
regulated among the two conditions and are represented in red. (C) Table showing all 
27 significantly regulated phosphopeptides (q-value <0.01) among BepD-BXBIDBhe 
/BepD-BXBIDBhe 5Ymuts.  
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Figure 18. SHP-2 and STAT3 specifically co-immunoprecipitates with 
GFP-BepD-BXBIDBhe. (A) Upon immunoprecipitation with GFP nanobodies 
coupled to agarose beads, immunoblot of SHP-2 was determined from total cell 
lysates (input), the supernatant (flow-through), and the precipitate (IP) of JAWSII 
cells ectopically expressing corresponding BepD constructs depicted in figure. (B) 
Immunoblots of STAT3 and STAT3 phosphorylation at Tyr-705 were determined from 
total cell lysates (input), the supernatant (flow-through), and the precipitate (IP) of 
JAWSII cells ectopically expressing corresponding BepD constructs depicted in 
figure. 
Figure 19. The enhanced phospho-STAT3 expression is BepD specific. 
Immunoblot of STAT3 phosphorylation at Tyr-705 was determined from total cell 
lysate of BMDCs infected with corresponding Bartonella strains depicted in figure. 
Actin was used as a loading control. Quantitative data showed as the mean ± SEM 
from two independent experiments. Data from one representative experiment (n = 2) 
are presented. 
Figure 20. The function of EPIYA-related motifs in STAT3 phosphorylation is 
delineated in BepD-BXBIDBhe by tyrosine to phenylalanine exchanges. 
Immunoblot of STAT3 phosphorylation at Tyr-705 was determined from total cell 
lysate of BMDCs infected with corresponding Bartonella strains depicted in figure. 
Actin was used as a loading control. Quantitative data showed as the mean ± SEM 
from two independent experiments. Data from one representative experiment (n = 2) 
are presented. 
Figure 21. STAT3 phosphorylation caused by BepD-BXBIDBhe is sustained until 
24 hpi. Immunoblot of STAT3 phosphorylation at Tyr-705 was determined for the 
indicated time periods from total cell lysate of BMDCs infected with strains 
expressing BepD-BXBIDBhe or BepD-BXBIDBhe 5Ymuts. Actin was used as a loading 
control. Quantitative data showed as the mean ± SEM from two independent 
experiments. Data from one representative experiment (n = 2) are presented. 
Figure 22. Lower doses of bacterial inoculation develop higher bacteremia by B. 
taylorii intradermal infection. Mice were inoculated in the ear dermis with Sm
R
 Bta 
wild-type: five mice per group with 1 × 10
7
, 1 × 10
5
, or 1 × 10
3
 CFU/mouse. Blood 
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was drawn at the indicated dpi, diluted and plated on sheep blood supplemented CBA 
plates for counting bacterial CFU. 
Figure 23. BepABta and BepDBta seem to be potent for the fitness of bacteremia 
development. Mice were inoculated in the ear dermis with Sm
R
 Bta wild-type (blue), 
Bta ΔvirD4 (brown), Bta ΔbepA (red), Bta ΔbepD (green), or Bta ΔbepAD 
(purple): five mice per group with 1 × 10
5
 CFU/mouse. Blood was drawn at the 
indicated dpi, diluted and plated on sheep blood supplemented CBA plates for 
counting bacterial CFU. 
Figure 24. Bta mutants with deletion of bepA or/and bepD tend to lose the fitness 
to reach the highest peak of bacteremia. The infections were performed as 
described for Fig 22. The highest peak of each bacteremia was displayed at 14 dpi. 
Figure S1. Up to 70% of BMDCs differentiated by Flt3L are CD11c
+
. BMDCs 
were generated by culturing BM cells with Flt3 ligand for 7 – 10 days. Cell 
suspensions were stained with anti-CD11c antibody combined with anti-CD11b or 
anti-B220 antibodies to determine subtypes of DCs: conventional DCs or 
plasmacytoid DCs, respectively. Staining with anti-MHCII indicated the activation 
state of DCs 
Figure S2. Immunoblots confirm the protein levels of the indicated Beps by 
overexpression in Bhe ΔbepA-G. All constructs for overexpression of individual 
Beps were derived from the flag-tag expression vector pPG100. Bartonella bacterial 
culture was harvested after 48 h of growth on CBA plates supplemented with 
appropriate antibiotics and IPTG (500 µM). The anti-Flag western blot (A-D) was 
obtained from total lysate of corresponding Bartonella strains depicted in figure. 
Figure S3. BepA homologs show the significant similarity from the Bartonella 
lineage 4 species. (A) The BepA homologs from Bartonella species depicted in the 
figure (BepABtr, BepABgr, BepABbi, and BepABta) were aligned to BepABhe using 
Geneious Pro 5.3.4. The amino acid sequence alignment with pairwise % identity is 
indicated. The FIC and BID domains were aligned independently. (B) The sequence 
alignment of BID domains of BepA homologs.  
Figure S4. Except BepABgr, BepA homologs mediate downregulations of cytokine 
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genes TNF-α, IL-6, and IL-12. BMDCs were infected with Bhe ΔbepA-G mutant 
complemented with overexpression of indicated BepA homologs at MOI = 25. After 
24 hpi, regulations of TNF-α, IL-6, and IL-12 were determined by quantitative 
real-time PCR. Results were normalized to expression of the housekeeping gene 
GAPDH. 
Figure S5. BepD homologs show the conserved EPIYA-related motifs from the 
Bartonella lineage 4 species. (A) The BepD homologs from Bartonella species 
depicted in the figure (BepDBtr, BepDBgr, BepDBbi, and BepDBta) were aligned to 
BepDBhe using Geneious Pro 5.3.4. The amino acid sequence alignment with pairwise 
% identity is indicated. The tyrosine-containing N-termini and BID domains were 
aligned independently. (B) The sequence alignments of tyrosine-containing N-termini 
of BepD homologs.  
Figure S6. BepD homologs mediate downregulations of genes of cytokines TNF-α, 
IL-6, and IL-12 but not of surface receptors. BMDCs were infected with Bhe 
ΔbepA-G mutant complemented with overexpression of indicated BepD homologs at 
MOI = 25. After 24 hpi, gene regulations of surface receptors (MHCII, CD80, and 
CD86) and cytokines (TNF-α, IL-6, and IL-12) were determined by quantitative 
real-time PCR. Results were normalized to expression of the housekeeping gene 
GAPDH. 
Figure S7. DC properties of JAWSII cells are confirmed by E. coli LPS treatment. 
(A) JAWSII cells were stained with anti-CD11c, anti-CD11b, or anti-B220 antibodies 
and analyzed by flow cytometry. (B) Upon E. coli LPS treatment with different 
concentrations (0.1 μg/ml, 1.0μg/ml, or 5.0 μg/ml) for 24 h, the surface expression of 
MHCII, CD40, CD80, and CD86 was monitored by flow cytometry analysis. 
Figure S8. Ectopic expression of the GFP or GFP-fusion proteins is well induced 
by doxycycline treatment. (A) All constructs for overexpression of indicated 
proteins were derived from lentiviral doxycycline-inducible vector 
pCLX-pTF-R1-DEST-R2-EBR65 and transduced into JAWSII cells. Upon 24 h 
doxycycline treatment (1 μg/ml), total cell lysate was harvested for the anti-GFP 
western blot. (B) Upon 24 h doxycycline treatment (1 μg/ml), these stable cell lines 
carrying indicated constructs were analyzed by flow cytometry. 
  RESULTS: Research article II  
- 103 - 
 
Figure S9. Genomic organization of the virB/D4 T4SS and beps loci in B. taylorii 
and B. henselae. Alignment of the conserved T4SS VirB/VirD4 (virB2-11 and virD4 
genes) and the highly variable translocated effectors (beps genes) in Bta and Bhe was 
analyzed using Geneious Pro 5.3.4. Sequence similarity is shown with the percent 
identity indicated according to the color scales. 
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3.2.8 Supplementary Tables  
Table 1: Bacterial strains and plasmids used in this study 
Bartonella strains  
Strain Relevant Genotype /Description Reference 
RSE247 Spontaneous Sm
R 
strain of B. henselae ATCC49882
T
,
  
serving as wild-type 
[70] 
MSE150 bepA-bepG deletion mutant, derivative of RSE247 [20] 
MSE156 MSE150 containing pPG101 (ΔbepA-G/pbepABhe) [24] 
MSE167 MSE150 containing pMS006 (ΔbepA-G/pbepBBhe) [24] 
MSE159 MSE150 containing pMS007 (ΔbepA-G/pbepCBhe) [24] 
PG4D03 MSE150 containing pPG104 (ΔbepA-G/pbepDBhe) [20] 
PG4D10  MSE150 containing pPG105 (ΔbepA-G/pbepEBhe) [71] 
TRB171 MSE150 containing pPG106 (ΔbepA-G/pbepFBhe) [71] 
TRB169 MSE150 containing pPG107 (ΔbepA-G/pbepGBhe) [71] 
MSE218 MSE150 containing pMS100-A (ΔbepA-G/pbepA-BIDBhe) [24] 
MSE220 MSE150 containing pMS100-D (ΔbepA-G/pbepD-BIDBhe) [24] 
LUB169 MSE150 containing pLU030 
(ΔbepA-G/pbepD-BXBIDBhe) 
This study 
LUB186 MSE150 containing pLU032  
(ΔbepA-G/pbepD-BXBIDBhe Y32F) 
This study 
LUB220 MSE150 containing pLU033  
(ΔbepA-G/pbepD-BXBIDBhe Y52F) 
This study 
LUB222 MSE150 containing pLU034  
(ΔbepA-G/pbepD-BXBIDBhe Y62F) 
This study 
LUB224 MSE150 containing pLU035  
(ΔbepA-G/pbepD-BXBIDBhe Y72F) 
This study 
LUB226 MSE150 containing pLU036  
(ΔbepA-G/pbepD-BXBIDBhe Y92F) 
This study 
LUB195 MSE150 containing pLU037  
(ΔbepA-G/pbepD-BXBIDBhe Y114F) 
This study 
LUB197 MSE150 containing pLU038  
(ΔbepA-G/pbepD-BXBIDBhe Y134F) 
This study 
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Table 1-continued 
LUB188 MSE150 containing pLU039  
(ΔbepA-G/pbepD-BXBIDBhe Y155F) 
This study 
LUB206 MSE150 containing pLU040  
(ΔbepA-G/pbepD-BXBIDBhe Y176F) 
This study 
LUB268 MSE150 containing pLU044  
(ΔbepA-G/pbepD-BXBIDBhe Y32/72/92/114/134F) 
This study 
MSE175 MSE150 containing pMS011 (ΔbepA-G/pbepABtr) [24] 
LUB234 MSE150 containing pLU054 (ΔbepA-G/pbepABgr) This study 
LUB270 MSE150 containing pLU065 (ΔbepA-G/pbepA-BIDBbi) This study 
LUB266 MSE150 containing pLU064 (ΔbepA-G/pbepA-BIDBta) This study 
LUB232 MSE150 containing pLU053 (ΔbepA-G/pbepDBtr) This study 
LUB258 MSE150 containing pLU061 (ΔbepA-G/pbepDBgr) This study 
LUB247 MSE150 containing pLU060 (ΔbepA-G/pbepDBbi) This study 
LUB242 MSE150 containing pLU058 (ΔbepA-G/pbepDBta) This study 
LUB046 Spontaneous Sm
R 
strain of B. taylorii,  
serving as wild-type 
This study 
LUB163 virD4 deletion mutant, derivative of LUB046 This study 
LUB291 bepA deletion mutant, derivative of LUB046 This study 
LUB293 bepD deletion mutant, derivative of LUB046 This study 
LUB297 bepA and bepD deletion mutant, derivative of LUB291 This study 
RSE149 Spontaneous Sm
R 
strain of B. tribocorum IBS 506T,  
serving as wild-type 
[19] 
CHDE142 B. grahamii, No 376, isolated from Microtus sp. [13] 
PEE0249  
 
B. birtlesii IBS 325T, isolated from Apodemus spp. [72] 
E. Coli strains   
Name Relevant characteristics Reference 
DH5α F- (Φ80dlacZDM15) D (lacZY AargF)U169 deoR recA1 
endA1hsdR17 (rk-, mK+), sup E44 l -thi-1 gyrA96 relA1 l -CH616 
[73] 
β2150 F' lacZΔM15 lacIq traD36 proA+B+ thrB1004 pro thi strA hsdS 
ΔdapA::erm (Ermr) pir 
[31] 
Helper strain β2150 containing pRK2013 [31] 
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Table 1-continued 
Plasmids 
  
Name Relevant characteristics Reference 
pPG100 Bartonella shuttle vector, encoding a short FLAG epitope [20] 
pPG101 Derivative of pPG100, encoding FLAG::Bhe BepA [24] 
pMS006 Derivative of pPG100, encoding FLAG::Bhe BepB [24] 
pMS007 Derivative of pPG100, encoding FLAG::Bhe BepC [24] 
pPG104 Derivative of pPG100, encoding FLAG::Bhe BepD [20] 
pPG105 Derivative of pPG100, encoding FLAG::Bhe BepE [71] 
pPG106 Derivative of pPG100, encoding FLAG::Bhe BepF [71] 
pPG107 Derivative of pPG100, encoding FLAG::Bhe BepG [71] 
pMS100-A Derivative of pPG100, encoding FLAG::Bhe BepA-BID [24] 
pMS100-D Derivative of pPG100, encoding FLAG::Bhe BepD-BID [24] 
pLU030 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID 
This study 
pLU032 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y32F 
This study 
pLU033 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y52F 
This study 
pLU034 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y62F 
This study 
pLU035 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y72F 
This study 
pLU036 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y92F 
This study 
pLU037 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y114F 
This study 
pLU038 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y134F 
This study 
pLU039 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y155F 
This study 
pLU040 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y176F 
This study 
pLU044 Derivative of pPG100,  
encoding FLAG::Bhe BepD-BXBID Y32/72/92/114/134F 
This study 
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Table 1-continued 
pMS011 Derivative of pPG100, encoding FLAG::Btr BepA [24] 
pLU054 Derivative of pPG100, encoding FLAG::Bgr BepA This study 
pLU065 Derivative of pPG100, encoding FLAG::Bbi BepA-BID This study 
pLU064 Derivative of pPG100, encoding FLAG::Bta BepA-BID This study 
pLU053 Derivative of pPG100, encoding FLAG::Btr BepD This study 
pLU061 Derivative of pPG100, encoding FLAG::Bgr BepD This study 
pLU060 Derivative of pPG100, encoding FLAG::Bbi BepD This study 
pLU058 Derivative of pPG100, encoding FLAG::Bta BepD This study 
pTR1000 Mutagenesis vector for in-frame deletion  
in Bartonella spp.  
[20] 
pLU068 Derivative of pTR1000, used for bepABta deletion This study 
pLU069 Derivative of pTR1000, used for bepDBta deletion This study 
pLU072 Derivative of pTR1000, used for virD4Bta deletion This study 
pLU073 pDONR-GFP, for gateway cloning This study 
pLU074 pDONR-Bhe BepD-BXBID, for gateway cloning This study 
pLU075 pDONR-Bhe BepD-BID, for gateway cloning This study 
pLU076 pDONR-Bhe BepD-BXBID 5Ymuts,  
for gateway cloning 
This study 
pLU077 pCLX, encoding GFP This study 
pLU078 pCLX, encoding GFP::Bhe BepD-BXBID This study 
pLU079 pCLX, encoding GFP::Bhe BepD-BID This study 
pLU080 pCLX, encoding GFP::Bhe BepD-BXBID 5Ymuts This study 
pMDL packaging vector for plenty [18] 
pREV packaging vector for plenty [18] 
pVSVG packaging vector for plenty [18] 
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Table 2: Oligonucleotides used in this study 
Cloning primers 
Name 
Sequence (5'-3') 
(restriction endonuclease cleavage sites are underlined) 
Restriction site   
prLU174 CGGCATATGTCAGGAAAGACAACACCCCCTCCGACA NdeI 
prLU175 CGGCATATGTTACATACCAAAGGCCATTCC NdeI 
prLU259 GGGAATTCCATATGCCAAAAGCAAAAGAA NdeI 
prLU260 GGGAATTCCATATGTTAGCAAGCCATAGCAAA NdeI 
prLU283 GGGAATTCCATATGGAGTTAAAAAACACGCTCATTCCA NdeI 
prLU284 GGGAATTCCATATGTTAGCTAGCCATAGCAAGCACATT NdeI 
prLU285 GGGAATTCCATATGGAACTTGAAAAAGTGCTCATCCC NdeI 
prLU286 GGGAATTCCATATGTTAGCTGGCCATAGCGAGCG NdeI 
prLU265 GGGAATTCCATATGCCAAAAGCCAAAGAA NdeI 
prLU266 GGGAATTCCATATGTTAGCTGGCTATAGCGAG NdeI 
prLU281 GGGAATTCCATATGAAAAAAAGTCACCCAACCGCT NdeI 
prLU282 GGGAATTCCATATGTTACATGGCAAAAGCCATTCC NdeI 
prLU234 GGGCATATGAAAAAACACCAGCCATCCCC NdeI 
prLU235 GGGCATATGTTACATCGCAAACGCCATTCC NdeI 
prLU74 CTTCATATGAAAAAGAATCATCCATCCCCTTCTC NdeI 
prLU75 AATCATATGTTACATCGCAAAAGCCATTCCTTTTCC NdeI 
prLU299 GCTCTAGAGCAGAGTTTTTCTCTCGAAGATCTTGC XbaI 
prLU318 CTGAAACACCAAGACTTTTCGCAAGTGTTTTGTTACCTCCTTATA
ATATAGCGTTGT 
 
prLU319 AAACACTTGCGAAAAGTCTTGGTGTTTCAG  
prLU302 GCTCTAGACCAGGCGCAAAGGGAATATTGCACACA XbaI 
prLU63 GCCTCTAGAGTGCGGAAGAGGCTGTTCCACAGCTAGTTG XbaI 
prLU320 GCTTGGGGATTTCACACCAAGTACTTTGTATGTTTCCTTTCAAGA
ATTATTTTAGAA 
 
prLU304 AAAGTACTTGGTGTGAAATCCCCAAGC  
prLU305 GCTCTAGACGGTATAGTCTTTTCTGGGCGTTTTGG XbaI 
prLU59 CCGTCTAGATGTTTATGGCAGCTCAAAAACATTAAACGAAC  
  RESULTS: Research article II  
- 142 - 
 
Table 2-continued  
prLU60 CAGCAGCCGCTAACATTTCTTTTCTTCTCATTGTCTCTTACTTTC
GATTTTTTCTGACTATGCCAC 
 
prLU61 AGAAGAAAAGAAATGTTAGCGGCTGCTG  
prLU62 GGCTCTAGAAGCACAACGTTCATACAGTTTGTGTGGG XbaI 
prLU197 GGTGGCGGGCCCGGGATGCCAGGAAGGGCA  
prLU199 GGTGGCGGGCCCGGGATGTCAGGAAAGACA  
prLU276 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAGGAGATAGA
ACCATGGTGAGCAAGGGCGAGGAGCTG 
 
prLU277 GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACTTGTACAGCT
CGTCCATGC 
 
prLU278 GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACATACCAAAG
GCCATTCCTT 
 
   
Primers for tyrosine to phenylalanine exchange mutant     
Name Sequence (5'-3') YF   
prLU172 GCAGAACCCCTCTTTGCACAGGTAAAT Y32F 
 prLU173 ATTTACCTGTGCAAAGAGGGGTTCTGC Y32F 
 prLU183 AGAAGAAACTATCTTTGCACCTCAAAACC Y52F 
 prLU184 GGTTTTGAGGTGCAAAGATAGTTTCTTCT Y52F 
 prLU185 ACCAGAAACTATCTTTGCACCCCAAAAAC Y62F 
 prLU186 GTTTTTGGGGTGCAAAGATAGTTTCTGGT Y62F 
 prLU252 CCTCTAGGAAATCCCTTTGACAGACTTGGTGGG Y72F 
 prLU253 CCCACCAAGTCTGTCAAAGGGATTTCCTAGAGG Y72F 
 prLU187 ACTAGTAGACCCCTTTGCAGTAACTGATG Y92F 
 prLU188 CATCAGTTACTGCAAAGGGGTCTACTAGT Y92F 
 prLU189 AGAAAATCCCCTCTTTGAGGGAGTTGGCG Y114F 
 prLU190 CGCCAACTCCCTCAAAGAGGGGATTTTCT Y114F 
 prLU191 ACCAGAACATCTCTTTGCAGAGCTTGAAT Y134F 
 prLU192 ATTCAAGCTCTGCAAAGAGATGTTCTGGT Y134F 
 
prLU160 TAGAATCTGTCTTTGCAACAGTTGGCA Y155F 
 prLU161 TGCCAACTGTTGCAAAGACAGATTCTA Y155F 
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Table 2-continued   
prLU193 TAAAAAATCCCCTCTTCGAAGGAGTTGGCC Y176F 
 prLU194 GGCCAACTCCTTCGAAGAGGGGATTTTTTA Y176F 
 
    qPCR Primers   
Name Sequence (5'-3') Gene   
prLU214 AACGACCCCTTCATTGAC GAPDH 
 
prLU215 TCCACGACATACTCAGCAC GAPDH 
 
prLU236 TTGTTGACAGCGGTCCATCTA CD40 
 
prLU237 GCCATCGTGGAGGTACTGTTT CD40 
 
prLU290 CTCACCAGGAAGCCTGC crem 
 
prLU291 CAGCTCCCGCTTGCGAGTTG crem 
 
prLU238 TGCTGCTGATTCGTCTTTCAC CD80 
 
prLU239 GAGGAGAGTTGTAACGGCAAG CD80 
 
prLU240 CTGGACTCTACGACTTCACAATG CD86 
 
prLU241 AGTTGGCGATCACTGACAGTT CD86 
 
prLU330 GAGGATACCACTCCCAACAGACC IL-6 
 
prLU331 AAGTGCATCATCGTTGTTCATACA IL-6 
 
prLU334 CATCTTCTCAAAATTCGAGTGACAA TNF-α 
 
prLU335 TGGGAGTAGACAAGGTACAACCC TNF-α 
 
prLU336 GGAAGCACGGCAGCAGAATA IL-12 
 
prLU337 AACTTGAGGGAGAAGTAGGAATGG IL-12 
 
    
Sequencing primers for B. taylorii   
Name Sequence (5'-3')     
prLU006 GTTTAAGGTCACAGAAATTTATTATGATCCCTTC   
prLU007 GAATATCGTTAAAGCACCTAAAGCGATTGG   
prLU008 CCTTGCATAAGAATAATTTGTTCATCTTGACGCAT   
prLU009 CATCATCGTCGTCATCACGCA   
prLU010 GGAACCCTCATGAGCCGTATTTTTGGCTTCGT   
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Table 2-continued   
prLU011 TGCAAAACAGAGTCAATATAACCACTTTCTTGAT   
prLU012 TCTTGCCAAAGCAGCAGGCCATCAGCTT   
prLU013 CTTCACGTTGTGTACGTGGTACACTATCAT   
prLU014 GCTATATGAACATTCTAGAAGAAGCGCGTG   
prLU015 CAAATTCAAGCTCTGCATAGAGATGTTCTGG   
prLU016 ATAAGATGTTTGCAGTTCAACCCAATGCTT   
prLU017 CCTCTCTCAAATCAGGAAATTGCCCGCAGAGTTC   
prLU018 ATGCCAAGGATTTGCTTACCAGCAAGCGGAGCAAA   
prLU021 ATCCCTTCAAGTGCATGGCTGCTGATGG   
prLU022 GCTTGTTTAATGCAAGTGTTGAAACGTT    
prLU023 CATGAACTTGAGAGCATAGTTCCAAGTTAT   
prLU024 GTGCATGACCATAATCCCAAAGGAACATTC   
prLU025 CGGTAAGAGCTAGCGATGAAGAGCGACT   
prLU026 TAACAACAGAGTTAATTCAATAGAGCGA   
prLU027 CACAATCAGAAGAAACTATCTATGCACC   
prLU028 AAACCACCACGCTGTAATGGCAAA   
prLU029 AGGGAGTTTAACGATATTCCTTGTTCC   
prLU030 GAACGCCTGACACAGGCTAGTATTGAAGCA   
prLU031 CATTAAGTCCAGCACGTCTCATTTGAGA   
prLU032 TGCGCTATTCGTAGCTCTCATAATCGACAT   
prLU033 TAGAAGAGCCCCTCTATGCGACGCCT   
prLU034 CTGCGTGACAATATTGGACCACCGTATTAC   
prLU035 ACCGGCTTGGTGCTCGACCACGCACAGT   
prLU036 GCATGCGGTTTCTTGACCATCTTCGGTA   
prLU037 TGCGTGCCAGCACCTTGGCAGGGATAAT   
prLU038 ATCGTCACGCAAGAGAAGAACGCCAGACTT   
prLU039 CAGCACATAGGGAAGGAACAGCGCCTTC   
prLU040 CTATGAAGTAAAGGAGAGAAGCATCGC   
prLU041 CAAACCATGAGCGCGCTCCCGCTTCTCC   
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Table 2-continued   
prLU042 GGTATTGGCTGGATGTACGGCTTTATTGAT   
prLU043 TATCACCTCTGGATCAGATCTATATTCCGA   
prLU044 TCGGAATATAGATCTGATCCAGAGGTGATA   
prLU045 CCTTGAACAAAACATTGCGCATAATAAA   
prLU046 ACCACCAGAACAACAAAGAGAAGCTTTG   
prLU047 TGCTTCATGAGCACAACGTTCATACAGT   
prLU048 CACAGTGTGCTCACGATTCAGCAAGAGCAA   
prLU049 GCGCCGCAACAAAGTATTCAACGGCATA   
prLU050 TATGCCGTTGAATACTTTGTTGCGGCGC   
prLU051 TTGCTCTTGCTGAATCGTGAGCACACTGTG   
prLU052 GAACGCATGAATCTTGCTAGCATTGCGTCA   
prLU053 CCACTGCCGGAGGAATGACAATTTGAATAC   
prLU054 GGCAACTTGCCAAGCAACGGAATTGCCA   
prLU055 GGCAACAAGGTCATTGTACATGCTACAG   
prLU056 AGGTGGATCTACATCTCCATTATGCCTT   
prLU057 TCGCATGCATGGCATGCGCGTGCGGATG   
prLU058 GTTATCGCTTCATCATAGTTGTTGGGAG   
prLU071 CACGCCCAGGTATGACCGATGGTTTA   
prLU072 CAGCACCAGAGAGTTTTGAAGCTGCAC   
prLU073 GCACCAGTTGAACGACGAAACCGTCGC   
prLU080 CATTATGGTGACCTTGGAAACACC   
prLU081 ATTCGTTGCCATTGTCGTTACAAC   
prLU082 GTCATTCTCTTCCGTGCGCTTCCTG   
prLU083 AATTCAGGCCATCCAGGTTCGA   
prLU084 TCTGAAGCCGGATTCCAGAGCAGTG   
prLU087 CTCAACAATTGCACACACGATTATTGAG    
prLU088 TGGTTAGGGTTTGTCCCATATTCG   
prLU095 ATAACATAGAACCCACAATGTAGAGAATAACAAT   
prLU098 CCTTGAACAAAACATTGCGCATAATAAA   
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Table 2-continued   
prLU106 CATCCCTATGTTTTGCCATTGAAAATTATGCCG    
prLU109 GCGATAAAGGCTGTAAGCTGTAAAGCAA    
prLU110 AATAAAGCCGTACATCCAGCCAATGCCCAC   
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Table 3: Primary antibodies used in this study 
Primary antibodies   
Specificity Source / Reference 
Flag Sigma 
GFP Molecular Probes 
Actin Millipore 
STAT3 Cell Signaling 
SHP-2 BD Transduction Laboratories 
phospho-STAT3 Cell Signaling 
phospho-tyrosine Millipore 
Secondary anti-mouse IgG-HRP antibodies GE healthcare 
Secondary anti-rabbit IgG-HRP antibodies GE healthcare 
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3.3 Additional data (preliminary) 
This chapter mainly describes in vivo preliminary data. To study the relevance of Beps 
in the modulation of host immune response, we aimed to establish various in vivo 
assays. All of work has been done in mice with two murine-specific strains: B. 
birtlesii (Bbi) and B. taylorii (Bta). Unless indicated, Balb/c mice (6 to 8 weeks old) 
were used. Although both strains are considered to lead to homogenous infections in 
mice, Bta developed more reliable and higher bacteremia than Bbi. Bbi wild-type (IBS 
325
T
) was used in the chapter 3.3.2. In addition, spontaneous streptomycin-resistant 
(Sm
R
) variants of Bta (LUB046) and Bbi (JKB016) were selected and used as 
“wild-type” in the following experiments. However, we realized later that SmR Bbi 
(JKB016) was attenuated and failed to develop the bacteremia. Thus, the studies of 
Bbi infection in mice (chapter 3.3.3 and 3.3.4) need to be carefully interpreted and 
re-performed. 
In vivo work has been done with the great support from Dr. R. Okujava and C. Mistl. 
Particulartly, the adoptive transfer of BMDCs was set up together with Rusudan. 
Furthermore, Claudia assisted me to establish the neonatal mice model.   
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3.3.1 Upregulation of co-stimulatory molecules by Bhe Δ
bepA-G infection is MyD88-independent 
Introduction 
DCs with highly professional antigen presenting function as critical sentinels in 
antimicrobial immune responses. Exposure to microbial components (PAMPs) such as 
LPS can provoke DC maturation characterized by upregulation of co-stimulatory 
molecules expression and of pro-inflammatory cytokine secretion. The DC maturation 
plays a central role in initiating and modulating the immune adaptive response [1]. 
TLR4, one of the pattern recognition receptors presented on DCs, is a potent receptor 
and signal transducer in response to bacterial LPS. Upon engagement with ligands, 
TLR4 recruits the adaptor proteins via the cytoplasmic TIR domain, such as MyD88, 
and subsequently triggers the activation of NF-κB pathway and MAKP signaling 
cascades. MyD88-depedent pathway is commonly shared within all the TLR signaling, 
with the exception of TLR3 [2]. The LPS of enteric bacteria, such as E. coli, is 
recognized by TLR4 with regard to their highly endotoxic activities. Unlike to other 
bacterial pathogens, LPS of Bartonella was shown to be modified with significantly 
lower endotoxic effect [3, 4]. However, previous work done in this thesis showed that 
infection by Bartonella effector-free strain (Bhe ΔbepA-G) triggered BMDC full 
maturation with enhanced expression of MHCII, CD40, and CD86, as well as 
increased production of pro-inflammatory cytokines (e.g., TNF-α and IL-6) (chapter 
3.2, Fig. 1 and 2). We became interested in understanding which TLR signaling of 
DCs is activated by Bartonella infection. To address this question, we investigated the 
maturation patterns of wild-type, MyD88/Ripk2-, and TLR4-deficient BMDCs in 
response to Bhe infection. These knock-out strains (MyD88
−/−
/Ripk2
−/−
 and TLR4
−/−
) 
of C57BL6 mice were kindly provided from Prof. W. Hardt. MyD88 is a potent 
adaptor protein in most TLR singling pathways. Ripk2 plays a central role in 
NOD-like receptor (NLR) activation.  
Results  
To assess the effects of Bartonella infection on DCs, BMDCs were generated by 
culturing bone marrow cells with Flt3 ligand (the experimental procedure is described 
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in chapter 3.2). BMDCs derived from C57BL6 wild-type, MyD88
−/−
/Ripk2
−/−
, and 
TLR4
−/−
 mice were infected with Bhe wild-type or Bhe ΔbepA-G. E. coli LPS, a TLR4 
ligand, served as the positive control to monitor the state of DC maturation. After 24 
hpi, we measured the surface expression of co-stimulatory (CD40, CD80, and CD86) 
and MHCII molecules using flow cytometry analysis (Fig. 1). As expected, E. coli 
LPS enhanced the expression of MHCII, CD40, CD80, and CD86 on wild-type 
BMDCs. These phenotypic changes of DC maturation patterns caused by E. coli LPS 
were diminished in TLR4- but not MyD88/Ripk2-deficient BMDCs. Consistent with 
pervious results (chapter 3.2), infection with Bhe ΔbepA-G compared to Bhe wild-type 
led to significantly higher expression of MHCII and CD86 on wild-type BMDCs. 
Similar to E. coli LPS stimulation, this enhanced expression of MHCII and CD86 in 
response to Bartonella infection seemed to be reduced in TLR4- but not 
MyD88/Ripk2-deficient BMDCs. However, since this was one experiment and results 
were quite variable, more replicates are needed before we draw a strong conclusion. 
Furthermore, the secretion of pro-inflammatory cytokines was measured (Fig. 2). 
Upon stimulation of E. coli LPS, wild-type BMDCs produced TNF-α and 
dramatically high IL-6. This cytokine induction by E. coli LPS was abolished in both 
TLR4- and MyD88/Ripk2-deficient BMDCs. Confirming with previous results 
(chapter 3.2), infection with Bhe ΔbepA-G compared to Bhe wild-type resulted in high 
levels of cytokine secretion (TNF-α and IL-6) in wild-type BMDCs. This induction of 
cytokines by Bartonella infection was abolished in MyD88/Ripk2-deficient BMDCs. 
However, in response to Bartonella infection, only TNF-α but not IL-6 production 
was reduced in TLR4-deficient BMDCs. 
Discussion 
LPS, a major component of the cell wall of gram-negative bacteria, is recognized by 
TLR4 and induces a variety of biological responses (e.g., cytokine secretion from 
macrophages and B cell proliferative response). MyD88-deficient mice show 
complete resistance to LPS responses, indicating that MyD88 is an essential 
component in LPS signaling [5]. However, it is known that while TLR4 moves from 
cytoplasm membrane to the endosomes, its downstream signaling is switched from 
MyD88-dependent to MyD88-independent pathway with another required adaptor 
TRIF [6]. Kaisho et al published that upon E. coli LPS stimulation, BMDCs and 
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splenic DCs from both wild-type and MyD88-deficient, but not TLR4-deficient mice 
are able to enhance the expression of co-stimulatory molecules. Furthermore, they 
demonstrated that both NF-κB and JNK are still activated with delayed kinetics in 
MyD88-deficient BMDCs, although IRAK activation is abolished [7]. Another study 
emphasizes that various bacterial endotoxins selectively induce MyD88-dependent 
and -independent signaling pathways of TLR4 [8]. Moreover, the 
MyD88-independent (TRIF/TICAM-1) pathway of TLR4 signaling activated by 
endotoxins was proved to be critical for DC maturation, in particular the upregulation 
of co-stimulatory molecules [9]. Consistent with these findings, our preliminary 
results showed that E. coli LPS-induced co-stimulatory molecules of BMDCs were 
dependent on TLR4 but can proceed in the absence of MyD88/Ripk2. The cytokine 
production triggered by E. coli LPS through TLR4 relied on a 
MyD88/Ripk2-dependent manner. Similarly, in response to Bartonella infection, 
MyD88 and Ripk2 were not required for the upregulation of co-stimulatory molecules 
on BMDCs but essential for cytokine production. Single gene knock-out mice are 
needed to specify the relevance of MyD88 and Ripk2 in response to Bartonella 
infection. Though low endotoxic activities of Bartonella LPS, TLR4 seemed to play a 
role in triggering the TNF-α but not IL-6 secretion, implying that another receptor 
may be activated to mediate IL-6 induction. Further examination of different receptors 
involving in Bartonella recognition will be performed. Moreover,  
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Figure 1. Upregulation of co-stimulatory receptors in BMDCs is through 
MyD88/Ripk2-independent manner. BMDCs were derived from wild-type 
(blue), MyD88/Ripk2- (red), or TLR4-deficient (green) mice. In the following, 
BMDCs were incubated with E. coli LPS (1 μg/ml), or infected with Bhe 
wild-type or Bhe ΔbepA-G (MOI = 25). After 24 hpi, cells were stained with 
fluorescently labeled antibodies and analyzed by flow cytometry. Expression 
levels of the maturation markers were presented as relative GMFI. All data were 
normalized to infection with Bhe ΔbepA-G. Data were analyzed from one 
experiment.  
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Figure 2. Cytokine production of BMDCs is MyD88- or Ripk2-dependent. 
BMDCs were derived from wild-type (blue), MyD88/Ripk2- (red), or 
TLR4-deficient (green) mice. In the following, BMDCs were incubated with E. 
coli LPS (1 μg/ml), or infected with Bhe wild-type or Bhe ΔbepA-G (MOI = 25) 
for 24 h. Amounts of TNF-α and IL-6 in the cell culture supernatants were 
measured by ELISA. Data were analyzed from one experiment. 
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3.3.2 B. birtlesii infection with a lower-dose inoculum induces 
higher bacteremia. 
Introduction  
Natural infection in animals, such as cats with Bhe, is mainly considered to be 
asymptomatic, despite developing long-lasting bacteremia. However, some evidence 
showed that experimental Bhe infection through intradermal (i.d.) route in cats 
induces various symptoms (e.g., fever, lymphadenopathy, and reproductive failure) 
[10, 11]. To investigate the pathogenicity of Bartonella on the laboratory mice, two 
types of murine models have been described: a homologous infection using several 
species of Bartonella isolated from wild rodents [12-14] and a heterologous infection 
with Bhe [15-17]. The very high inoculum doses (> 1 × 10
7
 CFU/mouse) used in most 
previous publications may be much higher than those occurring in natural infections. 
This may be the reason why experimental setup of homologous infection results in 
various clinical symptoms.  
How various inoculum doses impact the Bbi infection in mice was studied by 
Marignac et al. Three groups of eight C57BL/6 mice inoculated through the 
subcutaneous (s.c.) route with 5 × 10
3
, 5 × 10
5
 or 1.4 × 10
7
 CFU/mouse of Bbi showed 
similar bacteremia kinetics. Interestingly, the bacteremia was significantly higher and 
lasted one week longer with the lower inoculum doses compared to the higher 
inoculum doses [18]. It suggests that high inoculum doses may prime an efficient 
immune response to eliminate bacteria faster. Taken this into consideration, i.d. 
infection of a murine-specific strain Bbi with different inoculum doses was performed 
to determine minimal infection dose in our murine model. 
Results  
In two independent experiments, Balb/c mice were intradermally infected with 1 × 
10
2
, 1 × 10
5
, or 1 × 10
7
 CFU/mouse of Bbi wild-type (IBS 325T). Blood samples were 
collected from each mouse until up to 8 weeks (Fig. 1). Combining these two 
experiments, four out of four (100%) mice with 1 × 10
7
 CFU inoculum were all 
bacteremic at day 7. For the other two groups with lower-doses inoculum, the 
bacteremia became less synchronized. Four out of six (67%) mice with 1 × 10
5
 CFU 
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inoculum and three out of six (50%) mice with 1 × 10
2
 CFU inoculum were 
bacteremic. The highest peak of bacteremia reached to 10
6
 CFU/ml blood in the group 
inoculated with 1 × 10
2
 CFU inoculum. 
Discussion  
Consistent with the pervious study by Marignac et al. [18], our results confirmed that 
bacterial doses of inoculation affected the development of bacteremia in the host. 
Although reduced numbers of mice became bacteremic with low inoculum doses of 
Bbi infection, as soon as bacteria colonized in the blood, they tended to develop 
higher bacteremia and to delay the clearance. This phenomenon was also observed 
with Bta infection (chapter 3.2, Fig. 22). There as well higher levels and longer 
duration of bacteremia were observed with lower inoculum doses. Taken bacteremia 
results from two strains together, it suggests that Bartonella infection with low 
inoculum doses may be more capable of evading immune response, thereby resulting 
in high bacteremia. In nature, Bartonella transmission occurs passively when a vector 
leaves infective bacteria on the host skin (e.g., infected vector feces), indicating only a 
few bacteria are likely to be transferred to the host. Therefore, low inoculum doses 
may be closer to the natural situation and are more preferable to be used for 
Bartonella study in vivo. 
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Figure 1. B. birtlesii bacteremia kinetics in Balb/c mice through the 
intradermal infection. In the first experiment (upper), mice (n = 4) were 
inoculated with Bbi wild-type in the ear dermis: two with 1 × 10
5
 CFU (red) and 
two with 1 × 10
2
 CFU (green). In the second experiment (lower), mice (n = 12) 
were inoculated with Bbi wild-type in the ear dermis: four with 1 × 10
7
 CFU 
(blue), four with 1 × 10
5
 CFU (red), and four with 1 × 10
5
 CFU (green). Blood 
was drawn at the indicated days post-infection, diluted and plated on sheep blood 
supplemented CBA plates for counting the bacterial CFU. 
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3.3.3 B. birtlesii infection leads to lymphadenopathy in mice 
Introduction  
The clinical syndrome of cat scratch disease (CSD) was first reported in 1950 by 
Debré et al. The most typical form of CSD manifests subacute regional 
lymphadenopathy with an associated inoculation site due to a cat scratch or bite [19]. 
CSD granulomas resulting from Bhe infection are markedly characterized by the high 
content of B lymphocytes and neutrophils [20]. Similarly, a heterologous infection 
with Bhe in the murine model leads to lymphadenopathy as observed for CSD in 
humans but fails to establish bacteremia [16]. This lymph node swelling caused by 
heterologous Bartonella infections may indicate that bartonellae transport via the 
lymphatic system and trigger the granulomatous inflammation. However, Bartonella 
infection develops subclinical symptoms in the reservoir hosts. Thus, we speculate 
that homologous strains have evolved specific strategies to evade from host immune 
responses, thereby resulting in the prolonged bacteremia. In this study, we 
investigated the local inflammation by Bbi infection in mice, in particular focusing on 
ears and draining lymph nodes (LNs). 
Results  
To access the local inflammation in response to homologous infection, Bbi was used 
in the i.d. infection model where the bacteria were inoculated in the derma on the ear 
pinnae of mice. Mice were injected with 1 × 10
7 
CFU/mouse of Bbi wild-type (Sm
R
 
Bbi) or Bbi Tn-virD4, a translocation-deficient strain. Additionally, a group of mice 
were injected with phosphate-buffered saline (PBS) for comparison of the host 
response to the injection itself. At 2 dpi, cell suspensions from ears and draining 
lymph nodes were harvested. Cell samples of ear dermis were stained with a panel of 
fluorescently labeled antibodies specific for surface receptors of mouse DCs, 
macrophages, and neutrophils and analyzed by flow cytometry (Fig. 1). Moreover, the 
activation state of the dermal DCs (CD11c
+
) and macrophages (F4/80
+
) was 
determined by measuring MHCII expression levels. The activated neutrophils (LyG6
+
) 
were detected by anti-CD11b antibody staining. Analysis of the total population of 
DCs showed no difference among all three tested conditions. Compared to injection 
with PBS, infections with Bbi wild-type and Bbi Tn-virD4 recruited comparable 
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populations of macrophages (~ 20%) and neutrophils (~ 10-15%) to the ear dermis. 
These recruited neutrophils were CD11b
+
, indicating that they were activated.  
Previously, Dr. R. Okujava reported that Bbi i.d. infection (1 × 10
7
 CFU/mouse) led to 
the swelling LNs after 2 dpi even till 7 dpi. Indeed, the similar phenotype was 
observed in this study. Compared to PBS injection, infections with Bbi wild-type and 
Bbi Tn-virD4 caused the enlarged draining LNs (superficial cervical LNs) at 2 dpi. To 
determine the cell composition of swelling LNs, cell suspensions were stained with 
fluorescently labeled anti-CD3 and anti-CD19 antibodies specific for mouse T cells 
and B cells, respectively. Subtypes of T cells were distinguished by staining with 
anti-CD4 and anti-CD8 antibodies. Distant LNs (axillary and brachial LNs) were 
collected as a negative control. The diagram showing the locations of the principal 
LNs is displayed in Figure 2 [21]. Flow cytometric analysis revealed that comparable 
results were observed between infections with Bbi wild-type and Bbi Tn-virD4 (Fig. 
3). Compared to PBS injection, Bbi infection increased total population of CD19
+
 B 
cells ~ 10% in the draining LNs. Interestingly, a subgroup of cells expressing 
CD3
+
/CD19
+
 was increased ~ 5%. Staining with anti-CD4 and anti-CD8 antibodies 
showed a slight increased population of CD4
+
/CD8
+
 double positive cells. However, 
the population of single positive CD8
+
 maintained the same, but CD4
+
 cells decreased. 
In distant LNs, the cell composition remained similar in all three conditions. 
Discussion  
The results from two different locations (ears and draining LNs) showed no 
significant difference between infections with Bbi wild-type and Bbi Tn-virD4. Both 
Bbi strains induced the recruitment of macrophages and neutrophils to the inoculation 
site of the ear dermis and led to B cell-rich swelling draining LNs. It implies that 
T4SS of Bartonella does not involve in these phenotypes. However, the enlarged LNs 
caused by Bbi infection were not observed with low inoculum doses (1 × 10
5
 
CFU/mouse) (data not shown). This result along with previous data (chapter 3.3.2) 
may suggest that high inoculum doses of Bartonella non-selectively induce strong 
host innate immune responses, thus resulting in local immune cell recruitment, LN 
enlargement, and eventually low bacteremia. 
It was shown that B. grahamii (Bgr), a rodent-specific Bartonella species, compared 
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to Bhe develops only a mild and short-lived lymphadenopathy in mice. The distinct 
course of LN swelling resulted from Bhe is due to the lymphocyte proliferation rather 
than migration. However, the relative increase of B cells compared to T cells is 
equivalent, but the rise of the absolute B cell and T cell numbers is larger in the case 
of Bhe infection because of the much pronounced lymphadenopathy [17]. Thus, using 
the relative percentage of cell population in this experiment may be not a proper way 
to study the lymphadenopathy caused by Bbi infection. The absolute cell numbers will 
be analyzed for the next investigation. 
Based on our results, a subgroup of CD3
+
/CD19
+
 double-positive cells was increased 
in the swelling LNs. However, we cannot exclude that these CD3
+
/CD19
+
 cells were 
doublets involving T cells. B cells appear as large cells that require a wide 
lymphocyte gate to be detected. By doing so, the risk of inclusion of cell doublets in 
the analysis is high. The expression of CD4 or CD8 molecules is associated with T 
helper or cytotoxic T cells, respectively. During thymic T cell development, a 
CD4
+
/CD8
+
 immature T cell stage exists. In the following, the expression of CD4 and 
CD8 cell surface molecules on mature T cells is thought to be mutually exclusive. 
Increasing evidence revealed that extrathymic CD4
+
/CD8
+
 double positive T cells are 
enhanced in the peripheral blood in patients with viral infections where these cells 
may harbor antiviral functions [22]. Besides, CD4
+
/CD8
+
 T cell population is 
commonly found in reactive LNs of nodular lymphocyte predominant Hodgkin 
lymphoma as a clue for the diagnosis [23]. These phenotypically distinct T cells 
appear to be comprised of memory cells based on their responses of antigen recall, 
expression of memory T cell markers, production of IFN-γ, and localization to 
inflammatory sites [24]. Interestingly, our results showed the CD4
+
/CD8
+
 population 
of T cells were slightly increased by Bbi infection. However, the function and 
significance of this induced small group of T cells remains to be elucidated.  
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Figure 1. Bbi infection induces the recruitment of macrophages and 
neutrophils to the ear dermis. Mice (n = 4) were intradermally infected with Bbi 
(1 × 10
7
 CFU/mouse). Two inoculated with Bbi wild-type and two with Bbi 
Tn-virD4. Besides, two mice were injected with PBS. At 2 dpi, cell suspensions 
from the ear dermis were stained with anti-CD11c, anti-F4/80, or anti-LyG6 
antibodies to determine DCs, macrophages, or neutrophils, respectively. The 
activation state of DCs and macrophages was determined by measuring MHCII 
expression levels. The activated neutrophils were detected by anti-CD11b staining. 
Results are presented as percentages of the total acquired events. 
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Draining lymph nodes 
Distant lymph nodes 
Figure 2. A scheme of the murine lymphatic system. All superficial LNs are 
bilateral and can be classified as: cervical superficial LNs (referred as draining 
LNs in red), situated immediately above the submandibular salivary glands; 
axillary LNs, present in the axillary fossa; brachial LNs, in proximity to the angle 
of the scapula; inguinal lymph nodes situated closed to the bifurcation of the 
superficial epigastric vein. Both axillary and brachial LNs are referred as distanced 
LNs in blue [21]. 
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Figure 3. Bbi infection induces recruitment of B cells to the draining LNs. 
Mice (n = 4) were intradermally infected with Bbi (1 × 10
7
 CFU/mouse). Two 
inoculated with Bbi wild-type and two with Bbi Tn-virD4. Besides, two mice were 
injected with PBS. At 2 dpi, cell suspensions of draining LNs (A) and distant LNs 
(B) were stained with a panel of fluorescently labeled anti-CD19 and anti-CD3 
antibodies specific for B cells and T cells, respectively. Subtypes of T cells were 
distinguished by staining with anti-CD4 and anti-CD8 antibodies. Results are 
presented as percentages of the total acquired events.  
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3.3.4 Bartonella-infected BMDCs migrate from the site of 
injection to draining LNs 
Introduction 
It was shown that Bhe infection leads to subacute regional lymphadenopathy in mice 
(also observed in chapter 3.3.3) and bacterial DNA is detected in LNs after 6 hpi, 
indicating that Bartonella is transported via the lymphatic system in the host [16]. 
Furthermore, a recent publication by Okujava et al revealed that Bhe affects BMDC 
cell migration through a T4SS-dependent manner [25]. Taken these two independent 
lines of evidence together, we speculate that Bartonella initially enters migratory cells, 
likely DCs, in the intradermal inoculation. In the following, DCs may serve as 
vehicles for Bartonella transport via the lymphatic system towards the blood stream. 
To assess this hypothesis, we established the hind-foot adoptive transfer of 
Bartonella-infected BMDCs in mice. Followed with the lymphatic drainage, 
migration of injected BMDCs was traced. Additionally, bacteremia development was 
analyzed to study whether Bartonella potentially exploits DCs as the carriers, 
eventually leading to successful colonization in erythrocytes. 
Results 
Adoptive transfer of Bartonella-infected BMDCs was established in Balb/c mice. 
BMDCs were infected ex vivo with Bbi wild-type (SmR Bbi) at MOI = 50. After 15 
hpi, infected BMDCs were treated with gentamycin (200 μg/ml) for 2 hours to 
remove extracellular bacteria. In the following, 5 × 105 uninfected or Bbi-infected 
BMDCs labeled with Vibrant DiO were injected subcutaneously (s.c.) in the right 
hind foot of mouse. The lymph drainage from the hind-foot primarily goes through 
the popliteal (PO) LN and inguinal (IN) LN. The PO LN drains centrally to the iliac 
(IL) LNs and following to the renal (RE) LN. (Fig. 1) [26]. At 1, 2, and 3 dpi, cell 
suspensions of the PO and IN LNs (referred as draining LNs) were collected and 
analyzed by flow cytometry. Our results clearly showed both uninfected and 
Bbi-infected BMDCs were able to migrate from the hind-foot to the draining LNs. 
Compared to the uninjected side as the negative control, the labeled cells were 
recovered from the draining LNs (0.2 - 0.3%) even until 3 dpi (Fig. 2). The absolute 
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cell numbers were showed in the figure 3. The highest amounts of fluorescent cells 
were detected at 1 dpi and decreased gradually. 
Discussion 
Our results showed that Bbi-infected BMDCs similar as uninfected BMDCs were 
detected within the draining LNs at 1 dpi, indicating that Bbi infection did not impair 
the DC migratory capability. However, only few bacterial colonies were recovered 
form cell suspensions of draining LNs (data not shown). It is difficult to interpret how 
well Bbi wild-type survived in BMDCs and passaged to lymphatic system in the 
established adoptive transfer model. Bacteria may be already released from BMDCs 
before cell suspensions were harvested. To address this question, bacteremia analysis 
could be a better way. The development of bacteremia from mice adoptively 
transferred with Bbi-infected BMDCs was analyzed from 3 to 28 dpi. However, five 
out of five mice were abacteremic. Later, we realized that different from Bbi 
wild-type (IBS 325T) leading to stable bacteremia (chapter 3.3.2), the Sm
R
 Bbi 
wild-type used in this experiment was attenuated and failed to develop the bacteremia 
in the i.d. infection model. Thus, experiments of adoptive transfer were re-performed 
using Sm
R
 Bta wild-type which was confirmed to be capable of establishing stable 
bacteremia in mice (chapter 3.2, Fig 22). Five out of Five mice became bacteremic 
with inoculation of Bta-infected BMDCs through the hind-foot of mouse (data not 
shown). It suggests that BMDCs may potentially serve as vehicles for Bartonella 
transport, thereby resulting in colonization in erythrocytes. However, more 
investigations are needed to exclude that BMDCs are lysed during injection and 
bacteria are exposed directly under the skin. 
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Draining lymph nodes 
Figure 1. A diagram shows lymphatic drainage in the mouse. The adoptive 
transfer was performed through hind-foot (arrow in blue). The lymph drainage 
from the hind-foot primarily goes through the popliteal (PO) LN and inguinal (IN) 
LN. The popliteal LN drains centrally to the iliac (IL) LNs and following to the 
renal (RE) LN. Both PO and IN LNs are referred as draining LNs labeled in red. 
[26] 
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Figure 2. Both uninfected and Bartonella-infected BMDCs migrate from the 
hind-foot to draining LNs. BMDCs were infected ex vivo with Bbi wild-type 
(Sm
R
 Bbi) at MOI = 50. Gentamycin (200 μg/ml) treatment was used to remove 
extracellular bacteria. In the following, 5 × 10
5
 uninfected (n = 1) or Bbi-infected 
(n = 2) BMDCs labeled with Vibrant DiO (FL1 channel) were injected 
subcutaneously (s.c.) in the right hind foot of mouse. At 1 dpi, cell suspensions of 
PO and IN LNs were collected from both sides and analyzed by flow cytometry.  
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Injection DAY 1 DAY 2 DAY 3 
BMDCs 3687 1136 1883 
#1 Bbi-infected BMDCs 4441 1513 1309 
#2 Bbi-infected BMDCs 2492 226 475 
 
  
Figure 3. The absolute numbers of fluorescent cells are detected in draining 
LNs. BMDCs were infected ex vivo with Bbi wild-type (Sm
R
 Bbi) at MOI = 50. 
Gentamycin (200 μg/ml) treatment was used to remove extracellular bacteria. In 
the following, 5 × 10
5
 uninfected (n = 1) or Bbi-infected (n = 2) BMDCs labeled 
with Vibrant DiO (FL1 channel) were injected subcutaneously (s.c.) in the right 
hind foot of mouse. At 1, 2, and 3 dpi, cell suspensions of PO and IN LNs were 
collected from both sides and analyzed by flow cytometry. This figure presents the 
absolute number of FL1 positive cells after subtraction of the background of 
autoflourescent events from control LNs.  
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3.3.5 B. taylorii infection in the neonatal murine model leads 
to extremely high bacteremia but not to bacterial persistence 
Introduction  
As reported, the domestic cats naturally infected with a feline-specific strain Bhe 
developed prolonged bacteremia for several weeks to more than one year [27]. With 
current experimental setup, Balb/c mice (6 to 8 weeks old) infected with homologous 
strains Bbi and Bta led to transient two-month bacteremia, which may be much 
shorter from those occurring in nature. As exemplified by H. pylori, experimental 
infection in mice during the neonatal period leads to bacterial persistence based on a 
mechanism of tolerogenic DCs reprogramming via a T4SS independent manner [28]. 
To get closer with the situation that Bartonella homogenous infection may persist for 
life, a neonatal murine model for Bta infection was established. Neonatal life is 
characterized by heightened sensitivity to infectious agents with severely reduced 
specific cellular and humoral immune responses. The sensitivity of newborns to 
infectious diseases is partly due to the lack of pre-existing immunological memory 
and the small number of immune cells presenting in peripheral lymphoid tissues. 
Aside from these quantitative differences, newborn immune cells are qualitatively 
distinct from adult cells. However, neonates are considered as immunodeviant instead 
of immunodeficient. Depending on the conditions of antigen exposure, neonates are 
able to mount various responses, ranging from deficient or deviant to fully mature 
[29]. Newborn mice are defined experimentally as those ages from 1 to 10 days. 
There are major changes in lymphoid-organ development during the first week. 
However, some adaptive immune responses are similar in 7-day-old and 1-day-old 
mice. In this study, Bta infections in mice at different ages: 7 days or 1 day, as well as 
in two species: C57BL6 or Balb/c were compared. 
Results  
Mice were infected with Bta wild-type during the neonatal period (i.e., at the age of 7 
days or 1 day) through an intraperitoneal route. After injection, neonates were placed 
back to the same cage with the mother mouse. Until they reached 21 days old, 
infected mice were separated by gender. Blood samples were collected from 21 dpi 
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until no detectable bacteremia. When C57BL6 mice were infected at the age of 7 days, 
four out of four (100%) mice with 1 × 10
7
 CFU inoculum, five out of five (100%) 
mice with 1 × 10
5 
CFU inoculum, and one out of four (25%) mice with 1 × 10
3
 CFU 
inoculum were bacteremic. The highest peak of bacteremia was almost 10
8
 CFU/ml 
blood in the group inoculated with 1 × 10
5
 CFU/mouse (Fig. 1). When C57BL6 mice 
were infected at 1 day old, six out of six (100%) mice with 1 × 10
7
 CFU inoculum, six 
out of six (100%) mice with 1 × 10
5
 CFU inoculum, and one out of two (50%) mice 
with 1 × 10
3
 CFU inoculum were bacteremic. The highest peak of bacteremia reached 
to 7 × 10
8
 CFU/ml blood in the groups inoculated with 1 × 10
5
 CFU/mouse and 1x10
3
 
CFU/mouse (Fig. 2A). Furthermore, when Balb/c mice were infected with Bta 
wild-type at the age of day 1, all of the mice with different inoculum doses (1 × 10
7
, 1 
× 10
5
, and 1 × 10
3
 CFU/mouse) were bacteremic. The highest peak of bacteremia 
reached 3 × 10
9 
CFU/ml blood in the groups inoculated with 1 × 10
5
 CFU/mouse and 
1 × 10
3 
CFU/mouse (Fig. 2B). The bacteremia kinetics was similar in all of tested 
groups (range, 8 to 9 weeks). 
Discussion 
In this study, Bta infection in neonatal mice (both at the age of 7 days and 1 day) did 
not lead to bacterial persistence. Similar to infection in 8 weeks old mice (considered 
as adults), the bacteremia kinetics in neonatal mice was in a range until 8 to 9 weeks. 
Based on pervious results in adult mice (chapter 3.2, Fig. 22), the highest peak of 
bacteremia reached at 14 dpi. In neonatal murine model, we started to collect blood 
sample at 21 dpi due to handling issues. Thus, we might have missed the highest peak 
of bacteremia in the neonates. Even so, Bta infection in 1-day-old C57BL6 mice 
showed that the highest detectable peak of bacteremia was around 1 log higher than 
infection in adult mice. Infection in 1-day-old Balb/c mice led to almost 2 log higher 
bacteremia than infection in adult mice. Interestingly, the age of infected mice has a 
significant effect on bacteremia development. Comparing bacteremia of different 
mice strains showed that Balb/c mice were more susceptible to Bartonella infection. 
Based on extremely high bacteremia in the neonatal mice model, it indicates that 
immunodeviant neonates poorly control the Bartonella replication in the early phase. 
While mice grow up and develop an intact immune system, the bacteremia is 
gradually cleared out. So far, it was never supported by in vivo data where Bartonella 
survives and replicates in the primary niche before the bacteremic stage. Based on the 
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extremely high bacteremia in newborn mice, this neonatal murine model may provide 
a better platform to study the primary niche of Bartonella infection. 
 
  
  RESULTS: Additional data  
- 177 - 
 
 
 
 
  
Figure 1. Bacteremia kinetics of B. taylorii infection in 7-day-old mice. 
7-day-old C57BL6 mice (n = 14) were inoculated with Bta wild-type via i.p. route: 
five with 1 × 10
7
 CFU (blue), five with 1 × 10
5
 CFU (red), and four with 1 × 10
3
 
CFU (green). Blood was drawn at the indicated days post-infection, diluted and 
plated on sheep blood supplemented CBA plates for counting bacterial CFU. 
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Figure 2. Bacteremia kinetics of B. taylorii infection in 1-day-old mice. (A) 
1-day-old C57BL6 mice (n = 14) were inoculated intraperitoneally with Bta 
wild-type: six with 1 × 10
7
 CFU (blue), six with 1 × 10
5
 CFU (red), and two with 
1 × 10
3
 CFU (green). (B) 1-day-old Balb/c mice (n = 19) were inoculated 
intraperitoneally with Bta wild-type: eight with 1 × 10
7
 CFU (blue), six with 1 × 
10
5
 CFU (red), and five with 1 × 10
3
 CFU (green). For both experiments, blood 
was drawn at the indicated days post-infection, diluted and plated on sheep blood 
supplemented CBA plates for counting bacterial CFU. 
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3.3.6 Bta Δ bepDE loses the fitness of bacteremia 
development 
Introduction 
The immunomodulatory activities of BepDBhe were majorly studied in vitro analyses 
(chapter 3.2). In the following, we became interested in the role of BepD in an in vivo 
establishment of Bartonella infection. However, Bhe causes bacteremia as a hallmark 
of infection in its feline natural reservoir host only, which for ethical reasons is not an 
accessible experimental model. To establish an optimal murine model for the 
functional analysis of Beps, Bta, a murine-specific strain, was introduced with its 
feasibility of genetic manipulations. Annotation of the genomic fragment revealed that 
only five effector proteins can be annotated in Bta instead of seven Beps (BepA-G) in 
Bhe. Among them, two Beps, BepDBta and BepEBta contain putative 
tyrosine-phosphorylation motifs as homologs of BepDBhe (identity of the N-terminal 
fragment: 53%) and BepEBhe (identity of the N-terminal fragment: 24%), respectively. 
To avoid their potentially redundant functions, a mutant strain of Bta with deletions of 
both genes bepD and bepE was constructed (referred to Bta ΔbepDE). Mice were 
infected intradermally with Bta ΔbepDE and bacteremia was monitored up to 8 
weeks. 
Results 
In this experiment, ten mice were intradermally infected: five with Bta wild-type (1 × 
10
5
 CFU/mouse) and five with Bta ΔbepDE (1 × 105 CFU/mouse). Different from Bta 
wild-type infection which led to five out of five (100%) bacteremic mice at 7 dpi, Bta 
ΔbepDE infection resulted in three out of five (60%) mice developing less 
synchronized bacteremia. The highest peak of bacteremia caused by Bta wild-type 
reached to 10
6
 CFU/ml blood. Although 60% mice were bacteremic, Bta ΔbepDE 
developed lower titer (range from 10
3
 to 10
5
 CFU/ml) and shorter duration (range 
from 3 to 5 weeks) of bacteremia (Fig. 1). 
Discussion 
Infection with Bta ΔbepDE led to lower and shorter bacteremia, indicating that less 
fitness of bacteremia development resulted from combined consequences of loss of 
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BepDBta and BepEBta. However, when the effect of BepDBta and BepEBta on DC 
maturation was analyzed in vitro, we realized that impaired DC maturation only 
resulted from BepDBta but not BepEBta. Most likely, these two effectors containing 
EPIYA-related motifs process different functions. To study the specific relevance of 
BepDBta in vivo, Bta ΔbepD was generated and analyzed in the Research article II 
(chapter 3.2).  
A recent publication by Dr. R. Okujava demonstrated a potent role of BepE in 
bacterial dissemination from derma to blood. In vitro analysis revealed that BepEBhe 
rescued the cell fragmentation which was triggered by BepCBhe. In the rat model, 
when the B. tribocorum mutant Btr ΔbepDE was abacteremic through the i.d. 
infection, complementation with BepEBtr, BepEBhe or BID domains of BepEBhe 
restored bacteremia. [25]. However, though leading to impaired bacteremia, Bta 
ΔbepDE was not abacteremic. One of the possibilities is that BID domain of other Bta 
effectors aside from BepDBta and BepEBta may possess similar function as BID 
domains of BepEBhe. Also, it remains unclear whether any of Bta effectors containing 
a FIC domain triggers the deleterious phenotypes as BepCBhe.   
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Figure 1. Bta ΔbepDE loses the fitness of bacteremia development. Mice (n = 
10) were inoculated intradermally: five with 1 x 10
5 
CFU of Bta wild-type (blue), 
and five with 1 x 10
5 
CFU of Bta ΔbepDE (red). Blood was drawn at the indicated 
days post-infection, diluted and plated on sheep blood supplemented CBA plates 
for counting bacterial CFU. 
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Functional interaction between BadA and VirB/D4 T4SS 
The first published report “Bartonella henselae trimeric autotransporter adhesin BadA 
expression interferes with effector translocation by the VirB/D4 type IV secretion 
system” (chapter 3.1) in my Ph.D. thesis was accomplished by collaboration with the 
group of Prof. V. Kempf. Our findings revealed that most Bartonella clinical isolates 
had lost expression of either BadA or VirB/D4 during in vitro passages. Only one 
exception of clinical isolate (strain San Antonio 3 variant-2) from our screen stably 
coexpressed BadA and VirB/D4. Furthermore, the phenotypic effects of coexpression 
of both virulence factors demonstrated that BadA interfered with the function of 
VirB/D4 T4SS, but kept its intact capabilities. Based on our data obtained from this 
study, we propose that BadA negatively affects VirB/D4-dependent Bep translocation 
and invasome formation by likely forming a physical barrier between the bacterial cell 
envelope and the host cell membrane. In contrast, BadA-dependent phenotypes are 
not affected by a functional VirB/D4 T4SS. Both virulence factors, each displaying 
multiple functions in host cell interaction, were described to be essential for 
Bartonella pathogenicity. Potentially, BadA and VirB/D4 are differentially regulated 
during the different stages of the infection cycle of Bartonella. Further experiments to 
elucidate the regulatory patterns of these two systems are needed. 
Immunomodulatory properties of BepA and BepD 
Through the intradermal infection, Bartonella VirB/D4 T4SS is known to be an 
indispensable virulence factor for the successful development of bacteremia. 
Particularly, it is required at an early stage of infection before the onset of 
intraerythrocytic bacteremia. Since DCs are one of the potential vehicles for 
Bartonella transport in the host organism, we sought to examine the functional 
consequences of professional antigen-presenting DCs in response to Bartonella 
infection. This resulted in the second manuscript “Bartonella translocated effectors, 
BepA and BepD, interfere with the maturation of dendritic cells” (chapter 3.2). Our 
data revealed that Bartonella infected DCs remained a “semi-mature” developmental 
stage, which was characterized by reduced surface expression of MHCII complex and 
co-stimulatory receptors CD40 and CD86, as well as strongly diminished secretion of 
the pro-inflammatory cytokines TNF-α and IL-6. These phenotypic changes of 
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impaired DC maturation observed upon Bartonella infection were attributed to two 
effector proteins, BepA and BepD.  
The BID domain of BepA strongly affected the downregulation of CD40 expression 
and TNF-α production, likely through cAMP elevation in BMDCs. In the following, 
how PKA and Epac-1, known as key players in the downstream of cAMP signaling, 
antagonistically interact with each other for the anti-inflammatory response of BepA 
will be further analyzed. Also, although BepA homologs share high sequence identity, 
the functional readouts of them were not congruent. Further investigations are needed 
to elucidate a potential cell type or host species specificity of BepA. 
The phenotypic changes of infected BMDCs triggered by Bartonella BepD were 
represented by the downregulation of surface MHCII and CD86 expression, as well as 
by the repression of TNF-α and IL-6 production. Besides in primary BMDCs, ectopic 
expression of BepD in JAWSII cells showed antagonistic effects on LPS-triggering 
TLR signaling. In this study, we demonstrated that BepD led to a prolonged STAT3 
phosphorylation and activation similar to IL-10 signaling, which may explain the 
immunosuppressive properties of BepD. Moreover, constitutive 
tyrosine-phosphorylation of BepD in JAWSII cells suggests that BepD acts as a 
signaling hub to actively trigger the STAT3 activation, in contrast to IL-10 receptor, 
which is thought to only become active upon engagement of its extracellular signals. 
To further verify this hypothesis, we will examine the effects of STAT3 protein 
knockdown by RNA interference on the immunomodulatory activity of BepD. 
DCs reaching a stage of semi-maturation are believed to be capable of driving naïve T 
cell into a regulatory cell fate characteristic for immunotolerance. To support this idea, 
functional analyses of these semi-mature DCs are needed. One was performed by 
using ex vivo T cell response assay. BMDCs from naïve mice were infected with 
Bartonella and subsequently co-cultured with OTII-transgenic T cells under 
conditions of ovalbumin-specific priming. Subsequently, the state of T cell activation 
was monitored by cell proliferation. However, in this experiment, BMDCs without 
Bartonella infection already primed a strong T cell activation, and thus this result was 
not conclusive (data not shown). In addition, to translate our findings into an in vivo 
context, we analyzed the bacteremia as a hallmark of Bartonella infection in mice. 
Although a trend of losing the bacterial fitness was observed after infection with B. 
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taylorii strains harboring deletions of bepA or/and bepD, the effects of BepA and 
BepD on bacteremia development were not strong. To sensitize our murine model, 
lower doses of inoculum will be tested in the next experiment. Also, further 
investigations uncovering the local inflammation (particularly at the site of injection 
and draining lymph nodes (LNs)) of Bartonella infection will be performed.  
Immunological signaling triggered by Bartonella infection 
Even though LPS of Bartonella shows unusual structural features connected to a 
significantly lower endotoxic activity, a strong inflammation in BMDCs was observed 
after infection with an effector-free strain of Bartonella (see chapter 3.2). We became 
interested in studying which immunological signaling in DCs was triggered by 
Bartonella infection (chapter 3.3.1). Examination of BMDCs from TLR4- and 
MyD88/Ripk2- deficient mice revealed that upregulation of surface MHCII complex 
and co-stimulatory receptors by E. coli LPS treatment or by Bartonella infection was 
through a MyD88/Ripk2-indepednent pathway. Contrarily, MyD88 or Ripk2 plays an 
essential role in cytokine production (TNF-α and IL-6). Results obtained from this 
experiment indicate that Bartonella infection of BMDCs provokes both 
MyD88/Ripk2-dependent and -independent immunological signaling pathways. To 
specify the relevance of MyD88 and Ripk2 to DC inflammation, single gene 
knock-out BMDCs will be used. Furthermore, upon Bartonella infection, TNF-α 
production was diminished in TLR4-deficient BMDCs, whereas IL-6 induction 
remained the same. It implies that besides TLR4, another receptor engaged with 
Bartonella to mediate IL-6 production. To assess this question, other TLR-deficient 
BMDCs will be analyzed.  
Bartonella transport at an early stage of infection 
To explore how Bartonella transport in the host organism, different in vivo analyses 
were established. We found that intradermal infection of B. birtlesii led to the 
enlargement of draining LNs in mice (chapter 3.3.3). Moreover, bacterial colonies 
could be recovered from the draining LNs at 24 hours post-infection (Dr. R. Okujava, 
data not shown). Taken together, these results indicate that Bartonella is transported 
through the lymphatic system and triggers the granulomatous inflammation in the 
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LNs. Furthermore, the adoptive transfer of Bartonella-infected BMDCs revealed that 
infected BMDCs were capable of migrating from the site of inoculation to draining 
LNs and eventually led to the bacteremia (chapter 3.3.4). Although there were some 
technical concerns, this result supports the idea that DCs are potential vehicles for 
bacterial spreading in the host. Upon migration, it is tempting to speculate that 
Bartonella colonizes the primary niche for preparing its competency to subsequently 
interact with erythrocytes. However, so far this assumption is not yet supported by in 
vivo experimental data. A neonatal murine model established in this thesis may 
provide a better platform to study the primary niche of Bartonella infection. 
Compared to adult mice, Bartonella infection in newborn mice developed extremely 
high bacteremia (chapter 3.3.5), indicating that immunodeviant neonates poorly 
control the Bartonella replication in the early phase of infection. 
A potential model of Bartonella stealth-infection strategy 
To summarize, a potential model of Bartonella stealth-infection strategy can be built 
based on results obtained from my Ph.D. thesis (Figure in next page). Upon 
inoculation into the host, Bartonella initially enters migratory cells, such as DCs, 
which assist the passage of bacteria from the intradermal environment via lymphatic 
system to the primary niche, eventually culminating in their release to the 
bloodstream. On one hand, DCs may be exploited by Bartonella for bacterial 
transport passing through the draining LNs. On the other hand, in the LNs, 
“semi-mature” DCs triggered by Bartonella infection may possess potential 
tolerogenic activities to subvert T cell response. The induction of semi-maturation 
observed in DCs is attributed to two effector proteins, BepA and BepD. Moreover, the 
underlying mechanisms of BepA and BepD involve in distinct host signaling 
pathways, cAMP and STAT3, respectively. In my Ph.D. thesis, this is the first time to 
reveal the immunomodulatory properties of the VirB/D4 T4SS reflecting part of the 
Bartonella stealth-infection strategy for a chronic bartonellosis. 
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Figure. A potential model of Bartonella infection cycle. Upon inoculation into the host, 
Bartonella initially enters migratory cells, such as DCs, for bacterial transport from the intradermal 
environment via lymphatic system to the primary niche, eventually culminating in their release to 
the bloodstream. Upon Bartonella infection, “semi-mature” DCs possess potential tolerogenic 
activities to subvert T cell response in the LNs. This induction of the semi-maturation observed in 
DCs is attributed to two effector proteins, BepA and BepD. The underlying mechanisms of BepA 
and BepD involve in distinct host signaling pathways, cAMP and STAT3, respectively. 
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